2-(4-chlorophenyl)-3-methylbutyric acid - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	2-(4-chlorophenyl)-3-methylbutyric acid	go back to main search page
Accession:	CHEBI:39345	browse the term
Definition:	A monocarboxylic acid consisting of isovaleric acid having a 4-chlorophenyl group at the 2-position.
Synonyms:	exact_synonym:	2-(4-chlorophenyl)-3-methylbutanoic acid
	related_synonym:	Formula=C11H13ClO2; InChI=1S/C11H13ClO2/c1-7(2)10(11(13)14)8-3-5-9(12)6-4-8/h3-7,10H,1-2H3,(H,13,14); InChIKey=VTJMSIIXXKNIDJ-UHFFFAOYSA-N; SMILES=CC(C)C(C(O)=O)c1ccc(Cl)cc1
	xref:	CAS:2012-74-0

show annotations for term's descendants Sort by:
Rat (1710) Mouse (1671) Human (1674) Chinchilla (0) Bonobo (0) Dog (0) Squirrel (0) Pig (0) Green Monkey (0) Naked Mole-rat (0) All
Genes (1710)

fenvalerate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

alpha-2-macroglobulin

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of A2M protein

NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786

G

alpha 1,3-galactosyltransferase 2

increases expression

fenvalerate results in increased expression of A3GALT2 mRNA

NCBI chr 5:141,101,329...141,113,760
Ensembl chr 5:141,107,983...141,115,641

G

AP2 associated kinase 1

increases expression

fenvalerate results in increased expression of AAK1 mRNA

NCBI chr 4:119,300,128...119,451,834
Ensembl chr 4:119,295,257...119,450,969

G

ATP binding cassette subfamily B member 1A

multiple interactions
decreases activity
decreases expression

fenvalerate inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]
fenvalerate results in decreased activity of ABCB1 protein
fenvalerate results in decreased expression of ABCB1A mRNA

PMID:21783720 PMID:30307764

NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709

G

ATP binding cassette subfamily B member 6

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ABCB6 protein

NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924

G

ATP binding cassette subfamily G member 1

increases expression

fenvalerate results in increased expression of ABCG1 mRNA

NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948

G

ATP binding cassette subfamily G member 4

increases expression

fenvalerate results in increased expression of ABCG4 mRNA

NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881

G

ATP binding cassette subfamily G member 5

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ABCG5 protein

NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563

G

ABHD11 antisense RNA 1 (tail to tail)

increases expression

fenvalerate results in increased expression of BICDL3P mRNA

NCBI chr12:21,681,118...21,682,106

G

abhydrolase domain containing 8

increases expression

fenvalerate results in increased expression of ABHD8 mRNA

NCBI chr16:18,144,464...18,151,201
Ensembl chr16:18,144,464...18,157,667

G

histo-blood group ABO system transferase 3

increases expression

fenvalerate results in increased expression of ABO3 mRNA

NCBI chr 3:9,743,861...9,761,049
Ensembl chr 3:9,646,515...9,761,043

G

ABR activator of RhoGEF and GTPase

increases expression

fenvalerate results in increased expression of ABR mRNA

NCBI chr10:61,262,516...61,461,331
Ensembl chr10:61,262,516...61,461,505

G

acetyl-CoA acetyltransferase 2

decreases expression

fenvalerate results in decreased expression of ACAT2 protein

NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821

G

acyl-CoA binding domain containing 4

increases expression

fenvalerate results in increased expression of ACBD4 mRNA

NCBI chr10:88,048,058...88,062,612
Ensembl chr10:88,048,108...88,058,500

G

angiotensin I converting enzyme

affects methylation

fenvalerate affects the methylation of ACE gene

NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131

G

acetylcholinesterase

multiple interactions
affects activity
decreases activity
increases activity

[cypermethrin co-treated with fenvalerate] results in decreased activity of ACHE protein
fenvalerate affects the activity of ACHE protein
fenvalerate results in decreased activity of ACHE protein
fenvalerate results in increased activity of ACHE protein

PMID:8385837 PMID:10355540 PMID:15186033

NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651

G

atypical chemokine receptor 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ACKR3 protein

NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237

G

acyl-CoA oxidase 1

increases activity

fenvalerate metabolite results in increased activity of ACOX1 protein

NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232

G

acyl-CoA synthetase bubblegum family member 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ACSBG2 protein

NCBI chr 9:1,683,846...1,715,517
Ensembl chr 9:1,683,847...1,714,518

G

acyl-CoA synthetase long-chain family member 1

increases expression

fenvalerate results in increased expression of ACSL1 mRNA

NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541

G

actinin, alpha 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ACTN1 protein

NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251

G

activin A receptor type 1C

increases expression

fenvalerate results in increased expression of ACVR1C mRNA

NCBI chr 3:42,815,490...42,892,423
Ensembl chr 3:42,822,610...42,892,327

G

ADAM metallopeptidase domain 2

increases expression

fenvalerate results in increased expression of ADAM2 mRNA

NCBI chr15:40,242,651...40,284,025
Ensembl chr15:40,242,783...40,283,952

G

ADAM metallopeptidase domain 22

increases expression

fenvalerate results in increased expression of ADAM22 mRNA

NCBI chr 4:25,716,055...25,970,932
Ensembl chr 4:25,715,990...25,964,962

G

ADAM metallopeptidase domain 23

increases expression

fenvalerate results in increased expression of ADAM23 mRNA

NCBI chr 9:64,862,649...65,009,718
Ensembl chr 9:64,862,878...65,006,515

G

ADAM metallopeptidase domain 7

increases expression

fenvalerate results in increased expression of ADAM7 mRNA

NCBI chr15:42,833,796...42,882,201
Ensembl chr15:42,833,796...42,882,201

G

ADAM metallopeptidase domain 8

increases expression

fenvalerate results in increased expression of ADAM8 mRNA

NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801

G

ADAM metallopeptidase with thrombospondin type 1 motif, 7

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ADAMTS7 protein

NCBI chr 8:90,704,727...90,744,333
Ensembl chr 8:90,704,727...90,744,328

G

adenosine deaminase, RNA-specific, B1

decreases expression

fenvalerate results in decreased expression of ADARB1 mRNA

NCBI chr20:11,222,569...11,350,854
Ensembl chr20:11,222,583...11,350,852

G

adenylate cyclase 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADCY2 protein

NCBI chr 1:34,375,639...34,822,252
Ensembl chr 1:34,375,895...34,822,236

G

adenylate cyclase 4

increases expression

fenvalerate results in increased expression of ADCY4 mRNA

NCBI chr15:29,266,280...29,282,153
Ensembl chr15:29,266,287...29,282,108

G

ADCYAP receptor type I

increases expression

fenvalerate results in increased expression of ADCYAP1R1 mRNA

NCBI chr 4:84,593,558...84,642,700
Ensembl chr 4:84,593,892...84,642,700

G

adducin 1

increases expression
multiple interactions

fenvalerate results in increased expression of ADD1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADD1 protein

PMID:30307764 PMID:34896426

NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182

G

adhesion G protein-coupled receptor B3

increases expression

fenvalerate results in increased expression of ADGRB3 mRNA

NCBI chr 9:27,421,168...28,148,979
Ensembl chr 9:27,421,168...28,148,855

G

adhesion G protein-coupled receptor G6

increases expression

fenvalerate results in increased expression of ADGRG6 mRNA

NCBI chr 1:8,812,889...8,954,239
Ensembl chr 1:8,812,904...8,954,123

G

adhesion G protein-coupled receptor L3

increases expression

fenvalerate results in increased expression of ADGRL3 mRNA

NCBI chr14:26,336,320...27,104,060
Ensembl chr14:26,368,277...27,105,860

G

adenosine A1 receptor

decreases expression

fenvalerate results in decreased expression of ADORA1 mRNA

NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801

G

adrenoceptor beta 3

increases expression

fenvalerate results in increased expression of ADRB3 mRNA

NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552

G

adenylosuccinate synthase 2

increases expression

fenvalerate results in increased expression of ADSS2 mRNA

NCBI chr13:89,769,240...89,799,577
Ensembl chr13:89,769,244...89,799,604

G

AE binding protein 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of AEBP1 protein

NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877

G

afadin, adherens junction formation factor

increases expression

fenvalerate results in increased expression of AFDN mRNA

NCBI chr 1:53,905,344...54,034,216
Ensembl chr 1:53,905,373...54,034,216

G

amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase

increases expression

fenvalerate results in increased expression of AGL mRNA

NCBI chr 2:204,705,053...204,760,966
Ensembl chr 2:204,705,053...204,760,828

G

1-acylglycerol-3-phosphate O-acyltransferase 3

increases expression

fenvalerate results in increased expression of AGPAT3 mRNA

NCBI chr20:10,330,960...10,415,358
Ensembl chr20:10,384,507...10,415,358

G

ATP/GTP binding carboxypeptidase 1

increases expression

fenvalerate results in increased expression of AGTPBP1 mRNA

NCBI chr17:5,120,540...5,238,874
Ensembl chr17:5,120,609...5,238,869

G

alanine-glyoxylate aminotransferase 2

increases expression

fenvalerate results in increased expression of AGXT2 mRNA

NCBI chr 2:59,336,252...59,377,664
Ensembl chr 2:59,336,283...59,377,926

G

allograft inflammatory factor 1-like

increases expression

fenvalerate results in increased expression of AIF1L mRNA

NCBI chr 3:15,229,476...15,254,033
Ensembl chr 3:15,229,524...15,254,023

G

apical junction component 1 homolog

increases expression

fenvalerate results in increased expression of AJM1 mRNA

NCBI chr 3:8,394,942...8,401,323
Ensembl chr 3:8,392,889...8,401,321

G

adenylate kinase 2

decreases expression

fenvalerate results in decreased expression of AK2 protein

NCBI chr 5:141,308,650...141,364,633
Ensembl chr 5:141,346,063...141,364,632

G

adenylate kinase 3

increases expression

fenvalerate results in increased expression of AK3 protein

NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625

G

adenylate kinase 5

increases expression

fenvalerate results in increased expression of AK5 mRNA

NCBI chr 2:241,397,297...241,581,483
Ensembl chr 2:241,397,297...241,581,458

G

adenylate kinase 7

decreases expression

fenvalerate results in decreased expression of AK7 mRNA

NCBI chr 6:124,611,789...124,679,978
Ensembl chr 6:124,611,902...124,679,961

G

A-kinase anchoring protein 1

increases expression

fenvalerate results in increased expression of AKAP1 mRNA

NCBI chr10:73,621,021...73,654,123
Ensembl chr10:73,621,883...73,653,896

G

A-kinase anchoring protein 13

increases expression

fenvalerate results in increased expression of AKAP13 mRNA

NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:129,314,402...129,619,646

G

A-kinase anchoring protein 14

increases expression

fenvalerate results in increased expression of AKAP14 mRNA

NCBI chr X:116,395,512...116,410,697
Ensembl chr X:116,395,516...116,410,697

G

A-kinase anchoring protein 3

increases expression

fenvalerate results in increased expression of AKAP3 mRNA

NCBI chr 4:159,688,049...159,714,067
Ensembl chr 4:159,699,289...159,713,903

G

A-kinase anchoring protein 5

decreases expression

fenvalerate results in decreased expression of AKAP5 mRNA

NCBI chr 6:95,051,527...95,061,075
Ensembl chr 6:95,051,537...95,061,578

G

A-kinase anchoring protein 7

increases expression

fenvalerate results in increased expression of AKAP7 mRNA

NCBI chr 1:20,087,190...20,217,799
Ensembl chr 1:20,087,373...20,217,797

G

AKT serine/threonine kinase 1

multiple interactions
increases phosphorylation

[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased phosphorylation of AKT1 protein
fenvalerate results in increased phosphorylation of AKT1 protein

NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921

G

AKT serine/threonine kinase 3

increases expression

fenvalerate results in increased expression of AKT3 mRNA

NCBI chr13:88,943,708...89,225,831
Ensembl chr13:88,946,091...89,225,708

G

albumin

decreases expression

fenvalerate results in decreased expression of ALB protein

NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836

G

aldehyde dehydrogenase 6 family, member A1

increases expression

fenvalerate results in increased expression of ALDH6A1 mRNA

NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656

G

aldolase, fructose-bisphosphate A

decreases expression

fenvalerate results in decreased expression of ALDOA protein

NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182

G

arachidonate 15-lipoxygenase

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ALOX15 protein

NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874

G

alpha-kinase 3

increases expression

fenvalerate results in increased expression of ALPK3 mRNA

NCBI chr 1:135,014,455...135,062,294
Ensembl chr 1:135,014,499...135,062,302

G

alkaline phosphatase, biomineralization associated

multiple interactions
increases activity

fenvalerate inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; fenvalerate inhibits the reaction [Progesterone results in increased activity of ALPL protein]
fenvalerate results in increased activity of ALPL protein

PMID:15696646 PMID:16326432 PMID:29149346

NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446

G

ALX homeobox 3

increases expression

fenvalerate results in increased expression of ALX3 mRNA

NCBI chr 2:195,231,197...195,241,609
Ensembl chr 2:195,231,197...195,241,609

G

amelogenin, X-linked

increases expression

fenvalerate results in increased expression of AMELX mRNA

NCBI chr X:25,076,362...25,087,660
Ensembl chr X:25,076,362...25,087,660

G

anti-Mullerian hormone

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of AMH mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of AMH mRNA

PMID:34896426 PMID:36053783

NCBI chr 7:8,906,776...8,909,192
Ensembl chr 7:8,906,836...8,909,282

G

antagonist of mitotic exit network 1 homolog

increases expression

fenvalerate results in increased expression of AMN1 mRNA

NCBI chr 4:182,155,140...182,182,085
Ensembl chr 4:182,155,142...182,182,016

G

androgen regulated protein

increases expression

fenvalerate results in increased expression of ANDPRO mRNA

NCBI chr 3:136,718,601...136,725,131
Ensembl chr 3:136,718,602...136,724,966

G

ankyrin 2

increases expression

fenvalerate results in increased expression of ANK2 mRNA

NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923

G

ankyrin repeat and EF-hand domain containing 1

increases expression

fenvalerate results in increased expression of ANKEF1 mRNA

NCBI chr 3:123,847,832...123,883,060
Ensembl chr 3:123,847,817...123,883,059

G

ANKH inorganic pyrophosphate transport regulator

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ANKH protein

NCBI chr 2:78,153,027...78,280,181
Ensembl chr 2:78,153,026...78,280,187

G

ankyrin repeat and IBR domain containing 1

increases expression

fenvalerate results in increased expression of ANKIB1 mRNA

NCBI chr 4:30,333,678...30,457,781
Ensembl chr 4:30,333,677...30,457,781

G

ankyrin repeat domain 1

increases expression

fenvalerate results in increased expression of ANKRD1 mRNA

NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919

G

ankyrin repeat domain 52

increases expression

fenvalerate results in increased expression of ANKRD52 mRNA

NCBI chr 7:806,829...820,481
Ensembl chr 7:806,767...820,481

G

ankyrin repeat domain 6

increases expression

fenvalerate results in increased expression of ANKRD6 mRNA

NCBI chr 5:47,197,981...47,343,183
Ensembl chr 5:47,202,873...47,343,090

G

ankyrin repeat domain 60

increases expression

fenvalerate results in increased expression of ANKRD60 mRNA

NCBI chr 3:162,365,158...162,376,491
Ensembl chr 3:162,364,896...162,375,596

G

ankyrin repeat domain 63

increases expression

fenvalerate results in increased expression of ANKRD63 mRNA

NCBI chr 3:105,675,148...105,679,970
Ensembl chr 3:105,663,638...105,682,404

G

ankyrin repeat domain 9

decreases expression

fenvalerate results in decreased expression of ANKRD9 mRNA

NCBI chr 6:130,001,914...130,008,792
Ensembl chr 6:129,998,486...130,008,923

G

anoctamin 3

increases expression

fenvalerate results in increased expression of ANO3 mRNA

NCBI chr 3:97,235,671...97,550,090
Ensembl chr 3:97,238,354...97,550,154

G

anoctamin 8

increases expression

fenvalerate results in increased expression of ANO8 mRNA

NCBI chr16:18,163,853...18,173,248
Ensembl chr16:18,163,843...18,173,545

G

anoctamin 9

increases expression

fenvalerate results in increased expression of ANO9 mRNA

NCBI chr 1:196,208,863...196,230,381
Ensembl chr 1:196,197,341...196,229,900

G

ANTXR cell adhesion molecule 1

increases expression

fenvalerate results in increased expression of ANTXR1 mRNA

NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:119,590,771...119,778,232

G

annexin A6

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ANXA6 protein

NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433

G

apolipoprotein D

increases expression

fenvalerate results in increased expression of APOD mRNA

NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305

G

apolipoprotein E

increases expression

fenvalerate results in increased expression of APOE mRNA

NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932

G

apolipoprotein L11a

increases expression

fenvalerate results in increased expression of APOL11A mRNA

NCBI chr 7:109,248,260...109,262,266
Ensembl chr 7:109,248,942...109,253,716

G

androgen receptor

multiple interactions
decreases activity
increases expression

[Dihydrotestosterone co-treated with fenvalerate] results in decreased expression of AR mRNA; Dihydrotestosterone inhibits the reaction [fenvalerate results in increased activity of AR protein]; fenvalerate inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]
fenvalerate results in decreased activity of AR protein
fenvalerate results in increased expression of AR protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of AR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of AR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of AR mRNA

PMID:15064155 PMID:16125883 PMID:16857237 PMID:20410157 PMID:21232584 More...

NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925

G

ADP-ribosylation factor 2

increases expression

fenvalerate results in increased expression of ARF2 mRNA

NCBI chr10:88,867,836...88,889,654
Ensembl chr10:88,867,836...88,889,659

G

arginase 2

increases expression

fenvalerate results in increased expression of ARG2 mRNA

NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378

G

Rho GTPase activating protein 10

increases expression

fenvalerate results in increased expression of ARHGAP10 mRNA

NCBI chr19:30,448,572...30,710,315
Ensembl chr19:30,448,637...30,710,313

G

Rho guanine nucleotide exchange factor 28

increases expression

fenvalerate results in increased expression of ARHGEF28 mRNA

NCBI chr 2:29,263,888...29,560,595
Ensembl chr 2:29,263,886...29,560,672

G

AT-rich interaction domain 3B

increases expression

fenvalerate results in increased expression of ARID3B mRNA

NCBI chr 8:58,193,268...58,240,901
Ensembl chr 8:58,193,418...58,238,318

G

ariadne RBR E3 ubiquitin protein ligase 1

increases expression

fenvalerate results in increased expression of ARIH1 mRNA

NCBI chr 8:59,777,378...59,879,762
Ensembl chr 8:59,777,379...59,880,245

G

arkadia C-terminal like ring finger ubiquitin ligase 2C

increases expression

fenvalerate results in increased expression of ARK2C mRNA

NCBI chr18:70,984,566...71,100,836
Ensembl chr18:70,989,731...71,100,836

G

ARF like GTPase 5C

increases expression

fenvalerate results in increased expression of ARL5C mRNA

NCBI chr10:82,985,213...82,993,425
Ensembl chr10:82,985,216...82,992,002

G

ARF like GTPase 8B

increases expression

fenvalerate results in increased expression of ARL8B mRNA

NCBI chr 4:141,748,634...141,792,605
Ensembl chr 4:141,748,587...141,792,596

G

ARF like GTPase 9

increases expression

fenvalerate results in increased expression of ARL9 mRNA

NCBI chr14:31,157,573...31,166,803
Ensembl chr14:31,157,586...31,166,699

G

armadillo repeat containing 5

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ARMC5 protein

NCBI chr 1:182,820,141...182,826,913
Ensembl chr 1:182,820,141...182,826,907

G

armadillo-like helical domain containing 4

increases expression

fenvalerate results in increased expression of ARMH4 mRNA

NCBI chr15:22,975,895...23,076,986
Ensembl chr15:22,975,895...23,076,949

G

aryl hydrocarbon receptor nuclear translocator 2

increases expression

fenvalerate results in increased expression of ARNT2 mRNA

NCBI chr 1:138,236,235...138,392,868
Ensembl chr 1:138,189,940...138,393,153

G

actin related protein 2/3 complex, subunit 1B

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of ARPC1B protein

NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747

G

arylsulfatase G

increases expression

fenvalerate results in increased expression of ARSG mRNA

NCBI chr10:94,412,261...94,551,224
Ensembl chr10:94,447,399...94,542,941

G

ADP-ribosyltransferase 1

increases expression

fenvalerate results in increased expression of ART1 mRNA

NCBI chr 1:156,478,096...156,487,172
Ensembl chr 1:156,482,621...156,487,172

G

aristaless related homeobox

increases expression

fenvalerate results in increased expression of ARX mRNA

NCBI chr X:58,016,233...58,028,149
Ensembl chr X:58,016,233...58,028,142

G

acid sensing ion channel subunit 2

increases expression

fenvalerate results in increased expression of ASIC2 mRNA

NCBI chr10:65,870,592...66,940,577
Ensembl chr10:65,870,594...66,940,424

G

acetylserotonin O-methyltransferase

increases expression

fenvalerate results in increased expression of ASMT mRNA

NCBI chr12:16,304,719...16,309,568
Ensembl chr12:16,304,719...16,309,568

G

aspartate beta-hydroxylase domain containing 1

increases expression

fenvalerate results in increased expression of ASPHD1 mRNA

NCBI chr 1:181,552,968...181,556,902
Ensembl chr 1:181,552,884...181,556,090

G

ASPSCR1 tether for SLC2A4, UBX domain containing

increases expression

fenvalerate results in increased expression of ASPSCR1 mRNA

NCBI chr10:105,952,215...105,990,059
Ensembl chr10:105,952,227...105,989,904

G

activating transcription factor 3

increases expression

fenvalerate results in increased expression of ATF3 mRNA

NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631

G

atrophin 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ATN1 protein

NCBI chr 4:157,554,287...157,568,092
Ensembl chr 4:157,551,276...157,568,132

G

atos homolog A

increases expression

fenvalerate results in increased expression of ATOSA mRNA

NCBI chr 8:75,694,828...75,772,565
Ensembl chr 8:75,695,022...75,772,549

G

ATPase Na+/K+ transporting subunit alpha 4

increases expression

fenvalerate results in increased expression of ATP1A4 mRNA

NCBI chr13:84,683,766...84,719,790
Ensembl chr13:84,683,768...84,719,687

G

ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ATP2A1 protein

NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838

G

ATPase plasma membrane Ca2+ transporting 3

increases expression

fenvalerate results in increased expression of ATP2B3 mRNA

NCBI chr X:151,216,483...151,289,069
Ensembl chr X:151,216,507...151,286,775

G

ATPase plasma membrane Ca2+ transporting 4

increases expression

fenvalerate results in increased expression of ATP2B4 mRNA

NCBI chr13:45,156,137...45,255,292
Ensembl chr13:45,156,146...45,255,246

G

ATPase secretory pathway Ca2+ transporting 1

increases expression

fenvalerate results in increased expression of ATP2C1 mRNA

NCBI chr 8:106,034,777...106,155,854
Ensembl chr 8:106,034,636...106,156,006

G

ATP synthase F1 subunit alpha

decreases expression

fenvalerate results in decreased expression of ATP5F1A protein

NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794

G

ATPase H+ transporting V0 subunit a4

increases expression

fenvalerate results in increased expression of ATP6V0A4 mRNA

NCBI chr 4:66,760,163...66,842,126
Ensembl chr 4:66,760,159...66,842,110

G

ATPase H+ transporting V1 subunit C2

increases expression

fenvalerate results in increased expression of ATP6V1C2 mRNA

NCBI chr 6:40,080,545...40,144,199
Ensembl chr 6:40,080,547...40,120,028

G

ATPase H+ transporting V1 subunit G3

increases expression

fenvalerate results in increased expression of ATP6V1G3 mRNA

NCBI chr13:49,800,256...49,825,247
Ensembl chr13:49,794,222...49,825,247

G

ATPase phospholipid transporting 8B2

increases expression

fenvalerate results in increased expression of ATP8B2 mRNA

NCBI chr 2:175,378,514...175,402,265
Ensembl chr 2:175,378,517...175,401,883

G

ataxin 1

increases expression

fenvalerate results in increased expression of ATXN1 mRNA

NCBI chr17:18,737,491...19,142,360
Ensembl chr17:18,737,533...19,142,360

G

aurora kinase A and ninein interacting protein

increases expression

fenvalerate results in increased expression of AUNIP mRNA

NCBI chr 5:146,722,329...146,734,924
Ensembl chr 5:146,722,337...146,736,501

G

aurora kinase A

increases expression

fenvalerate results in increased expression of AURKA mRNA

NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390

G

aurora kinase C

increases expression

fenvalerate results in increased expression of AURKC mRNA

NCBI chr 1:66,843,653...66,849,775
Ensembl chr 1:66,843,653...66,864,386

G

activator of transcription and developmental regulator AUTS2

increases expression

fenvalerate results in increased expression of AUTS2 mRNA

NCBI chr12:24,104,187...25,194,123
Ensembl chr12:24,104,192...25,194,416

G

advillin

increases expression
multiple interactions

fenvalerate results in increased expression of AVIL mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of AVIL protein

PMID:30307764 PMID:34896426

NCBI chr 7:62,825,459...62,844,103
Ensembl chr 7:62,826,025...62,844,071

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5

increases expression

fenvalerate results in increased expression of B3GNT5 mRNA

NCBI chr11:81,141,102...81,153,206
Ensembl chr11:81,140,599...81,156,166

G

BAALC binder of MAP3K1 and KLF4

increases expression

fenvalerate results in increased expression of BAALC mRNA

NCBI chr 7:69,918,998...69,992,289
Ensembl chr 7:69,918,998...69,992,288

G

BRISC and BRCA1 A complex member 2

increases expression

fenvalerate results in increased expression of BABAM2 mRNA

NCBI chr 6:24,369,021...24,788,416
Ensembl chr 6:24,369,022...24,833,951

G

brain abundant, membrane attached signal protein 1

increases expression

fenvalerate results in increased expression of BASP1 mRNA

NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043

G

BCL2 associated X, apoptosis regulator

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BAX mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BAX mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of BAX mRNA

PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368

G

bromodomain adjacent to zinc finger domain, 1A

increases expression

fenvalerate results in increased expression of BAZ1A mRNA

NCBI chr 6:72,389,701...72,512,516
Ensembl chr 6:72,389,703...72,512,459

G

bromodomain adjacent to zinc finger domain, 1B

increases expression

fenvalerate results in increased expression of BAZ1B mRNA

NCBI chr12:21,431,985...21,489,956
Ensembl chr12:21,431,985...21,490,426

G

Bardet-Biedl syndrome 7

increases expression

fenvalerate results in increased expression of BBS7 mRNA

NCBI chr 2:119,434,760...119,474,665
Ensembl chr 2:119,434,760...119,474,396

G

brevican

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BCAN protein

NCBI chr 2:173,454,479...173,467,717
Ensembl chr 2:173,454,482...173,467,460

G

BCAS3, microtubule associated cell migration factor

increases expression

fenvalerate results in increased expression of BCAS3 mRNA

NCBI chr10:70,213,710...70,673,080
Ensembl chr10:70,214,098...70,673,080

G

BCL2, apoptosis regulator

multiple interactions

[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of BCL2 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BCL2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of BCL2 mRNA

PMID:28949029 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743

G

Bcl2-like 1

multiple interactions

[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of BCL2L1 protein

NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479

G

bradykinin receptor B2

increases expression

fenvalerate results in increased expression of BDKRB2 mRNA

NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497

G

brain-derived neurotrophic factor

increases expression
decreases expression

fenvalerate results in increased expression of BDNF mRNA
fenvalerate results in decreased expression of BDNF mRNA

PMID:16166269 PMID:34358930

NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615

G

BEN domain containing 4

increases expression

fenvalerate results in increased expression of BEND4 mRNA

NCBI chr14:40,753,048...40,788,686
Ensembl chr14:40,753,077...40,783,504

G

brain expressed X-linked 2

increases expression

fenvalerate results in increased expression of BEX1 mRNA

NCBI chr X:99,019,847...99,021,375
Ensembl chr X:99,019,000...99,021,503

G

beaded filament structural protein 1

increases expression

fenvalerate results in increased expression of BFSP1 mRNA

NCBI chr 3:131,195,087...131,252,668
Ensembl chr 3:131,195,087...131,229,337

G

BH3 interacting domain death agonist

multiple interactions

[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in decreased expression of BID protein

NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720

G

beta-galactosidase-like protein

increases expression

fenvalerate results in increased expression of BIN2A mRNA

NCBI chr 8:25,248,570...25,287,173
Ensembl chr 8:25,248,570...25,287,173

G

bone morphogenetic protein 6

increases expression

fenvalerate results in increased expression of BMP6 mRNA

NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365

G

bisphosphoglycerate mutase

decreases expression

fenvalerate results in decreased expression of BPGM protein

NCBI chr 4:63,139,730...63,168,581
Ensembl chr 4:63,140,018...63,168,581

G

BPI fold containing family B, member 2

increases expression

fenvalerate results in increased expression of BPIFB2 mRNA

NCBI chr 3:142,356,990...142,377,053
Ensembl chr 3:142,358,051...142,377,044

G

BRCA1, DNA repair associated

affects binding
increases expression
multiple interactions

fenvalerate binds to BRCA1 protein
fenvalerate results in increased expression of BRCA1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRCA1 protein

PMID:30307764 PMID:32278787 PMID:34896426

NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304

G

bromodomain testis associated

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRDT protein

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr14:2,387,372...2,445,857
Ensembl chr14:2,387,796...2,445,842

G

BRF1 general transcription factor IIIB subunit

decreases expression

fenvalerate results in decreased expression of BRF1 mRNA

NCBI chr 6:132,034,378...132,081,313
Ensembl chr 6:132,037,272...132,081,278

G

BMP/retinoic acid inducible neural specific 2

increases expression

fenvalerate results in increased expression of BRINP2 mRNA

NCBI chr13:70,431,006...70,532,766
Ensembl chr13:70,431,010...70,531,810

G

BMP/retinoic acid inducible neural specific 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRINP3 protein

NCBI chr13:58,413,883...58,846,828
Ensembl chr13:58,413,883...58,846,770

G

C1q and TNF related 4

increases expression

fenvalerate results in increased expression of C1QTNF4 mRNA

NCBI chr 3:76,854,368...76,872,991
Ensembl chr 3:76,857,735...76,874,139

G

similar to human chromosome 1 open reading frame 52

decreases expression

fenvalerate results in decreased expression of C2H1ORF52 mRNA

NCBI chr 2:234,853,378...234,860,045
Ensembl chr 2:234,853,410...234,860,040

G

complement C3

affects expression
multiple interactions

fenvalerate affects the expression of C3 protein
fenvalerate affects the expression of and results in increased activity of C3 protein

NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429

G

complement C3a receptor 1

increases expression

fenvalerate results in increased expression of C3AR1 mRNA

NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701

G

calcium binding protein, spermatid associated 1

increases expression

fenvalerate results in increased expression of CABS1 mRNA

NCBI chr14:20,096,962...20,099,024
Ensembl chr14:20,096,899...20,099,181

G

calcium voltage-gated channel subunit alpha1 A

increases expression

fenvalerate results in increased expression of CACNA1A mRNA

NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225

G

calcium voltage-gated channel subunit alpha1 B

increases expression

fenvalerate results in increased expression of CACNA1B mRNA

NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091

G

calcium voltage-gated channel subunit alpha1 C

increases expression
multiple interactions

fenvalerate results in increased expression of CACNA1C mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA1C protein

PMID:30307764 PMID:34896426

NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648

G

calcium voltage-gated channel subunit alpha1 S

increases expression
multiple interactions

fenvalerate results in increased expression of CACNA1S mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA1S protein

PMID:30307764 PMID:34896426

NCBI chr13:47,493,949...47,564,194
Ensembl chr13:47,493,949...47,564,318

G

calcium voltage-gated channel auxiliary subunit alpha2delta 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA2D1 protein

NCBI chr 4:18,950,611...19,374,969
Ensembl chr 4:18,951,002...19,374,969

G

calcium voltage-gated channel auxiliary subunit beta 2

increases expression

fenvalerate results in increased expression of CACNB2 mRNA

NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106

G

calcium voltage-gated channel auxiliary subunit beta 4

increases expression

fenvalerate results in increased expression of CACNB4 mRNA

NCBI chr 3:36,906,771...37,169,165
Ensembl chr 3:36,910,427...37,168,944

G

calcium voltage-gated channel auxiliary subunit gamma 5

increases expression

fenvalerate results in increased expression of CACNG5 mRNA

NCBI chr10:92,827,441...92,869,632
Ensembl chr10:92,829,196...92,869,614

G

calcium voltage-gated channel auxiliary subunit gamma 7

increases expression

fenvalerate results in increased expression of CACNG7 mRNA

NCBI chr 1:65,800,059...65,831,246
Ensembl chr 1:65,800,355...65,831,006

G

calcitonin-related polypeptide alpha

increases expression

fenvalerate results in increased expression of CALCA mRNA

NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105

G

calcitonin receptor

increases expression

fenvalerate results in increased expression of CALCR mRNA

NCBI chr 4:31,661,270...31,736,392
Ensembl chr 4:31,661,273...31,736,392

G

calcium homeostasis modulator family member 6

increases expression

fenvalerate results in increased expression of CALHM6 mRNA

NCBI chr20:26,095,591...26,097,336
Ensembl chr20:26,095,592...26,097,278

G

calmodulin 1

increases expression

fenvalerate results in increased expression of CALM1 mRNA; fenvalerate results in increased expression of CALM1 protein

NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227

G

calcium/calmodulin-dependent protein kinase IG

increases expression

fenvalerate results in increased expression of CAMK1G mRNA

NCBI chr13:104,877,909...104,901,658
Ensembl chr13:104,877,910...104,901,556

G

calcium/calmodulin-dependent protein kinase kinase 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CAMKK1 protein

NCBI chr10:57,637,335...57,660,498
Ensembl chr10:57,637,391...57,660,498

G

calcium/calmodulin-dependent protein kinase kinase 2

increases expression

fenvalerate results in increased expression of CAMKK2 mRNA

NCBI chr12:33,791,023...33,845,000
Ensembl chr12:33,791,052...33,843,279

G

CaM kinase-like vesicle-associated

increases expression

fenvalerate results in increased expression of CAMKV mRNA

NCBI chr 8:108,626,821...108,641,169
Ensembl chr 8:108,626,821...108,641,169

G

calmodulin regulated spectrin-associated protein 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CAMSAP1 protein

NCBI chr 3:8,746,176...8,806,067
Ensembl chr 3:8,746,176...8,806,072

G

calpain 10

increases expression

fenvalerate results in increased expression of CAPN10 mRNA

NCBI chr 9:93,498,132...93,510,494
Ensembl chr 9:93,498,478...93,510,494

G

calpain 3

increases expression

fenvalerate results in increased expression of CAPN3 mRNA

NCBI chr 3:107,407,518...107,457,858
Ensembl chr 3:107,407,850...107,457,858

G

calpain 8

increases expression

fenvalerate results in increased expression of CAPN8 mRNA

NCBI chr13:94,252,218...94,316,146
Ensembl chr13:94,253,054...94,316,146

G

cell cycle associated protein 1

increases expression

fenvalerate results in increased expression of CAPRIN1 mRNA

NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502

G

carbonic anhydrase 2

decreases expression

fenvalerate results in decreased expression of CAR2 protein

NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818

G

carbonic anhydrase 6

decreases expression

fenvalerate results in decreased expression of CA6 mRNA

NCBI chr 5:160,658,104...160,676,644
Ensembl chr 5:160,658,105...160,676,644

G

capping protein regulator and myosin 1 linker 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CARMIL3 protein

NCBI chr15:28,978,440...28,995,865
Ensembl chr15:28,979,007...28,996,225

G

CASC3 exon junction complex subunit

increases expression

fenvalerate results in increased expression of CASC3 mRNA

NCBI chr10:83,769,014...83,788,966
Ensembl chr10:83,769,001...83,788,966

G

caspase 3

multiple interactions
increases cleavage

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]]; [U 0126 co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] inhibits the reaction [fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]]; fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]; U 0126 promotes the reaction [fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]]
fenvalerate results in increased cleavage of CASP3 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CASP3 mRNA; CAT protein inhibits the reaction [fenvalerate results in increased cleavage of CASP3 protein]

PMID:28949029 PMID:30307764 PMID:34896426

NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648

G

caspase 9

increases expression
multiple interactions

fenvalerate results in increased expression of CASP9 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CASP9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CASP9 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of CASP9 mRNA

PMID:30307764 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626

G

castor zinc finger 1

increases expression

fenvalerate results in increased expression of CASZ1 mRNA

NCBI chr 5:159,243,965...159,393,935
Ensembl chr 5:159,243,995...159,393,400

G

catalase

multiple interactions
decreases activity
increases activity

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the activity of CAT protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased activity of CAT protein; [cypermethrin co-treated with fenvalerate] results in increased activity of CAT protein; CAT protein inhibits the reaction [fenvalerate results in increased cleavage of CASP3 protein]; CAT protein inhibits the reaction [fenvalerate results in increased cleavage of PARP1 protein]
fenvalerate metabolite results in decreased activity of CAT protein; fenvalerate results in decreased activity of CAT protein
fenvalerate results in increased activity of CAT protein

PMID:10355540 PMID:15892188 PMID:30307764 PMID:33396045 PMID:35678313

NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478

G

core-binding factor subunit beta

increases expression

fenvalerate results in increased expression of CBFB mRNA

NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751

G

cobalamin binding intrinsic factor

increases expression

fenvalerate results in increased expression of CBLIF mRNA

NCBI chr 1:208,605,983...208,620,231
Ensembl chr 1:208,605,983...208,620,344

G

cerebellin 1 precursor

increases expression

fenvalerate results in increased expression of CBLN1 mRNA

NCBI chr19:19,608,763...19,612,572
Ensembl chr19:19,608,716...19,612,572

G

coiled-coil and C2 domain containing 1A

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CC2D1A protein

NCBI chr19:24,011,897...24,026,937
Ensembl chr19:24,011,938...24,026,936

G

coiled-coil and C2 domain containing 2A

increases expression

fenvalerate results in increased expression of CC2D2A mRNA

NCBI chr14:67,349,004...67,435,883
Ensembl chr14:67,351,353...67,435,949

G

coiled-coil domain containing 127

increases expression

fenvalerate results in increased expression of CCDC127 mRNA

NCBI chr 1:28,928,420...28,935,885
Ensembl chr 1:28,928,325...28,935,893

G

coiled-coil domain containing 13

increases expression

fenvalerate results in increased expression of CCDC13 mRNA

NCBI chr 8:121,455,202...121,507,487
Ensembl chr 8:121,457,697...121,502,337

G

coiled-coil domain containing 25

increases expression

fenvalerate results in increased expression of CCDC25 mRNA

NCBI chr15:40,055,368...40,087,758
Ensembl chr15:40,055,368...40,087,758

G

coiled-coil domain containing 30

increases expression

fenvalerate results in increased expression of CCDC30 mRNA

NCBI chr 5:132,926,767...133,019,635
Ensembl chr 5:132,926,615...133,019,659

G

coiled-coil domain containing 65

increases expression

fenvalerate results in increased expression of CCDC65 mRNA

NCBI chr 7:129,857,118...129,870,803
Ensembl chr 7:129,857,247...129,870,803

G

cholecystokinin A receptor

increases expression

fenvalerate results in increased expression of CCKAR mRNA

NCBI chr14:57,292,397...57,300,747
Ensembl chr14:57,292,397...57,300,747

G

C-C motif chemokine ligand 2

decreases expression

fenvalerate results in decreased expression of CCL2 mRNA

NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226

G

C-C motif chemokine ligand 3

increases expression

fenvalerate results in increased expression of CCL3 mRNA

NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938

G

C-C motif chemokine ligand 7

increases expression

fenvalerate results in increased expression of CCL7 mRNA

NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303

G

cellular communication network factor 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CCN1 protein

NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484

G

cellular communication network factor 4

increases expression

fenvalerate results in increased expression of CCN4 mRNA

NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248

G

cellular communication network factor 5

increases expression

fenvalerate results in increased expression of CCN5 mRNA

NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636

G

cyclin A2

increases expression

fenvalerate results in increased expression of CCNA2 mRNA

NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577

G

C-C motif chemokine receptor like 2

increases expression

fenvalerate results in increased expression of CCRL2 mRNA

NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664

G

coiled-coil serine-rich protein 2

decreases expression

fenvalerate results in decreased expression of CCSER2 mRNA

NCBI chr16:12,613,103...12,725,764
Ensembl chr16:12,613,103...12,725,738

G

chaperonin containing TCP1 subunit 3

decreases expression

fenvalerate results in decreased expression of CCT3 protein

NCBI chr 2:173,765,701...173,790,353
Ensembl chr 2:173,765,698...173,790,757

G

chaperonin containing TCP1 subunit 8

increases expression

fenvalerate results in increased expression of CCT8 protein

NCBI chr11:26,710,370...26,722,079
Ensembl chr11:26,710,370...26,722,079

G

CD24 molecule

increases expression

fenvalerate results in increased expression of CD24 mRNA

NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662

G

Cd28 molecule

increases expression

fenvalerate results in increased expression of CD28 mRNA

NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685

G

CD36 molecule

decreases expression

fenvalerate results in decreased expression of CD36 mRNA

NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903

G

CD38 molecule

increases expression

fenvalerate results in increased expression of CD38 mRNA

NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986

G

CD9 molecule

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CD9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CD9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CD9 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222

G

cell division cycle 45

increases expression

fenvalerate results in increased expression of CDC45 mRNA

NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619

G

cadherin 11

increases expression

fenvalerate results in increased expression of CDH11 mRNA

NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272

G

cadherin 13

increases expression

fenvalerate results in increased expression of CDH13 mRNA

NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459

G

cadherin 22

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CDH22 protein

NCBI chr 3:153,845,563...153,970,630
Ensembl chr 3:153,845,787...153,970,588

G

cadherin-related 23

increases expression

fenvalerate results in increased expression of CDH23 mRNA

NCBI chr20:28,240,643...28,622,490
Ensembl chr20:28,240,645...28,622,419

G

cyclin-dependent kinase 13

increases expression

fenvalerate results in increased expression of CDK13 mRNA

NCBI chr17:47,251,145...47,344,675
Ensembl chr17:47,251,163...47,341,721

G

cyclin dependent kinase 2

increases expression
multiple interactions
affects binding

fenvalerate results in increased expression of CDK2 mRNA
CDKN1B protein inhibits the reaction [fenvalerate results in increased expression of CDK2 mRNA]
fenvalerate binds to CDK2 protein

PMID:22850687 PMID:32278787

NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403

G

CDK5 regulatory subunit associated protein 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CDK5RAP2 protein

NCBI chr 5:83,792,282...83,961,129
Ensembl chr 5:83,792,284...83,960,782

G

cyclin-dependent kinase 6

increases expression

fenvalerate results in increased expression of CDK6 mRNA

NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634

G

cyclin-dependent kinase 9

increases expression

fenvalerate results in increased expression of CDK9 mRNA

NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:15,996,468...16,002,410

G

cyclin-dependent kinase inhibitor 1A

increases expression

fenvalerate results in increased expression of CDKN1A mRNA

NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585

G

cyclin-dependent kinase inhibitor 1B

multiple interactions
decreases expression
decreases response to substance

CDKN1B protein inhibits the reaction [fenvalerate results in increased expression of CDK2 mRNA]
fenvalerate results in decreased expression of CDKN1B mRNA; fenvalerate results in decreased expression of CDKN1B protein
CDKN1B protein results in decreased susceptibility to fenvalerate

NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982

G

CCAAT/enhancer binding protein epsilon

increases expression

fenvalerate results in increased expression of CEBPE mRNA

NCBI chr15:28,169,711...28,171,471
Ensembl chr15:28,169,704...28,171,814

G

chymotrypsin like elastase 1

decreases expression

fenvalerate results in decreased expression of CELA1 mRNA

NCBI chr 7:131,773,161...131,786,300
Ensembl chr 7:131,742,002...131,786,285

G

CUGBP, Elav-like family member 5

increases expression

fenvalerate results in increased expression of CELF5 mRNA

NCBI chr 7:8,225,787...8,250,322
Ensembl chr 7:8,225,825...8,250,322

G

centromere protein F

decreases expression

fenvalerate results in decreased expression of CENPF protein

NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669

G

centromere protein T

increases expression

fenvalerate results in increased expression of CENPT mRNA

NCBI chr19:33,734,684...33,741,159
Ensembl chr19:33,734,685...33,741,142

G

centromere protein X

decreases expression

fenvalerate results in decreased expression of CENPX mRNA

NCBI chr10:105,991,469...105,994,310

G

centrosomal protein 126

increases expression

fenvalerate results in increased expression of CEP126 mRNA

NCBI chr 8:5,200,576...5,267,740
Ensembl chr 8:5,218,509...5,267,467

G

centrosomal protein 350

increases expression

fenvalerate results in increased expression of CEP350 mRNA

NCBI chr13:68,023,327...68,164,478
Ensembl chr13:68,026,891...68,165,214

G

centrosomal protein 68

increases expression

fenvalerate results in increased expression of CEP68 mRNA

NCBI chr14:94,447,973...94,470,533
Ensembl chr14:94,449,055...94,470,517

G

centrosomal protein 76

increases expression

fenvalerate results in increased expression of CEP76 mRNA

NCBI chr18:61,174,514...61,208,512
Ensembl chr18:61,178,310...61,208,504

G

CERK like autophagy regulator

increases expression

fenvalerate results in increased expression of CERKL mRNA

NCBI chr 3:64,238,714...64,344,695
Ensembl chr 3:64,237,522...64,340,675

G

carboxylesterase 1D

increases metabolic processing

CES1 protein results in increased metabolism of fenvalerate

NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035

G

carboxylesterase 2E

affects metabolic processing

CES2E protein affects the metabolism of fenvalerate

NCBI chr19:157,447...172,822
Ensembl chr19:157,407...172,856

G

cilia and flagella associated protein 100

increases expression

fenvalerate results in increased expression of CFAP100 mRNA

NCBI chr 4:122,914,693...122,938,994
Ensembl chr 4:122,914,698...122,938,580

G

cilia and flagella associated protein 144

increases expression

fenvalerate results in increased expression of CFAP144 mRNA

NCBI chr10:43,509,823...43,519,693
Ensembl chr10:43,509,826...43,520,086

G

cilia and flagella associated protein 161

decreases expression

fenvalerate results in decreased expression of CFAP161 protein

NCBI chr 1:137,743,783...137,768,685
Ensembl chr 1:137,743,784...137,768,730

G

cilia and flagella associated protein 300

decreases expression

fenvalerate results in decreased expression of CFAP300 protein

NCBI chr 8:5,180,180...5,198,840
Ensembl chr 8:5,180,675...5,198,807

G

complement factor B

decreases expression

fenvalerate results in decreased expression of CFB protein

NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505

G

cripto, FRL-1, cryptic family 1

increases expression

fenvalerate results in increased expression of CFC1 mRNA

NCBI chr 9:36,742,106...36,751,931
Ensembl chr 9:36,739,071...36,751,930

G

craniofacial development protein 1

increases expression

fenvalerate results in increased expression of CFDP1 mRNA

NCBI chr19:39,718,313...39,823,824
Ensembl chr19:39,718,347...39,823,824

G

CF transmembrane conductance regulator

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CFTR protein

NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756

G

chromatin assembly factor 1 subunit B

increases expression

fenvalerate results in increased expression of CHAF1B mRNA

NCBI chr11:33,200,894...33,221,076
Ensembl chr11:33,200,981...33,221,070

G

chromodomain helicase DNA binding protein 7

increases expression

fenvalerate results in increased expression of CHD7 mRNA

NCBI chr 5:21,812,007...21,995,358
Ensembl chr 5:21,812,070...21,995,358

G

checkpoint kinase 2

increases expression

fenvalerate results in increased expression of CHEK2 mRNA

NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286

G

CHM Rab escort protein

increases expression

fenvalerate results in increased expression of CHM mRNA

NCBI chr X:78,203,200...78,361,996
Ensembl chr X:78,203,204...78,361,943

G

cholinergic receptor nicotinic alpha 3 subunit

increases expression

fenvalerate results in increased expression of CHRNA3 mRNA

NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165

G

cholinergic receptor nicotinic alpha 9 subunit

increases expression

fenvalerate results in increased expression of CHRNA9 mRNA

NCBI chr14:42,235,218...42,241,939
Ensembl chr14:42,235,226...42,242,192

G

cholinergic receptor nicotinic beta 1 subunit

increases expression

fenvalerate results in increased expression of CHRNB1 mRNA

NCBI chr10:54,501,096...54,516,418
Ensembl chr10:54,501,093...54,516,345

G

cholinergic receptor nicotinic epsilon subunit

increases expression

fenvalerate results in increased expression of CHRNE mRNA

NCBI chr10:55,331,211...55,339,923
Ensembl chr10:55,331,212...55,335,530

G

carbohydrate sulfotransferase 5

increases expression

fenvalerate results in increased expression of CHST5 mRNA

NCBI chr19:39,860,729...39,881,019
Ensembl chr19:39,860,501...39,881,064

G

class II, major histocompatibility complex, transactivator

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CIITA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CIITA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CIITA mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of CIITA mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440

G

ciliary microtubule associated protein 3

increases expression

fenvalerate results in increased expression of CIMAP3 mRNA

NCBI chr 2:193,475,785...193,493,092
Ensembl chr 2:193,475,782...193,493,139

G

cold inducible RNA binding protein

decreases expression

fenvalerate results in decreased expression of CIRBP mRNA

NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818

G

cytokine inducible SH2-containing protein

increases expression

fenvalerate results in increased expression of CISH mRNA

NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250

G

cytoskeleton-associated protein 4

increases expression

fenvalerate results in increased expression of CKAP4 mRNA

NCBI chr 7:19,230,814...19,238,914
Ensembl chr 7:19,230,203...19,238,914

G

CLK4-associating serine/arginine rich protein

increases expression

fenvalerate results in increased expression of CLASRP mRNA

NCBI chr 1:79,232,260...79,256,462
Ensembl chr 1:79,232,261...79,256,354

G

claudin 10

increases expression

fenvalerate results in increased expression of CLDN10 mRNA

NCBI chr15:95,862,785...95,954,526
Ensembl chr15:95,862,760...95,954,526

G

C-type lectin domain containing 16A

decreases expression

fenvalerate results in decreased expression of CLEC16A mRNA

NCBI chr10:4,927,799...5,123,749
Ensembl chr10:4,928,030...5,123,578

G

chloride intracellular channel 4

increases expression

fenvalerate results in increased expression of CLIC4 mRNA

NCBI chr 5:147,453,702...147,513,455
Ensembl chr 5:147,453,712...147,513,452

G

clathrin heavy chain

increases expression

fenvalerate results in increased expression of CLTC mRNA

NCBI chr10:71,517,661...71,574,591
Ensembl chr10:71,517,663...71,573,737

G

clusterin

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CLU mRNA

NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315

G

chymase 1

increases expression

fenvalerate results in increased expression of CMA1 mRNA

NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233

G

chemerin chemokine-like receptor 1

increases expression

fenvalerate results in increased expression of CMKLR1 mRNA

NCBI chr12:42,974,462...43,027,321
Ensembl chr12:42,974,410...43,028,129

G

CKLF-like MARVEL transmembrane domain containing 4

increases expression

fenvalerate results in increased expression of CMTM4 mRNA

NCBI chr19:576,203...616,109
Ensembl chr19:576,203...616,109

G

cyclic nucleotide binding domain containing 2

increases expression

fenvalerate results in increased expression of CNBD2 mRNA

NCBI chr 3:144,819,166...144,884,825
Ensembl chr 3:144,819,195...144,901,583

G

cyclic nucleotide gated channel subunit beta 1

increases expression

fenvalerate results in increased expression of CNGB1 mRNA

NCBI chr19:9,726,595...9,791,111
Ensembl chr19:9,726,595...9,791,173

G

chondromodulin

increases expression

fenvalerate results in increased expression of CNMD mRNA

NCBI chr15:55,041,548...55,066,297
Ensembl chr15:55,041,561...55,066,297

G

CCR4-NOT transcription complex, subunit 6

increases expression

fenvalerate results in increased expression of CNOT6 mRNA

NCBI chr10:33,978,785...34,031,025
Ensembl chr10:33,980,831...34,031,025

G

consortin, connexin sorting protein

increases expression

fenvalerate results in increased expression of CNST mRNA

PMID:23397585 PMID:30307764

NCBI chr13:91,296,740...91,373,531
Ensembl chr13:91,296,142...91,373,531

G

ciliary neurotrophic factor receptor

increases expression

fenvalerate results in increased expression of CNTFR mRNA

NCBI chr 5:56,823,448...56,861,049
Ensembl chr 5:56,823,965...56,841,392

G

contactin 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CNTN3 protein

NCBI chr 4:134,841,268...135,214,460
Ensembl chr 4:134,842,266...135,125,613

G

collagen type X alpha 1 chain

decreases expression

fenvalerate results in decreased expression of COL10A1 mRNA

NCBI chr20:38,183,103...38,189,488
Ensembl chr20:38,182,494...38,189,494

G

collagen type I alpha 1 chain

increases expression

fenvalerate results in increased expression of COL1A1 mRNA

NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624

G

collagen type XXIII alpha 1 chain

increases expression

fenvalerate results in increased expression of COL23A1 mRNA

NCBI chr10:35,549,090...35,839,152
Ensembl chr10:35,549,113...35,836,314

G

collagen type XXVII alpha 1 chain

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of COL27A1 protein

NCBI chr 5:76,647,302...76,765,989
Ensembl chr 5:76,647,429...76,765,174

G

collagen type II alpha 1 chain

increases expression

fenvalerate results in increased expression of COL2A1 mRNA

NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546

G

collagen type V alpha 3 chain

increases expression

fenvalerate results in increased expression of COL5A3 mRNA

NCBI chr 8:19,304,564...19,349,809
Ensembl chr 8:19,304,571...19,349,853

G

collectin sub-family member 12

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of COLEC12 protein

NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618

G

COP1, E3 ubiquitin ligase

increases expression

fenvalerate results in increased expression of COP1 mRNA

NCBI chr13:71,467,164...71,561,826
Ensembl chr13:71,429,961...71,538,890

G

COP9 signalosome subunit 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of COPS2 protein

NCBI chr 3:113,084,174...113,110,090
Ensembl chr 3:113,084,176...113,109,947

G

COP9 signalosome subunit 7B

increases expression

fenvalerate results in increased expression of COPS7B mRNA

NCBI chr 9:87,238,132...87,263,967
Ensembl chr 9:87,238,375...87,263,967

G

cytochrome c oxidase subunit 5A

increases expression

fenvalerate results in increased expression of COX5A protein

NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781

G

cytochrome c oxidase subunit 6B2

increases expression

fenvalerate results in increased expression of COX6B2 mRNA

NCBI chr 1:69,094,009...69,095,312

G

carboxypeptidase A1

increases expression

fenvalerate results in increased expression of CPA1 mRNA

NCBI chr 4:59,257,417...59,263,544
Ensembl chr 4:59,257,417...59,263,544

G

carboxypeptidase A3

increases expression

fenvalerate results in increased expression of CPA3 mRNA

NCBI chr 2:102,712,483...102,744,219
Ensembl chr 2:102,712,589...102,744,203

G

cytoplasmic polyadenylation element binding protein 1

increases expression

fenvalerate results in increased expression of CPEB1 mRNA

NCBI chr 1:135,300,048...135,407,688
Ensembl chr 1:135,300,461...135,409,760

G

ciliogenesis and planar polarity effector complex subunit 1

increases expression

fenvalerate results in increased expression of CPLANE1 mRNA

NCBI chr 2:57,269,195...57,369,580
Ensembl chr 2:57,268,884...57,369,500

G

complexin 3

increases expression

fenvalerate results in increased expression of CPLX3 mRNA

NCBI chr 8:58,003,535...58,010,297
Ensembl chr 8:58,003,535...58,010,297

G

CRACD like

increases expression

fenvalerate results in increased expression of CRACDL mRNA

NCBI chr 9:39,834,321...39,950,763
Ensembl chr 9:39,834,833...39,951,086

G

cAMP responsive element binding protein 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CREB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CREB1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816

G

cAMP responsive element binding protein 3-like 4

increases expression

fenvalerate results in increased expression of CREB3L4 mRNA

NCBI chr 2:175,690,340...175,695,846
Ensembl chr 2:175,690,335...175,695,932

G

CREB binding protein

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CREBBP mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CREBBP mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888

G

CREB3 regulatory factor

increases expression

fenvalerate results in increased expression of CREBRF mRNA

NCBI chr10:16,399,170...16,479,650
Ensembl chr10:16,404,596...16,461,999

G

cAMP responsive element modulator

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CREM mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CREM mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of CREM mRNA

PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989

G

cartilage acidic protein 1

increases expression

fenvalerate results in increased expression of CRTAC1 mRNA

NCBI chr 1:241,091,679...241,233,677
Ensembl chr 1:241,078,864...241,233,421

G

crystallin, beta A1

decreases expression

fenvalerate results in decreased expression of CRYBA1 mRNA

NCBI chr10:62,608,373...62,614,726
Ensembl chr10:62,608,383...62,614,726

G

cold shock domain containing C2

decreases expression

fenvalerate results in decreased expression of CSDC2 mRNA

NCBI chr 7:113,451,998...113,466,464
Ensembl chr 7:113,451,998...113,466,463

G

colony stimulating factor 1

increases expression

fenvalerate results in increased expression of CSF1 mRNA

NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704

G

casein kinase 1, epsilon

increases expression

fenvalerate results in increased expression of CSNK1E mRNA

NCBI chr 7:110,983,322...111,006,926
Ensembl chr 7:110,983,318...111,006,794

G

casein kinase 1, gamma 3

increases expression

fenvalerate results in increased expression of CSNK1G3 mRNA

NCBI chr18:47,299,547...47,386,538
Ensembl chr18:47,299,579...47,386,535

G

cystatin D

increases expression

fenvalerate results in increased expression of CST5 mRNA

NCBI chr 3:137,573,194...137,577,754
Ensembl chr 3:137,573,194...137,577,754

G

cystatin E/M

increases expression

fenvalerate results in increased expression of CST6 mRNA

NCBI chr 1:202,655,322...202,657,030
Ensembl chr 1:202,655,322...202,657,030

G

CTD small phosphatase like

increases expression

fenvalerate results in increased expression of CTDSPL mRNA

NCBI chr 8:118,642,729...118,767,238
Ensembl chr 8:118,642,672...118,767,117

G

catenin delta 2

increases expression

fenvalerate results in increased expression of CTNND2 mRNA

NCBI chr 2:81,168,525...82,016,495
Ensembl chr 2:81,167,117...82,015,764

G

cystinosin, lysosomal cystine transporter

increases expression

fenvalerate results in increased expression of CTNS mRNA

NCBI chr10:57,801,551...57,817,213
Ensembl chr10:57,801,456...57,817,120

G

cullin 9

increases expression

fenvalerate results in increased expression of CUL9 mRNA

NCBI chr 9:14,435,948...14,479,552
Ensembl chr 9:14,436,111...14,479,548

G

CUB and zona pellucida-like domains 1

increases expression

fenvalerate results in increased expression of CUZD1 mRNA

NCBI chr 1:186,089,422...186,130,536
Ensembl chr 1:186,089,423...186,102,546

G

C-X3-C motif chemokine ligand 1

decreases expression

fenvalerate results in decreased expression of CX3CL1 mRNA

NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833

G

C-X-C motif chemokine ligand 14

decreases expression

fenvalerate results in decreased expression of CXCL14 mRNA

NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839

G

C-X-C motif chemokine receptor 2

increases expression

fenvalerate results in increased expression of CXCR2 mRNA

NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425

G

cytochrome b-245 beta chain

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYBB mRNA

NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586

G

cytochrome P450, family 11, subfamily a, polypeptide 1

decreases activity
increases expression
decreases expression
multiple interactions

fenvalerate results in decreased activity of CYP11A1 protein
fenvalerate results in increased expression of CYP11A1 mRNA
fenvalerate results in decreased expression of CYP11A1 mRNA; fenvalerate results in decreased expression of CYP11A1 protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of CYP11A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CYP11A1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of CYP11A1 mRNA

PMID:15907653 PMID:16001830 PMID:18053657 PMID:19683566 PMID:19892000 More...

NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338

G

cytochrome P450, family 17, subfamily a, polypeptide 1

decreases expression
multiple interactions

fenvalerate results in decreased expression of CYP17A1 mRNA; fenvalerate results in decreased expression of CYP17A1 protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP17A1 protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of CYP17A1 mRNA

PMID:20063364 PMID:20138952 PMID:33051911 PMID:33396045 PMID:34896426 More...

NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573

G

cytochrome P450, family 19, subfamily a, polypeptide 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP19A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYP19A1 mRNA

PMID:33051911 PMID:33396045

NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758

G

cytochrome P450, family 1, subfamily a, polypeptide 2

increases activity

fenvalerate results in increased activity of CYP1A2 protein

NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312

G

cytochrome P450, family 2, subfamily b, polypeptide 1

increases expression

fenvalerate results in increased expression of CYP2B1 mRNA

NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052

G

cytochrome P450, family 2, subfamily b, polypeptide 12

increases expression

fenvalerate results in increased expression of CYP2B12 mRNA

NCBI chr 1:82,007,609...82,019,409
Ensembl chr 1:82,007,609...82,080,480

G

cytochrome P450, family 2, subfamily b, polypeptide 3

increases activity
increases expression
multiple interactions
decreases activity

fenvalerate results in increased activity of CYP2B6 protein
fenvalerate results in increased expression of CYP2B6 mRNA; fenvalerate results in increased expression of CYP2B6 protein
fenvalerate inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion]
fenvalerate results in decreased activity of CYP2B6 protein

PMID:15548381 PMID:22310298 PMID:22634058

NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143

G

cytochrome P450, family 2, subfamily C, polypeptide 6

increases expression

fenvalerate results in increased expression of CYP2C19 mRNA

NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596

G

cytochrome P450, family 2, subfamily c, polypeptide 79

increases expression

fenvalerate results in increased expression of CYP2C8 mRNA

G

cytochrome P450, family 2, subfamily d, polypeptide 4

decreases activity

fenvalerate results in decreased activity of CYP2D6 protein

NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759

G

cytochrome P450, family 2, subfamily e, polypeptide 1

multiple interactions
decreases activity

fenvalerate inhibits the reaction [CYP2E1 protein results in increased hydroxylation of Chlorzoxazone]
fenvalerate results in decreased activity of CYP2E1 protein

NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023

G

cytochrome P450, family 3, subfamily a, polypeptide 2

increases activity
decreases activity
multiple interactions
increases expression

fenvalerate results in increased activity of CYP3A4 protein
fenvalerate results in decreased activity of CYP3A4 protein
Dexamethasone promotes the reaction [fenvalerate results in increased expression of CYP3A4 mRNA]; fenvalerate promotes the reaction [Dexamethasone results in increased expression of CYP3A4 mRNA]
fenvalerate results in increased expression of CYP3A4 mRNA; fenvalerate results in increased expression of CYP3A4 protein

PMID:15548381 PMID:19249324 PMID:20599767 PMID:22310298 PMID:22634058

NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008

G

cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1

multiple interactions
increases expression

Dexamethasone promotes the reaction [fenvalerate results in increased expression of CYP3A23-3A1 mRNA]; fenvalerate promotes the reaction [Dexamethasone results in increased expression of CYP3A23-3A1 mRNA]

NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030
Ensembl chr12:9,254,475...9,285,030

G

cytochrome P450, family 4, subfamily a, polypeptide 1

increases activity
increases expression

fenvalerate metabolite results in increased activity of CYP4A22 protein
fenvalerate metabolite results in increased expression of CYP4A22 protein

NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464

G

cytochrome P450, family 4, subfamily f, polypeptide 4

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP4F4 protein

NCBI chr 7:11,717,208...11,733,507
Ensembl chr 7:11,717,208...11,733,506

G

cytochrome P450, family 4, subfamily v, polypeptide 3

increases expression

fenvalerate results in increased expression of CYP4V3 mRNA

NCBI chr16:46,917,929...46,958,735
Ensembl chr16:46,918,401...46,943,395

G

cytochrome P450 family 7 subfamily A member 1

decreases expression

fenvalerate results in decreased expression of CYP7A1 mRNA

NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688

G

cysteinyl leukotriene receptor 1

increases expression

fenvalerate results in increased expression of CYSLTR1 mRNA

NCBI chr X:71,661,421...71,690,012
Ensembl chr X:71,663,821...71,690,121

G

cysteinyl leukotriene receptor 2

increases expression

fenvalerate results in increased expression of CYSLTR2 mRNA

NCBI chr15:48,189,476...48,228,750
Ensembl chr15:48,189,073...48,304,136

G

cystatin S

increases expression

fenvalerate results in increased expression of CYSS mRNA

NCBI chr 3:137,432,049...137,436,654
Ensembl chr 3:137,432,049...137,436,610

G

cytohesin 1

decreases expression

fenvalerate results in decreased expression of CYTH1 mRNA

NCBI chr10:103,402,727...103,485,826
Ensembl chr10:103,366,145...103,485,760

G

cytohesin 3

increases expression

fenvalerate results in increased expression of CYTH3 mRNA

NCBI chr12:10,840,137...10,933,792
Ensembl chr12:10,840,157...10,933,812

G

CXXC motif containing zinc binding protein

increases expression

fenvalerate results in increased expression of CZIB protein

NCBI chr 5:122,648,333...122,657,767
Ensembl chr 5:122,648,411...122,656,910

G

dishevelled-binding antagonist of beta-catenin 1

increases expression

fenvalerate results in increased expression of DACT1 mRNA

NCBI chr 6:89,790,676...89,818,254
Ensembl chr 6:89,790,644...89,817,906

G

dystroglycan 1

increases expression

fenvalerate results in increased expression of DAG1 mRNA

NCBI chr 8:108,890,926...108,955,611
Ensembl chr 8:108,890,929...108,952,325

G

DAZ associated protein 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DAZAP1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 7:9,423,673...9,448,116
Ensembl chr 7:9,424,178...9,538,818

G

D-box binding PAR bZIP transcription factor

decreases expression

fenvalerate results in decreased expression of DBP mRNA

NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745

G

dihydrolipoamide branched chain transacylase E2

increases expression

fenvalerate results in increased expression of DBT mRNA

NCBI chr 2:204,481,744...204,510,612
Ensembl chr 2:204,481,737...204,510,609

G

DDB1 and CUL4 associated factor 6

increases expression

fenvalerate results in increased expression of DCAF6 mRNA

NCBI chr13:77,626,257...77,727,645
Ensembl chr13:77,626,307...77,727,512

G

DNA cross-link repair 1B

increases expression

fenvalerate results in increased expression of DCLRE1B mRNA

NCBI chr 2:191,309,909...191,318,399
Ensembl chr 2:191,309,913...191,318,423

G

dynactin subunit 2

increases expression

fenvalerate results in increased expression of DCTN2 protein

NCBI chr 7:63,092,061...63,107,560
Ensembl chr 7:63,092,057...63,108,543

G

discoidin domain receptor tyrosine kinase 1

increases expression
multiple interactions

fenvalerate results in increased expression of DDR1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDR1 protein

PMID:30307764 PMID:34896426

NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468

G

DEAD/H-box helicase 11

increases expression

fenvalerate results in increased expression of DDX11 mRNA

NCBI chr 9:105,833,234...105,862,844
Ensembl chr 9:105,833,504...105,862,550

G

DEAD-box helicase 17

increases expression

fenvalerate results in increased expression of DDX17 mRNA

NCBI chr 7:111,091,127...111,109,353
Ensembl chr 7:111,089,445...111,109,193

G

DEAD-box helicase 25

increases expression
multiple interactions

fenvalerate results in increased expression of DDX25 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DDX25 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DDX25 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX25 mRNA

PMID:30307764 PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 8:33,894,224...33,910,377
Ensembl chr 8:33,894,232...33,921,764

G

DEAD-box helicase 3, X-linked

increases expression

fenvalerate results in increased expression of DDX3X mRNA

NCBI chr X:9,479,532...9,493,169
Ensembl chr X:9,479,532...9,493,168

G

DEAD box helicase 3, Y-linked

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DDX3Y mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX3Y mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr Y:1,115,095...1,135,754
Ensembl chr Y:1,116,309...1,135,706

G

DEAD-box helicase 46

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX46 protein

NCBI chr17:8,942,070...8,988,440
Ensembl chr17:8,944,454...8,988,439

G

DExD-box helicase 50

increases expression

fenvalerate results in increased expression of DDX50 mRNA

NCBI chr20:30,561,623...30,591,324
Ensembl chr20:30,560,544...30,591,152

G

defensin beta 1

increases expression

fenvalerate results in increased expression of DEFB1 mRNA

NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604

G

deuterosome assembly protein 1

increases expression

fenvalerate results in increased expression of DEUP1 mRNA

NCBI chr 8:12,380,300...12,442,649
Ensembl chr 8:12,380,302...12,442,199

G

DNA fragmentation factor subunit beta

increases expression

fenvalerate results in increased expression of DFFB mRNA

NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628

G

diacylglycerol kinase, beta

increases expression

fenvalerate results in increased expression of DGKB mRNA

NCBI chr 6:54,640,948...55,397,210
Ensembl chr 6:54,641,614...55,397,043

G

diacylglycerol kinase, delta

increases expression

fenvalerate results in increased expression of DGKD mRNA

NCBI chr 9:88,516,686...88,607,349
Ensembl chr 9:88,516,715...88,607,345

G

diacylglycerol kinase epsilon

increases expression

fenvalerate results in increased expression of DGKE mRNA

NCBI chr10:73,853,030...73,877,334
Ensembl chr10:73,855,583...73,877,100

G

deoxyguanosine kinase

increases expression

fenvalerate results in increased expression of DGUOK mRNA

NCBI chr 4:115,987,101...116,014,733
Ensembl chr 4:115,979,094...116,014,733

G

desert hedgehog signaling molecule

increases expression

fenvalerate results in increased expression of DHH mRNA

NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406

G

dehydrogenase/reductase 7C

increases expression

fenvalerate results in increased expression of DHRS7C mRNA

NCBI chr10:52,495,262...52,513,338
Ensembl chr10:52,495,262...52,513,338

G

DExH-box helicase 30

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DHX30 protein

NCBI chr 8:110,064,751...110,096,954
Ensembl chr 8:110,064,752...110,097,381

G

DExH-box helicase 34

increases expression

fenvalerate results in increased expression of DHX34 mRNA

NCBI chr 1:76,880,867...76,905,148
Ensembl chr 1:76,880,867...76,905,113

G

diaphanous-related formin 3

increases expression

fenvalerate results in increased expression of DIAPH3 mRNA

NCBI chr15:62,543,375...63,013,060
Ensembl chr15:62,543,375...63,012,975

G

iodothyronine deiodinase 3

increases expression

fenvalerate results in increased expression of DIO3 mRNA

NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660

G

divergent protein kinase domain 2A

increases expression

fenvalerate results in increased expression of DIPK2A mRNA

NCBI chr 8:95,070,695...95,089,815
Ensembl chr 8:95,030,279...95,089,815

G

dihydrolipoamide dehydrogenase

decreases expression

fenvalerate results in decreased expression of DLD protein

NCBI chr 6:47,904,153...47,924,814
Ensembl chr 6:47,903,914...47,924,795

G

discs large MAGUK scaffold protein 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DLG2 protein

NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475

G

discs large MAGUK scaffold protein 3

increases expression

fenvalerate results in increased expression of DLG3 mRNA

NCBI chr X:65,859,653...65,911,887
Ensembl chr X:65,860,172...65,910,322

G

DLG associated protein 1

increases expression

fenvalerate results in increased expression of DLGAP1 mRNA

NCBI chr 9:109,857,500...110,726,817
Ensembl chr 9:110,167,448...110,726,817

G

dihydrolipoamide S-succinyltransferase

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DLST protein

NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296

G

distal-less homeobox 3

increases expression

fenvalerate results in increased expression of DLX3 mRNA

NCBI chr10:80,064,489...80,069,891
Ensembl chr10:80,064,489...80,069,872

G

distal-less homeobox 5

increases expression

fenvalerate results in increased expression of DLX5 mRNA

NCBI chr 4:34,999,139...35,003,504
Ensembl chr 4:34,999,139...35,003,407

G

distal membrane arm assembly component 2 like

decreases expression

fenvalerate results in decreased expression of DMAC2L protein

NCBI chr 6:88,205,580...88,223,934
Ensembl chr 6:88,205,700...88,223,933

G

doublesex and mab-3 related transcription factor 2

increases expression

fenvalerate results in increased expression of DMRT2 mRNA

NCBI chr 1:223,317,543...223,324,131
Ensembl chr 1:223,317,642...223,324,131

G

DMRT-like family C1c1

increases expression

fenvalerate results in increased expression of DMRTC1C1 mRNA

NCBI chr X:67,896,973...67,904,182
Ensembl chr X:67,896,974...67,904,182

G

dynein, axonemal, heavy chain 1

increases expression

fenvalerate results in increased expression of DNAH1 mRNA

NCBI chr16:6,455,514...6,517,103
Ensembl chr16:6,456,002...6,518,350

G

dynein, axonemal, heavy chain 17

increases expression

fenvalerate results in increased expression of DNAH17 mRNA

NCBI chr10:103,244,144...103,364,953
Ensembl chr10:103,249,363...103,364,901

G

dynein axonemal intermediate chain 7

increases expression

fenvalerate results in increased expression of DNAI7 mRNA

NCBI chr 4:178,143,499...178,179,871
Ensembl chr 4:178,143,500...178,179,980

G

DnaJ heat shock protein family (Hsp40) member B13

increases expression

fenvalerate results in increased expression of DNAJB13 mRNA

NCBI chr 1:154,848,586...154,863,042
Ensembl chr 1:154,848,594...154,862,963

G

DnaJ heat shock protein family (Hsp40) member B2

increases expression

fenvalerate results in increased expression of DNAJB2 mRNA

NCBI chr 9:76,731,060...76,739,278
Ensembl chr 9:76,731,065...76,739,277

G

DnaJ heat shock protein family (Hsp40) member B3

increases expression

fenvalerate results in increased expression of DNAJB3 mRNA

NCBI chr 9:88,795,542...88,796,555
Ensembl chr 9:88,795,488...88,796,560

G

DnaJ heat shock protein family (Hsp40) member C17

increases expression

fenvalerate results in increased expression of DNAJC17 mRNA

NCBI chr 3:106,162,197...106,195,771
Ensembl chr 3:106,162,197...106,195,751

G

DnaJ heat shock protein family (Hsp40) member C30

increases expression

fenvalerate results in increased expression of DNAJC30 mRNA

NCBI chr12:21,628,319...21,629,398
Ensembl chr12:21,626,450...21,629,408

G

dynamin 1-like

increases expression

fenvalerate results in increased expression of DNM1L mRNA

NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482

G

DNA methyltransferase 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of DNMT1 mRNA

NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659

G

DNA methyltransferase 3 alpha

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3A mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of DNMT3A mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687

G

DNA methyltransferase 3 beta

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3B mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of DNMT3B mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124

G

aspartyl aminopeptidase

decreases expression

fenvalerate results in decreased expression of DNPEP protein

NCBI chr 9:76,799,931...76,808,841
Ensembl chr 9:76,783,966...76,808,716

G

DOP1 leucine zipper like protein A

decreases expression

fenvalerate results in decreased expression of DOP1A mRNA

NCBI chr 8:87,415,266...87,517,935
Ensembl chr 8:87,414,593...87,518,353

G

diphthamide biosynthesis 7

decreases expression

fenvalerate results in decreased expression of DPH7 mRNA

NCBI chr 3:7,770,368...7,778,994
Ensembl chr 3:7,770,379...7,778,982

G

dolichyl-phosphate mannosyltransferase subunit 1, catalytic

increases expression

fenvalerate results in increased expression of DPM1 mRNA

NCBI chr 3:156,919,979...156,939,522
Ensembl chr 3:156,919,979...156,939,536

G

dynein regulatory complex subunit 12 homolog

increases expression

fenvalerate results in increased expression of CCDC153 mRNA

NCBI chr 8:44,576,528...44,584,345
Ensembl chr 8:44,577,836...44,584,338

G

dynein regulatory complex subunit 3

increases expression

fenvalerate results in increased expression of DRC3 mRNA

NCBI chr10:45,149,094...45,200,659
Ensembl chr10:45,157,354...45,199,369

G

dopamine receptor D3

increases expression

fenvalerate results in increased expression of DRD3 mRNA

NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596

G

dopamine receptor D4

increases expression

fenvalerate results in increased expression of DRD4 mRNA

NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553

G

dystrophin related protein 2

increases expression

fenvalerate results in increased expression of DRP2 mRNA

NCBI chr X:97,607,577...97,658,117
Ensembl chr X:97,607,719...97,655,684

G

DS cell adhesion molecule

increases expression

fenvalerate results in increased expression of DSCAM mRNA

NCBI chr11:35,921,924...36,507,100
Ensembl chr11:35,926,896...36,507,415

G

desmoglein 1

increases expression

fenvalerate results in increased expression of DSG1 mRNA

NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443

G

dystonin

increases expression

fenvalerate results in increased expression of DST mRNA

NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615

G

destrin, actin depolymerizing factor

decreases expression

fenvalerate results in decreased expression of DSTN protein

NCBI chr 3:131,284,647...131,311,361
Ensembl chr 3:131,284,648...131,311,379

G

dual oxidase 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DUOX2 protein

NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902

G

dihydrouridine synthase 4-like

increases expression

fenvalerate results in increased expression of DUS4L mRNA

NCBI chr 6:48,228,111...48,242,553
Ensembl chr 6:48,228,111...48,242,449

G

dual specificity phosphatase 1

increases expression

fenvalerate results in increased expression of DUSP1 mRNA

NCBI chr10:16,680,478...16,683,275

G

dual specificity phosphatase 9

increases expression

fenvalerate results in increased expression of DUSP9 mRNA

NCBI chr X:151,351,897...151,355,822
Ensembl chr X:151,351,897...151,355,821

G

dishevelled segment polarity protein 2

increases expression

fenvalerate results in increased expression of DVL2 mRNA

NCBI chr10:54,723,356...54,732,823
Ensembl chr10:54,723,411...54,732,820

G

dynein cytoplasmic 2 heavy chain 1

increases expression

fenvalerate results in increased expression of DYNC2H1 mRNA

NCBI chr 8:4,189,067...4,412,183
Ensembl chr 8:4,189,257...4,412,183

G

DAZ interacting zinc finger protein 3

increases expression

fenvalerate results in increased expression of DZIP3 mRNA

NCBI chr11:51,823,235...51,893,353
Ensembl chr11:51,823,231...51,893,353

G

E2F transcription factor 8

increases expression

fenvalerate results in increased expression of E2F8 mRNA

NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098

G

EBF transcription factor 2

increases expression

fenvalerate results in increased expression of EBF2 mRNA

NCBI chr15:41,435,509...41,634,403
Ensembl chr15:41,435,509...41,634,403

G

endothelin converting enzyme-like 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ECEL1 protein

NCBI chr 9:87,819,516...87,829,154
Ensembl chr 9:87,816,718...87,826,675

G

enoyl-CoA hydratase 1

decreases expression

fenvalerate results in decreased expression of ECH1 protein

NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795

G

enhancer of mRNA decapping 3

decreases expression

fenvalerate results in decreased expression of EDC3 mRNA

NCBI chr 8:58,106,147...58,151,685
Ensembl chr 8:58,106,175...58,151,671

G

endothelin 2

increases expression

fenvalerate results in increased expression of EDN2 mRNA

NCBI chr 5:133,751,316...133,756,814
Ensembl chr 5:133,751,217...133,756,814

G

endothelin receptor type A

decreases expression

fenvalerate results in decreased expression of EDNRA mRNA

NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049

G

eukaryotic elongation factor-2 kinase

increases expression

fenvalerate results in increased expression of EEF2K mRNA

NCBI chr 1:175,393,119...175,456,756
Ensembl chr 1:175,393,154...175,455,164

G

EEIG family member 2

increases expression

fenvalerate results in increased expression of EEIG2 mRNA

NCBI chr 2:196,608,499...196,663,371
Ensembl chr 2:196,608,499...196,663,371

G

EF-hand calcium binding domain 2

increases expression

fenvalerate results in increased expression of EFCAB2 mRNA

NCBI chr13:90,152,002...90,237,918
Ensembl chr13:90,152,185...90,238,218

G

EF-hand domain containing 2

increases expression

fenvalerate results in increased expression of EFHC2 mRNA

NCBI chr X:5,360,499...5,564,004
Ensembl chr X:5,360,617...5,560,970

G

EFR3 homolog A

increases expression

fenvalerate results in increased expression of EFR3A mRNA

NCBI chr 7:97,552,677...97,633,369
Ensembl chr 7:97,552,677...97,633,369

G

early growth response 3

increases expression

fenvalerate results in increased expression of EGR3 mRNA

NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627

G

early growth response 4

increases expression

fenvalerate results in increased expression of EGR4 mRNA

NCBI chr 4:118,047,869...118,050,328
Ensembl chr 4:118,047,869...118,050,328

G

eukaryotic translation initiation factor 4A3

decreases expression

fenvalerate results in decreased expression of EIF4A3 protein

NCBI chr10:104,549,038...104,559,032
Ensembl chr10:104,549,038...104,559,057

G

elaC ribonuclease Z 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ELAC2 protein

NCBI chr10:49,632,308...49,655,614
Ensembl chr10:49,632,378...49,655,614

G

ELAV like RNA binding protein 2

increases expression

fenvalerate results in increased expression of ELAVL2 mRNA

NCBI chr 5:105,960,872...106,086,463
Ensembl chr 5:105,960,875...106,109,097

G

ELAV like RNA binding protein 4

increases expression

fenvalerate results in increased expression of ELAVL4 mRNA

NCBI chr 5:125,056,848...125,200,543
Ensembl chr 5:125,056,848...125,200,446

G

E74 like ETS transcription factor 2

increases expression

fenvalerate results in increased expression of ELF2 mRNA

NCBI chr 2:135,292,291...135,385,942
Ensembl chr 2:135,294,906...135,385,947

G

extracellular leucine-rich repeat and fibronectin type III domain containing 2

increases expression

fenvalerate results in increased expression of ELFN2 mRNA

NCBI chr 7:110,220,293...110,272,770
Ensembl chr 7:110,225,919...110,272,433

G

engulfment and cell motility 2

decreases expression

fenvalerate results in decreased expression of ELMO2 mRNA

NCBI chr 3:154,023,661...154,061,259
Ensembl chr 3:154,023,661...154,061,185

G

ELOVL fatty acid elongase 4

increases expression

fenvalerate results in increased expression of ELOVL4 mRNA

NCBI chr 8:84,702,916...84,729,466
Ensembl chr 8:84,702,362...84,729,697

G

ELOVL fatty acid elongase 6

decreases expression

fenvalerate results in decreased expression of ELOVL6 mRNA

NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186

G

ENAH, actin regulator

increases expression

fenvalerate results in increased expression of ENAH mRNA

NCBI chr13:93,617,747...93,738,119
Ensembl chr13:93,626,944...93,740,955

G

endonuclease domain containing 1

increases expression

fenvalerate results in increased expression of ENDOD1 mRNA

NCBI chr 8:11,209,113...11,238,507
Ensembl chr 8:11,211,110...11,238,892

G

ectonucleoside triphosphate diphosphohydrolase 4

increases expression

fenvalerate results in increased expression of ENTPD4 mRNA

NCBI chr15:44,630,878...44,658,654
Ensembl chr15:44,630,873...44,658,706

G

E1A binding protein p300

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of EP300 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EP300 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of EP300 mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088
Ensembl chr 7:113,106,247...113,136,088

G

exosomal polycystin 1 interacting protein

increases expression

fenvalerate results in increased expression of EPCIP mRNA

NCBI chr11:30,307,842...30,325,829
Ensembl chr11:30,310,350...30,325,439

G

Eph receptor A3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EPHA3 protein

NCBI chr11:1,138,485...1,474,102
Ensembl chr11:1,140,985...1,473,900

G

Eph receptor A4

increases expression

fenvalerate results in increased expression of EPHA4 mRNA

NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139

G

Eph receptor A6

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EPHA6 protein

NCBI chr11:39,757,501...40,708,901
Ensembl chr11:39,757,181...40,698,311

G

Eph receptor A7

increases expression

fenvalerate results in increased expression of EPHA7 mRNA

NCBI chr 5:42,975,353...43,128,703
Ensembl chr 5:42,975,405...43,127,112

G

epoxide hydrolase 1

increases activity

fenvalerate metabolite results in increased activity of EPHX1 protein

NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235

G

epoxide hydrolase 2

increases activity

fenvalerate metabolite results in increased activity of EPHX2 protein

NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615

G

epoxide hydrolase 4

increases expression

fenvalerate results in increased expression of EPHX4 mRNA

NCBI chr14:2,343,376...2,372,680
Ensembl chr14:2,340,248...2,373,022

G

epsin 2

increases expression

fenvalerate results in increased expression of EPN2 mRNA

NCBI chr10:46,197,785...46,259,673
Ensembl chr10:46,197,785...46,259,642

G

endoplasmic reticulum aminopeptidase 1

increases expression

fenvalerate results in increased expression of ERAP1 mRNA

NCBI chr 2:3,931,817...3,970,735
Ensembl chr 2:3,931,904...3,972,447

G

erb-b2 receptor tyrosine kinase 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ERBB3 protein

NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525

G

ELKS/RAB6-interacting/CAST family member 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ERC2 protein

NCBI chr16:2,812,712...3,673,624
Ensembl chr16:2,848,620...3,670,776

G

ERCC excision repair 3, TFIIH core complex helicase subunit

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ERCC3 protein

NCBI chr18:23,883,613...23,914,326
Ensembl chr18:23,883,580...23,914,329

G

ERCC excision repair 8, CSA ubiquitin ligase complex subunit

increases expression

fenvalerate results in increased expression of ERCC8 mRNA

NCBI chr 2:39,647,393...39,686,229
Ensembl chr 2:39,647,452...39,684,859

G

ERH, mRNA splicing and mitosis factor like 1

increases expression

fenvalerate results in increased expression of ERHL1 mRNA

NCBI chr 2:132,570,276...132,573,582
Ensembl chr 2:132,570,285...132,573,604

G

ermin

increases expression

fenvalerate results in increased expression of ERMN mRNA

NCBI chr 3:42,628,160...42,633,816
Ensembl chr 3:42,626,309...42,633,744

G

endothelial cell-specific molecule 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ESM1 protein

NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804

G

estrogen receptor 1

increases activity
multiple interactions
affects binding
increases expression

fenvalerate results in increased activity of ESR1 protein
fenvalerate binds to and results in increased activity of ESR1 protein
fenvalerate binds to ESR1 protein
fenvalerate results in increased expression of ESR1 mRNA

PMID:12396874 PMID:15064155 PMID:16626760 PMID:20410157 PMID:24388911

NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002

G

estrogen receptor 2

multiple interactions

fenvalerate binds to and results in increased activity of ESR2 protein

NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919

G

electron transfer flavoprotein subunit alpha

increases expression

fenvalerate results in increased expression of ETFA protein

NCBI chr 8:55,835,115...55,891,890
Ensembl chr 8:55,835,134...55,891,969

G

exocyst complex component 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EXOC3 protein

NCBI chr 1:29,091,298...29,122,056
Ensembl chr 1:29,091,294...29,122,045

G

EYA transcriptional coactivator and phosphatase 2

increases expression

fenvalerate results in increased expression of EYA2 mRNA

NCBI chr 3:154,335,598...154,519,006
Ensembl chr 3:154,335,400...154,518,793

G

enhancer of zeste 2 polycomb repressive complex 2 subunit

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EZH2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of EZH2 mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362

G

F2R like trypsin receptor 1

increases expression

fenvalerate results in increased expression of F2RL1 mRNA

NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226

G

coagulation factor VIII

increases expression

fenvalerate results in increased expression of F8 mRNA

NCBI chr18:140,848...172,330
Ensembl chr18:140,955...171,857

G

fatty acid binding protein 9

affects expression

fenvalerate affects the expression of FABP9 protein

NCBI chr 2:91,591,842...91,595,873
Ensembl chr 2:91,592,298...91,595,873

G

fatty acid desaturase 3

decreases expression

fenvalerate results in decreased expression of FADS3 mRNA

NCBI chr 1:206,685,667...206,702,538
Ensembl chr 1:206,685,894...206,704,769

G

fumarylacetoacetate hydrolase domain containing 2A

decreases expression

fenvalerate results in decreased expression of FAHD2A protein

NCBI chr 3:114,657,176...114,665,349
Ensembl chr 3:114,655,865...114,665,356

G

family with sequence similarity 110, member C

increases expression

fenvalerate results in increased expression of FAM110C mRNA

NCBI chr 6:47,638,466...47,644,723
Ensembl chr 6:47,638,276...47,644,634

G

family with sequence similarity 168, member A

increases expression

fenvalerate results in increased expression of FAM168A mRNA

NCBI chr 1:155,057,352...155,203,439
Ensembl chr 1:155,057,352...155,201,220

G

family with sequence similarity 171, member A1

increases expression

fenvalerate results in increased expression of FAM171A1 mRNA

NCBI chr17:75,024,582...75,148,348
Ensembl chr17:75,024,575...75,150,255

G

family with sequence similarity 181, member B

increases expression

fenvalerate results in increased expression of FAM181B mRNA

NCBI chr 1:147,166,428...147,167,925
Ensembl chr 1:147,124,740...147,168,298
Ensembl chr 1:147,124,740...147,168,298

G

family with sequence similarity 193, member A

increases expression

fenvalerate results in increased expression of FAM193A mRNA

NCBI chr14:76,250,103...76,382,525
Ensembl chr14:76,256,161...76,382,514

G

family with sequence similarity 209

increases expression

fenvalerate results in increased expression of FAM209 mRNA

NCBI chr 3:161,240,062...161,241,747
Ensembl chr 3:161,240,034...161,241,755

G

FAM20B, glycosaminoglycan xylosylkinase

increases expression

fenvalerate results in increased expression of FAM20B mRNA

NCBI chr13:68,801,663...68,839,979
Ensembl chr13:68,801,669...68,839,915

G

family with sequence similarity 219, member A

increases expression

fenvalerate results in increased expression of FAM219A mRNA

NCBI chr 5:56,679,272...56,729,959
Ensembl chr 5:56,680,613...56,729,924

G

family with sequence similarity 221, member A

increases expression

fenvalerate results in increased expression of FAM221A mRNA

NCBI chr 4:78,337,296...78,358,918
Ensembl chr 4:78,337,296...78,358,909

G

family with sequence similarity 241 member A

increases expression

fenvalerate results in increased expression of FAM241A mRNA

NCBI chr 2:216,344,563...216,375,193
Ensembl chr 2:216,343,822...216,375,242

G

family with sequence similarity 78, member B

increases expression

fenvalerate results in increased expression of FAM78B mRNA

NCBI chr13:79,162,393...79,250,958
Ensembl chr13:79,162,228...79,250,500

G

family with sequence similarity 81, member A

increases expression

fenvalerate results in increased expression of FAM81A mRNA

NCBI chr 8:70,762,852...70,821,898
Ensembl chr 8:70,763,614...70,821,875

G

family with sequence similarity 83, member F

increases expression

fenvalerate results in increased expression of FAM83F mRNA

NCBI chr 7:112,211,164...112,240,454
Ensembl chr 7:112,211,164...112,240,452

G

FA complementation group A

increases expression

fenvalerate results in increased expression of FANCA mRNA

NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527

G

FA complementation group B

increases expression

fenvalerate results in increased expression of FANCB mRNA

NCBI chr X:29,403,771...29,420,484
Ensembl chr X:29,403,771...29,420,192

G

fatty acyl CoA reductase 1

increases expression

fenvalerate results in increased expression of FAR1 mRNA

NCBI chr 1:167,644,622...167,705,868
Ensembl chr 1:167,644,677...167,705,730

G

FERM, ARH/RhoGEF and pleckstrin domain protein 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FARP1 protein

NCBI chr15:98,124,304...98,363,299
Ensembl chr15:98,182,329...98,363,299

G

Fas ligand

increases expression

fenvalerate results in increased expression of FASLG mRNA

NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215

G

fibulin 5

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FBLN5 protein

NCBI chr 6:120,899,219...120,977,829
Ensembl chr 6:120,899,224...120,977,755

G

fibrosin-like 1

increases expression

fenvalerate results in increased expression of FBRSL1 mRNA

NCBI chr12:46,231,466...46,320,607
Ensembl chr12:46,231,495...46,320,357

G

F-box and leucine-rich repeat protein 22

increases expression

fenvalerate results in increased expression of FBXL22 mRNA

NCBI chr 8:67,069,998...67,076,685
Ensembl chr 8:67,069,998...67,076,685

G

F-box and leucine-rich repeat protein 6

decreases expression

fenvalerate results in decreased expression of FBXL6 mRNA

NCBI chr 7:108,259,097...108,262,528
Ensembl chr 7:108,257,160...108,262,513

G

F-box protein 10

increases expression

fenvalerate results in increased expression of FBXO10 mRNA

NCBI chr 5:59,297,016...59,343,429
Ensembl chr 5:59,297,045...59,343,348

G

F-box protein 28

increases expression

fenvalerate results in increased expression of FBXO28 mRNA

NCBI chr13:93,995,993...94,021,464
Ensembl chr13:93,995,996...94,021,464

G

F-box and WD repeat domain containing 2

increases expression

fenvalerate results in increased expression of FBXW2 mRNA

NCBI chr 3:18,088,859...18,114,387
Ensembl chr 3:18,088,865...18,114,381

G

F-box and WD repeat domain containing 8

decreases expression

fenvalerate results in decreased expression of FBXW8 mRNA

NCBI chr12:38,426,466...38,517,076
Ensembl chr12:38,426,444...38,516,424

G

FCH and mu domain containing endocytic adaptor 1

increases expression

fenvalerate results in increased expression of FCHO1 mRNA

NCBI chr16:18,413,452...18,430,795
Ensembl chr16:18,413,363...18,435,104

G

ficolin B

increases expression

fenvalerate results in increased expression of FCNB mRNA

NCBI chr 3:11,393,713...11,402,198
Ensembl chr 3:11,393,739...11,402,151

G

Fc receptor-like 6

increases expression

fenvalerate results in increased expression of FCRL6 mRNA

NCBI chr13:85,062,709...85,072,308
Ensembl chr13:85,066,694...85,072,600

G

fem-1 homolog B

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FEM1B protein

NCBI chr 8:63,265,301...63,278,577
Ensembl chr 8:63,265,301...63,278,577

G

FES proto-oncogene, tyrosine kinase

increases expression

fenvalerate results in increased expression of FES mRNA

NCBI chr 1:134,337,698...134,346,934
Ensembl chr 1:134,337,698...134,346,934

G

fasciculation and elongation protein zeta 1

increases expression

fenvalerate results in increased expression of FEZ1 mRNA

NCBI chr 8:36,544,462...36,589,684
Ensembl chr 8:36,544,535...36,589,683

G

Fez family zinc finger 2

increases expression

fenvalerate results in increased expression of FEZF2 mRNA

NCBI chr15:12,768,614...12,777,554
Ensembl chr15:12,773,762...12,777,554

G

fibrinogen beta chain

increases expression

fenvalerate results in increased expression of FGB mRNA

NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979

G

FYVE, RhoGEF and PH domain containing 4

increases expression

fenvalerate results in increased expression of FGD4 mRNA

NCBI chr11:84,399,989...84,551,013
Ensembl chr11:84,399,816...84,546,972

G

fibroblast growth factor 12

increases expression

fenvalerate results in increased expression of FGF12 mRNA

NCBI chr11:71,997,151...72,564,757
Ensembl chr11:71,997,099...72,562,607

G

fibroblast growth factor 13

increases expression

fenvalerate results in increased expression of FGF13 mRNA

NCBI chr X:137,276,498...137,800,056
Ensembl chr X:137,276,511...137,800,391

G

fibroblast growth factor 14

increases expression

fenvalerate results in increased expression of FGF14 mRNA

NCBI chr15:101,045,033...101,679,888
Ensembl chr15:101,045,036...101,679,900

G

fibroblast growth factor 3

increases expression

fenvalerate results in increased expression of FGF3 mRNA

NCBI chr 1:200,001,162...200,005,539
Ensembl chr 1:200,001,261...200,005,187

G

fibroblast growth factor 9

increases expression

fenvalerate results in increased expression of FGF9 mRNA

NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309

G

fibrinogen-like 2

increases expression

fenvalerate results in increased expression of FGL2 mRNA

NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207

G

four and a half LIM domains 2

increases expression

fenvalerate results in increased expression of FHL2 mRNA

NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192

G

four and a half LIM domains 5

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FHL5 protein

NCBI chr 5:38,907,941...38,956,759
Ensembl chr 5:38,907,946...38,956,552

G

fin bud initiation factor homolog

increases expression

fenvalerate results in increased expression of FIBIN mRNA

NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676

G

filamin A interacting protein 1

increases expression

fenvalerate results in increased expression of FILIP1 mRNA

NCBI chr 8:80,761,283...80,956,556
Ensembl chr 8:80,764,604...80,922,549

G

filamin C

increases expression

fenvalerate results in increased expression of FLNC mRNA

NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,034,189...58,061,844

G

Fms related receptor tyrosine kinase 1

increases expression
multiple interactions

fenvalerate results in increased expression of FLT1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FLT1 protein

PMID:30307764 PMID:34896426

NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626

G

Fms related receptor tyrosine kinase 4

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FLT4 protein

NCBI chr10:33,913,725...33,954,770
Ensembl chr10:33,913,608...33,954,770

G

FLYWCH family member 2

increases expression

fenvalerate results in increased expression of FLYWCH2 mRNA

NCBI chr10:12,798,757...12,807,082
Ensembl chr10:12,798,762...12,806,439

G

flavin containing dimethylaniline monoxygenase 4

increases expression

fenvalerate results in increased expression of FMO4 mRNA

NCBI chr13:75,154,683...75,172,874
Ensembl chr13:75,154,684...75,172,874

G

flavin containing dimethylaniline monoxygenase 5

increases expression

fenvalerate results in increased expression of FMO5 mRNA

NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693

G

formin binding protein 1

increases expression

fenvalerate results in increased expression of FNBP1 mRNA

NCBI chr 3:14,309,067...14,424,378
Ensembl chr 3:14,309,640...14,424,881

G

forkhead box C1

increases expression

fenvalerate results in increased expression of FOXC1 mRNA

NCBI chr17:32,631,379...32,635,361
Ensembl chr17:32,633,142...32,634,803

G

forkhead box O3

affects methylation

fenvalerate affects the methylation of FOXO3 gene

NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561

G

fibroblast growth factor receptor substrate 2

increases expression

fenvalerate results in increased expression of FRS2 mRNA

NCBI chr 7:52,711,255...52,792,738
Ensembl chr 7:52,711,257...52,792,743

G

FRY like transcription coactivator

increases expression

fenvalerate results in increased expression of FRYL mRNA

NCBI chr14:34,956,623...35,189,738
Ensembl chr14:34,956,620...35,190,222

G

40S small subunit processome assembly factor 1

increases expression

fenvalerate results in increased expression of C19H1ORF131 mRNA

NCBI chr19:52,807,932...52,822,259
Ensembl chr19:52,807,934...52,822,267

G

fascin actin-bundling protein 1

increases expression

fenvalerate results in increased expression of FSCN1 mRNA

NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211

G

fascin actin-bundling protein 2, retinal

increases expression

fenvalerate results in increased expression of FSCN2 mRNA

NCBI chr10:105,634,783...105,641,322
Ensembl chr10:105,634,783...105,641,322

G

follicle stimulating hormone subunit beta

increases expression
multiple interactions

fenvalerate results in increased expression of FSHB mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FSHB protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of FSHB protein

PMID:30307764 PMID:34896426 PMID:36053783

NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370

G

follicle stimulating hormone receptor

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of FSHR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FSHR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of FSHR mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785

G

follistatin-like 4

increases expression

fenvalerate results in increased expression of FSTL4 mRNA

NCBI chr10:36,911,422...37,344,545
Ensembl chr10:36,911,420...37,338,588

G

forty-two-three domain containing 1

increases expression

fenvalerate results in increased expression of FYTTD1 mRNA

NCBI chr11:67,877,967...67,907,500
Ensembl chr11:67,877,967...67,907,511

G

fizzy and cell division cycle 20 related 1

increases expression

fenvalerate results in increased expression of FZR1 mRNA

NCBI chr 7:8,332,029...8,343,953
Ensembl chr 7:8,332,029...8,343,952

G

glucose-6-phosphate dehydrogenase

decreases activity

fenvalerate results in decreased activity of G6PDX protein

NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801

G

GABA type A receptor-associated protein

increases expression

fenvalerate results in increased expression of GABARAP mRNA

NCBI chr10:54,714,777...54,718,099
Ensembl chr10:54,714,198...54,717,765

G

gamma-aminobutyric acid type B receptor subunit 1

increases expression

fenvalerate results in increased expression of GABBR1 mRNA

NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994

G

gamma-aminobutyric acid type A receptor subunit gamma 1

increases expression

fenvalerate results in increased expression of GABRG1 mRNA

NCBI chr14:37,396,217...37,469,606
Ensembl chr14:37,396,294...37,635,956

G

gamma-aminobutyric acid type A receptor subunit gamma 2

increases expression

fenvalerate results in increased expression of GABRG2 mRNA

NCBI chr10:26,374,693...26,463,937
Ensembl chr10:26,374,694...26,464,346

G

gamma-aminobutyric acid type A receptor subunit gamma 3

increases expression

fenvalerate results in increased expression of GABRG3 mRNA

NCBI chr 1:107,627,450...108,247,483
Ensembl chr 1:107,627,390...108,246,763

G

galactose-3-O-sulfotransferase 1

increases expression

fenvalerate results in increased expression of GAL3ST1 mRNA

NCBI chr14:78,868,049...78,886,402
Ensembl chr14:78,870,793...78,886,388

G

galactokinase 1

increases expression

fenvalerate results in increased expression of GALK1 protein

NCBI chr10:101,243,146...101,247,323
Ensembl chr10:101,235,994...101,247,337

G

galactose mutarotase

decreases expression

fenvalerate results in decreased expression of GALM protein

NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310

G

polypeptide N-acetylgalactosaminyltransferase 14

increases expression

fenvalerate results in increased expression of GALNT14 mRNA

NCBI chr 6:21,756,039...21,977,533
Ensembl chr 6:21,755,195...21,972,192

G

polypeptide N-acetylgalactosaminyltransferase 16

increases expression

fenvalerate results in increased expression of GALNT16 mRNA

NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705

G

growth associated protein 43

increases expression

fenvalerate results in increased expression of GAP43 mRNA

NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045

G

glyceraldehyde-3-phosphate dehydrogenase, pseudogene 2

increases expression

fenvalerate results in increased expression of GAPDH-PS2 protein

NCBI chr16:24,029,979...24,031,270

G

glyceraldehyde-3-phosphate dehydrogenase, spermatogenic

decreases expression

fenvalerate results in decreased expression of GAPDHS protein

NCBI chr 1:85,979,096...85,994,153
Ensembl chr 1:85,979,098...85,993,640

G

golgi associated RAB2 interactor family member 4

increases expression

fenvalerate results in increased expression of GARIN4 mRNA

NCBI chr13:102,742,988...102,745,168
Ensembl chr13:102,742,988...102,745,168

G

glycyl-tRNA synthetase 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GARS1 protein

NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609

G

gastrin

increases expression

fenvalerate results in increased expression of GAST mRNA

NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496

G

GATA binding protein 1

increases expression

fenvalerate results in increased expression of GATA1 mRNA

NCBI chr X:14,529,706...14,537,530
Ensembl chr X:14,529,702...14,537,530

G

GATA binding protein 4

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of GATA4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of GATA4 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of GATA4 mRNA

PMID:33051911 PMID:34896426 PMID:36053783

NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636

G

GC, vitamin D binding protein

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GC protein

NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567

G

glutamate-cysteine ligase, catalytic subunit

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GCLC protein

NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544

G

growth differentiation factor 10

increases expression

fenvalerate results in increased expression of GDF10 mRNA

NCBI chr16:9,237,182...9,250,537
Ensembl chr16:9,237,261...9,249,343

G

glial cell derived neurotrophic factor

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of GDNF mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of GDNF mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of GDNF mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209

G

GDNF family receptor alpha 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of GFRA1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GFRA1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473

G

gamma-glutamyltransferase 1

affects expression
increases expression

fenvalerate affects the expression of GGT1
fenvalerate results in increased expression of GGT1 mRNA

PMID:12479040 PMID:30307764

NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442

G

growth hormone 1

increases expression

fenvalerate results in increased expression of GH1 mRNA

NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078

G

GTPase, IMAP family member 8

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GIMAP8 protein

NCBI chr 4:77,600,104...77,611,593
Ensembl chr 4:77,600,186...77,611,590

G

GIT ArfGAP 2

increases expression

fenvalerate results in increased expression of GIT2 mRNA

NCBI chr12:41,829,717...41,872,621
Ensembl chr12:41,829,730...41,871,097

G

gap junction protein, alpha 3

increases expression

fenvalerate results in increased expression of GJA3 mRNA

NCBI chr15:31,181,360...31,206,820
Ensembl chr15:31,181,369...31,206,810

G

gap junction protein, alpha 4

decreases expression

fenvalerate results in decreased expression of GJA4 mRNA

NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925

G

gap junction protein, alpha 5

increases expression

fenvalerate results in increased expression of GJA5 mRNA

NCBI chr 2:184,602,407...184,621,952
Ensembl chr 2:184,564,475...184,621,952

G

gap junction protein, beta 3

increases expression

fenvalerate results in increased expression of GJB3 mRNA

NCBI chr 5:139,649,227...139,654,970
Ensembl chr 5:139,649,195...139,654,980

G

gliadoralin-A like

increases expression

fenvalerate results in increased expression of GLAL mRNA

NCBI chr 4:165,928,441...165,931,317
Ensembl chr 4:165,922,843...165,989,527

G

glyoxalase domain containing 4

increases expression

fenvalerate results in increased expression of GLOD4 protein

NCBI chr10:61,077,535...61,095,876
Ensembl chr10:61,066,421...61,095,898

G

glutaminase

increases expression

fenvalerate results in increased expression of GLS mRNA

NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900

G

glutamate-ammonia ligase

increases expression

fenvalerate results in increased expression of GLUL protein

NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108

G

glia maturation factor, beta

increases expression

fenvalerate results in increased expression of GMFB protein

NCBI chr15:20,069,923...20,081,005
Ensembl chr15:20,067,263...20,080,331

G

guanine monophosphate synthase

decreases expression

fenvalerate results in decreased expression of GMPS protein

NCBI chr 2:148,441,369...148,491,908
Ensembl chr 2:148,435,643...148,485,875

G

G protein subunit alpha 14

decreases expression

fenvalerate results in decreased expression of GNA14 mRNA

NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423

G

G protein subunit alpha i1

increases expression

fenvalerate results in increased expression of GNAI1 mRNA

NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417

G

G protein subunit alpha o1

increases expression

fenvalerate results in increased expression of GNAO1 mRNA

NCBI chr19:11,034,874...11,192,531
Ensembl chr19:11,035,956...11,192,493

G

G protein subunit beta 2

increases expression

fenvalerate results in increased expression of GNB2 protein

NCBI chr12:19,159,002...19,164,021
Ensembl chr12:19,158,973...19,164,019

G

G protein subunit gamma 13

increases expression

fenvalerate results in increased expression of GNG13 mRNA

NCBI chr10:14,741,179...14,743,083
Ensembl chr10:14,741,239...14,743,083

G

G protein nucleolar 1

decreases expression
multiple interactions

fenvalerate results in decreased expression of GNL1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GNL1 protein

PMID:30307764 PMID:34896426

NCBI chr20:2,783,130...2,792,115
Ensembl chr20:2,778,985...2,792,115

G

gonadotropin releasing hormone 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of GNRH1 protein

NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581
Ensembl chr15:41,972,905...41,973,581

G

glucosamine (N-acetyl)-6-sulfatase

increases expression

fenvalerate results in increased expression of GNS mRNA

NCBI chr 7:56,889,148...56,923,173
Ensembl chr 7:56,889,232...56,923,151

G

golgi integral membrane protein 4

increases expression

fenvalerate results in increased expression of GOLIM4 mRNA

NCBI chr 2:160,640,837...160,733,475
Ensembl chr 2:160,640,938...160,733,253

G

gon-4 like

increases expression

fenvalerate results in increased expression of GON4L mRNA

NCBI chr 2:174,233,461...174,306,636
Ensembl chr 2:174,233,461...174,306,634

G

glutamic-oxaloacetic transaminase 1

increases activity

fenvalerate results in increased activity of GOT1 protein

NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633

G

glypican 3

increases expression

fenvalerate results in increased expression of GPC3 mRNA

NCBI chr X:131,868,986...132,236,824
Ensembl chr X:131,868,990...132,236,798

G

gephyrin

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GPHN protein

NCBI chr 6:96,954,365...97,483,617
Ensembl chr 6:96,892,148...97,483,612

G

glycoprotein m6a

increases expression

fenvalerate results in increased expression of GPM6A mRNA

NCBI chr16:36,641,282...36,973,377
Ensembl chr16:36,641,284...36,973,475

G

G protein-coupled receptor 153

decreases expression

fenvalerate results in decreased expression of GPR153 mRNA

NCBI chr 5:162,781,587...162,792,975
Ensembl chr 5:162,781,587...162,792,971

G

G protein-coupled receptor 162

increases expression

fenvalerate results in increased expression of GPR162 mRNA

NCBI chr 4:157,662,200...157,668,341
Ensembl chr 4:157,662,200...157,668,121

G

G protein-coupled receptor 176

increases expression

fenvalerate results in increased expression of GPR176 mRNA

NCBI chr 3:105,236,794...105,337,664
Ensembl chr 3:105,236,795...105,337,226

G

G protein-coupled receptor 20

increases expression

fenvalerate results in increased expression of GPR20 mRNA

NCBI chr 7:105,601,761...105,611,959
Ensembl chr 7:105,602,368...105,603,430

G

G protein-coupled receptor 83

increases expression

fenvalerate results in increased expression of GPR83 mRNA

NCBI chr 8:11,693,540...11,704,028
Ensembl chr 8:11,693,540...11,704,028

G

G protein-coupled receptor 85

increases expression

fenvalerate results in increased expression of GPR85 mRNA

NCBI chr 4:42,100,138...42,109,584
Ensembl chr 4:42,102,941...42,109,566

G

G protein-coupled receptor associated sorting protein 2

increases expression

fenvalerate results in increased expression of GPRASP2 mRNA

NCBI chr X:98,817,668...98,823,814
Ensembl chr X:98,817,593...98,824,402

G

glutamic--pyruvic transaminase

increases activity
multiple interactions

fenvalerate results in increased activity of GPT protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the activity of GPT protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased activity of GPT protein

PMID:15186033 PMID:33396045 PMID:35678313

NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494

G

glutathione peroxidase 4

affects expression

fenvalerate affects the expression of GPX4 protein

NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982

G

GRB2-related adaptor protein 2

increases expression

fenvalerate results in increased expression of GRAP2 mRNA

NCBI chr 7:112,117,142...112,190,880
Ensembl chr 7:112,117,142...112,190,877

G

growth regulating estrogen receptor binding 1

increases expression

fenvalerate results in increased expression of GREB1 mRNA

NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633

G

gremlin 1, DAN family BMP antagonist

increases expression

fenvalerate results in increased expression of GREM1 mRNA

NCBI chr 3:100,512,317...100,524,001
Ensembl chr 3:100,512,313...100,524,082

G

grainyhead-like transcription factor 1

increases expression

fenvalerate results in increased expression of GRHL1 mRNA

NCBI chr 6:41,207,325...41,257,516
Ensembl chr 6:41,207,348...41,254,301

G

glutamate ionotropic receptor AMPA type subunit 2

decreases expression
increases expression

fenvalerate results in decreased expression of GRIA2 protein
fenvalerate results in increased expression of GRIA2 mRNA

PMID:26961610 PMID:30307764

NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510

G

glutamate ionotropic receptor AMPA type subunit 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRIA3 protein

NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096

G

glutamate ionotropic receptor AMPA type subunit 4

increases expression

fenvalerate results in increased expression of GRIA4 mRNA

NCBI chr 8:1,562,118...2,035,035
Ensembl chr 8:1,562,119...2,034,979

G

glutamate ionotropic receptor kainate type subunit 2

increases expression

fenvalerate results in increased expression of GRIK2 mRNA

NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375

G

glutamate ionotropic receptor kainate type subunit 5

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRIK5 protein

NCBI chr 1:80,605,878...80,667,896
Ensembl chr 1:80,605,892...80,667,125

G

glutamate ionotropic receptor NMDA type subunit 1

increases expression
decreases expression

fenvalerate results in increased expression of GRIN1 mRNA
fenvalerate results in decreased expression of GRIN1 mRNA

PMID:30307764 PMID:34748853

NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603

G

glutamate ionotropic receptor NMDA type subunit 2D

increases expression

fenvalerate results in increased expression of GRIN2D mRNA

NCBI chr 1:96,306,871...96,346,994
Ensembl chr 1:96,308,365...96,344,793

G

glutamate ionotropic receptor NMDA type subunit 3A

increases expression

fenvalerate results in increased expression of GRIN3A mRNA

NCBI chr 5:64,006,847...64,206,408
Ensembl chr 5:64,009,980...64,206,085

G

glutamate ionotropic receptor NMDA type subunit 3B

increases expression

fenvalerate results in increased expression of GRIN3B mRNA

NCBI chr 7:9,730,861...9,737,183
Ensembl chr 7:9,730,862...9,737,183

G

glutamate receptor interacting protein 2

increases expression

fenvalerate results in increased expression of GRIP2 mRNA

NCBI chr 4:124,271,456...124,356,538
Ensembl chr 4:124,271,456...124,321,268

G

glutamate metabotropic receptor 1

increases expression
multiple interactions

fenvalerate results in increased expression of GRM1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRM1 protein

PMID:30307764 PMID:34896426

NCBI chr 1:5,058,285...5,453,170
Ensembl chr 1:5,058,292...5,453,170

G

glutamate metabotropic receptor 5

increases expression
multiple interactions

fenvalerate results in increased expression of GRM5 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRM5 protein

PMID:30307764 PMID:34896426

NCBI chr 1:141,310,069...141,884,980
Ensembl chr 1:141,312,368...141,882,274

G

glutamate metabotropic receptor 8

increases expression

fenvalerate results in increased expression of GRM8 mRNA

NCBI chr 4:55,805,762...56,731,690
Ensembl chr 4:55,805,955...56,730,831

G

granulin precursor

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRN protein

NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775

G

G1 to S phase transition 2

increases expression

fenvalerate results in increased expression of GSPT2 mRNA

NCBI chr X:59,587,237...59,589,758
Ensembl chr X:59,587,276...59,594,162

G

glutathione-disulfide reductase

decreases activity

fenvalerate metabolite results in decreased activity of GSR protein; fenvalerate results in decreased activity of GSR protein

NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661

G

glutathione S-transferase omega 1

decreases expression

fenvalerate results in decreased expression of GSTO1 protein

NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468

G

glutathione S-transferase pi 1

decreases expression

fenvalerate results in decreased expression of GSTP1 protein

NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226

G

general transcription factor II I

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GTF2I protein

NCBI chr12:22,400,933...22,476,243
Ensembl chr12:22,401,431...22,476,243

G

gametocyte specific factor 1-like

increases expression

fenvalerate results in increased expression of GTSF1L mRNA

NCBI chr 3:151,736,020...151,738,715
Ensembl chr 3:151,735,997...151,736,863

G

guanylate cyclase 1 soluble subunit alpha 1

increases expression

fenvalerate results in increased expression of GUCY1A1 mRNA

NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671

G

guanylate cyclase 1 soluble subunit alpha 2

increases expression

fenvalerate results in increased expression of GUCY1A2 mRNA

NCBI chr 8:500,212...900,201
Ensembl chr 8:500,212...889,203

G

guanylate cyclase 1 soluble subunit beta 2

decreases expression

fenvalerate results in decreased expression of GUCY1B2 mRNA

NCBI chr15:36,589,501...36,669,441
Ensembl chr15:36,598,883...36,669,441

G

guanylate cyclase 2C

increases expression

fenvalerate results in increased expression of GUCY2C mRNA

NCBI chr 4:169,568,505...169,649,092
Ensembl chr 4:169,568,529...169,649,092

G

guanylate cyclase 2E

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GUCY2E protein

NCBI chr10:53,954,918...53,975,576
Ensembl chr10:53,959,010...53,974,067

G

GULP PTB domain containing engulfment adaptor 1

decreases expression

fenvalerate results in decreased expression of GULP1 mRNA

NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005

G

glucuronidase, beta

increases activity

fenvalerate results in increased activity of GUSB protein

NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905

G

H2A.P histone

increases expression

fenvalerate results in increased expression of H2AP mRNA

NCBI chr X:12,907,962...12,908,516

G

3-hydroxyacyl-CoA dehydratase 4

increases expression

fenvalerate results in increased expression of HACD4 mRNA

NCBI chr 5:102,887,597...102,915,376
Ensembl chr 5:102,887,588...102,915,338

G

hydroxyacyl-CoA dehydrogenase

increases expression

fenvalerate results in increased expression of HADH mRNA

NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353

G

hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha

increases expression
multiple interactions

fenvalerate results in increased expression of HADHA mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HADHA protein

PMID:30307764 PMID:34896426

NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869

G

hydroxyacyl glutathione hydrolase

decreases expression

fenvalerate results in decreased expression of HAGH protein

NCBI chr10:13,874,883...13,889,527
Ensembl chr10:13,875,241...13,889,504

G

hydroxyacylglutathione hydrolase-like

increases expression

fenvalerate results in increased expression of HAGHL mRNA

NCBI chr10:14,804,957...14,809,495
Ensembl chr10:14,804,997...14,807,665

G

huntingtin-associated protein 1

affects methylation

fenvalerate affects the methylation of HAP1 gene

NCBI chr10:85,277,890...85,286,126
Ensembl chr10:85,277,890...85,286,126

G

hyaluronan and proteoglycan link protein 1

increases expression

fenvalerate results in increased expression of HAPLN1 mRNA

NCBI chr 2:20,631,640...20,696,388
Ensembl chr 2:20,631,640...20,693,777

G

HUWE1 associated protein modifying stress responses

increases expression

fenvalerate results in increased expression of HAPSTR1 mRNA

NCBI chr10:6,746,037...6,774,992
Ensembl chr10:6,746,048...6,774,992

G

hemoglobin subunit beta

decreases expression

fenvalerate results in decreased expression of HBB protein

NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012

G

hemoglobin subunit epsilon 1

increases expression

fenvalerate results in increased expression of HBE1 mRNA

NCBI chr 1:158,282,931...158,458,855
Ensembl chr 1:158,282,936...158,284,391

G

heparin-binding EGF-like growth factor

increases expression

fenvalerate results in increased expression of HBEGF mRNA

NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441

G

hyperpolarization-activated cyclic nucleotide-gated potassium channel 3

increases expression

fenvalerate results in increased expression of HCN3 mRNA

NCBI chr 2:174,551,861...174,567,459
Ensembl chr 2:174,551,680...174,565,966

G

hypocretin receptor 1

increases expression

fenvalerate results in increased expression of HCRTR1 mRNA

NCBI chr 5:142,477,214...142,486,674
Ensembl chr 5:142,477,214...142,486,674

G

histone deacetylase 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HDAC1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111

G

histone deacetylase 10

decreases expression
multiple interactions

fenvalerate results in decreased expression of HDAC10 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC10 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC10 mRNA

PMID:30307764 PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 7:120,199,126...120,205,850
Ensembl chr 7:120,199,129...120,204,228

G

histone deacetylase 4

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HDAC4 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of HDAC4 mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164

G

histidine decarboxylase

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HDC mRNA

NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341

G

HDGF like 3

increases expression

fenvalerate results in increased expression of HDGFL3 mRNA

NCBI chr 1:135,822,600...135,876,719
Ensembl chr 1:135,827,549...135,876,719

G

helt bHLH transcription factor

increases expression

fenvalerate results in increased expression of HELT mRNA

NCBI chr16:45,991,227...45,993,045
Ensembl chr16:45,991,227...45,992,960

G

helicase with zinc finger

decreases expression

fenvalerate results in decreased expression of HELZ mRNA

NCBI chr10:92,479,403...92,645,234
Ensembl chr10:92,501,518...92,638,383

G

hypoxia inducible factor 1 subunit alpha

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HIF1A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HIF1A mRNA

PMID:33396045 PMID:34896426

NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261

G

hypoxia inducible factor 3 subunit alpha

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HIF3A protein

NCBI chr 1:77,718,110...77,750,448
Ensembl chr 1:77,722,471...77,749,758

G

hexokinase 2

increases expression

fenvalerate results in increased expression of HK2 mRNA

NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530

G

3-hydroxy-3-methylglutaryl-CoA reductase

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HMGCR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HMGCR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMGCR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of HMGCR mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703

G

3-hydroxy-3-methylglutaryl-CoA synthase 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HMGCS1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HMGCS1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMGCS1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of HMGCS1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100

G

HMG-box containing 4

increases expression

fenvalerate results in increased expression of HMGXB4 mRNA

NCBI chr19:13,364,741...13,403,563
Ensembl chr19:13,364,807...13,403,563

G

heme oxygenase 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HMOX1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMOX1 mRNA

PMID:33396045 PMID:34896426

NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079

G

heterogeneous nuclear ribonucleoprotein A2/B1

affects expression

fenvalerate affects the expression of HNRNPA2B1 protein

NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249

G

heterogeneous nuclear ribonucleoprotein D

decreases expression

fenvalerate results in decreased expression of HNRNPD protein

NCBI chr14:9,615,375...9,638,975
Ensembl chr14:9,615,479...9,633,786

G

heterogeneous nuclear ribonucleoprotein K

increases expression

fenvalerate results in increased expression of HNRNPK protein

NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997

G

homeobox and leucine zipper encoding

increases expression

fenvalerate results in increased expression of HOMEZ mRNA

NCBI chr15:28,321,633...28,339,486
Ensembl chr15:28,320,819...28,339,745

G

homeo box B6

increases expression

fenvalerate results in increased expression of HOXB6 mRNA

NCBI chr10:81,258,726...81,267,458
Ensembl chr10:81,265,056...81,267,449

G

homeobox D8

increases expression

fenvalerate results in increased expression of HOXD8 mRNA

NCBI chr 3:59,607,793...59,610,359
Ensembl chr 3:59,607,996...59,610,361

G

heterochromatin protein 1, binding protein 3

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HP1BP3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HP1BP3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HP1BP3 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 5:150,435,781...150,463,004
Ensembl chr 5:150,433,740...150,463,000

G

hippocalcin

increases expression

fenvalerate results in increased expression of HPCA mRNA

NCBI chr 5:141,455,616...141,466,252
Ensembl chr 5:141,455,613...141,463,841

G

hippocalcin-like 4

increases expression

fenvalerate results in increased expression of HPCAL4 mRNA

NCBI chr 5:135,454,477...135,466,417
Ensembl chr 5:135,454,540...135,466,416

G

15-hydroxyprostaglandin dehydrogenase

increases expression

fenvalerate results in increased expression of HPGD mRNA

NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228

G

HPS1, biogenesis of lysosomal organelles complex 3 subunit 1

increases expression

fenvalerate results in increased expression of HPS1 mRNA

NCBI chr 1:241,551,180...241,577,292
Ensembl chr 1:241,551,175...241,577,268

G

hemopexin

decreases expression

fenvalerate results in decreased expression of HPX protein

NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328

G

histamine receptor H 2

increases expression

fenvalerate results in increased expression of HRH2 mRNA

NCBI chr17:10,366,004...10,407,791
Ensembl chr17:10,368,298...10,407,631

G

histamine receptor H4

increases expression

fenvalerate results in increased expression of HRH4 mRNA

NCBI chr18:4,166,270...4,182,426
Ensembl chr18:4,166,270...4,246,345

G

hydroxysteroid (17-beta) dehydrogenase 1

decreases expression
affects expression
increases expression

fenvalerate results in decreased expression of HSD17B1 mRNA
fenvalerate affects the expression of HSD17B1 protein
fenvalerate results in increased expression of HSD17B1 mRNA

PMID:16001830 PMID:21232584 PMID:30307764

NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927

G

hydroxysteroid (17-beta) dehydrogenase 14

increases expression

fenvalerate results in increased expression of HSD17B14 mRNA

NCBI chr 1:96,029,224...96,039,577
Ensembl chr 1:96,029,284...96,039,883

G

hydroxysteroid (17-beta) dehydrogenase 2

decreases expression

fenvalerate results in decreased expression of HSD17B2 mRNA

NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202

G

hydroxysteroid (17-beta) dehydrogenase 3

increases expression
multiple interactions

fenvalerate results in increased expression of HSD17B3 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HSD17B3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSD17B3 mRNA

PMID:30307764 PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HSD3B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSD3B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HSD3B1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999

G

heat shock transcription factor 2

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HSF2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSF2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HSF2 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr20:36,819,864...36,847,490
Ensembl chr20:36,819,864...36,850,174

G

heat shock transcription factor 2 binding protein

increases expression

fenvalerate results in increased expression of HSF2BP mRNA

NCBI chr20:10,035,562...10,123,059
Ensembl chr20:10,035,562...10,121,242

G

heat shock protein 90 alpha family class A member 1

decreases expression

fenvalerate results in decreased expression of HSP90AA1 protein

NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268

G

heat shock protein 90 beta family member 1

decreases expression

fenvalerate results in decreased expression of HSP90B1 protein

NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788

G

heat shock protein family A (Hsp70) member 12B

increases expression

fenvalerate results in increased expression of HSPA12B mRNA

NCBI chr 3:118,346,372...118,364,374
Ensembl chr 3:118,346,354...118,364,737

G

heat shock protein family A (Hsp70) member 2

increases expression

fenvalerate results in increased expression of HSPA2 mRNA

NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287

G

heat shock protein family A (Hsp70) member 4 like

decreases expression

fenvalerate results in decreased expression of HSPA4L protein

NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084

G

heat shock protein family A (Hsp70) member 5

affects expression

fenvalerate affects the expression of HSPA5 protein

NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891

G

heat shock protein family A (Hsp70) member 8

affects expression

fenvalerate affects the expression of HSPA8 protein

NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259

G

heat shock protein family B (small) member 7

increases expression

fenvalerate results in increased expression of HSPB7 mRNA

NCBI chr 5:153,727,782...153,731,268
Ensembl chr 5:153,727,588...153,731,266

G

5-hydroxytryptamine receptor 1F

increases expression

fenvalerate results in increased expression of HTR1F mRNA

NCBI chr11:2,642,751...2,644,150
Ensembl chr11:2,642,751...2,644,150

G

5-hydroxytryptamine receptor 2C

increases expression

fenvalerate results in increased expression of HTR2C mRNA

NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287

G

5-hydroxytryptamine receptor 6

increases expression

fenvalerate results in increased expression of HTR6 mRNA

NCBI chr 5:151,295,269...151,312,853
Ensembl chr 5:151,296,662...151,311,912

G

HtrA serine peptidase 4

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HTRA4 protein

NCBI chr16:67,001,605...67,015,074
Ensembl chr16:67,001,605...67,015,074

G

hyccin PI4KA lipid kinase complex subunit 2

increases expression

fenvalerate results in increased expression of HYCC2 mRNA

NCBI chr 9:60,056,883...60,129,176
Ensembl chr 9:60,056,890...60,093,007

G

hypoxia up-regulated 1

increases expression

fenvalerate results in increased expression of HYOU1 mRNA

NCBI chr 8:44,706,073...44,718,189
Ensembl chr 8:44,706,263...44,718,186

G

islet amyloid polypeptide

increases expression

fenvalerate results in increased expression of IAPP mRNA

NCBI chr 4:175,237,107...175,244,373
Ensembl chr 4:175,237,115...175,242,920

G

islet cell autoantigen 1-like

increases expression

fenvalerate results in increased expression of ICA1L mRNA

NCBI chr 9:61,410,959...61,469,884
Ensembl chr 9:61,412,091...61,470,134

G

intercellular adhesion molecule 2

increases expression

fenvalerate results in increased expression of ICAM2 mRNA

NCBI chr10:91,308,608...91,319,536
Ensembl chr10:91,308,538...91,315,293

G

inhibitor of DNA binding 2

increases expression

fenvalerate results in increased expression of ID2 mRNA

NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400

G

isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha

increases expression

fenvalerate results in increased expression of IDH3A protein

NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:54,971,740...54,991,084

G

isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta

increases expression

fenvalerate results in increased expression of IDH3B protein

NCBI chr 3:117,481,845...117,486,909
Ensembl chr 3:117,481,845...117,486,982

G

intraflagellar transport 81

increases expression

fenvalerate results in increased expression of IFT81 mRNA

NCBI chr12:33,957,744...34,037,164
Ensembl chr12:33,957,806...34,037,057

G

insulin-like growth factor 1

decreases expression
decreases secretion

fenvalerate results in decreased expression of IGF1 mRNA
fenvalerate results in decreased secretion of IGF1 protein

NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296

G

insulin-like growth factor 1 receptor

increases expression

fenvalerate results in increased expression of IGF1R mRNA

NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777

G

insulin-like growth factor 2

decreases expression
increases expression

fenvalerate results in decreased expression of IGF2 mRNA
fenvalerate results in increased expression of IGF2 mRNA

PMID:28369636 PMID:30307764

NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018

G

insulin-like growth factor 2 mRNA binding protein 1

increases expression

fenvalerate results in increased expression of IGF2BP1 mRNA

NCBI chr10:80,908,300...80,951,097
Ensembl chr10:80,908,076...80,951,129

G

insulin-like growth factor binding protein-like 1

increases expression

fenvalerate results in increased expression of IGFBPL1 mRNA

NCBI chr 5:60,076,428...60,091,833
Ensembl chr 5:60,076,429...60,091,833

G

immunoglobulin superfamily, member 9

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein

NCBI chr13:84,948,643...84,965,616
Ensembl chr13:84,948,619...84,965,607

G

IKBKB interacting protein

decreases expression

fenvalerate results in decreased expression of IKBIP mRNA

NCBI chr 7:25,579,865...25,598,548
Ensembl chr 7:25,579,832...25,605,162

G

interleukin 12B

increases expression

fenvalerate results in increased expression of IL12B mRNA

NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903

G

interleukin 1 receptor type 1

increases expression

fenvalerate results in increased expression of IL1R1 mRNA

NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937

G

interleukin 22 receptor subunit alpha 2

increases expression

fenvalerate results in increased expression of IL22RA2 mRNA

NCBI chr 1:14,353,736...14,377,844
Ensembl chr 1:14,364,489...14,377,844

G

interleukin 31 receptor A

decreases expression

fenvalerate results in decreased expression of IL31RA protein

NCBI chr 2:44,118,748...44,189,943
Ensembl chr 2:44,122,624...44,183,767

G

interleukin 5

increases expression

fenvalerate results in increased expression of IL5 mRNA

NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213

G

interleukin 6

increases expression

fenvalerate results in increased expression of IL6 mRNA

NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178

G

immunoglobulin-like domain containing receptor 1

increases expression

fenvalerate results in increased expression of ILDR1 mRNA

NCBI chr11:64,085,774...64,118,760
Ensembl chr11:64,008,566...64,118,760

G

inner membrane mitochondrial protein

increases expression

fenvalerate results in increased expression of IMMT mRNA

NCBI chr 4:103,880,482...103,919,116
Ensembl chr 4:103,880,459...103,919,109

G

interphotoreceptor matrix proteoglycan 1

increases expression

fenvalerate results in increased expression of IMPG1 mRNA

NCBI chr 8:81,243,624...81,389,722
Ensembl chr 8:81,243,624...81,389,722

G

InaF-motif containing 1

increases expression

fenvalerate results in increased expression of INAFM1 mRNA

NCBI chr 1:76,976,808...76,978,292

G

inner centromere protein

increases expression

fenvalerate results in increased expression of INCENP mRNA

NCBI chr 1:206,520,655...206,550,575
Ensembl chr 1:206,523,380...206,553,265

G

inhibin subunit beta A

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of INHBA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of INHBA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of INHBA protein

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982

G

inka box actin regulator 1

increases expression

fenvalerate results in increased expression of INKA1 mRNA

NCBI chr 8:108,674,263...108,675,953
Ensembl chr 8:108,674,263...108,675,953

G

indolethylamine N-methyltransferase

decreases expression

fenvalerate results in decreased expression of INMT mRNA

NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493

G

INO80 complex subunit E

increases expression

fenvalerate results in increased expression of INO80E mRNA

NCBI chr 1:181,461,406...181,472,059
Ensembl chr 1:181,461,408...181,472,469

G

INSM transcriptional repressor 2

increases expression

fenvalerate results in increased expression of INSM2 mRNA

NCBI chr 6:72,973,861...72,976,453

G

insulin receptor

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of INSR protein

NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883

G

insulin receptor-related receptor

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of INSRR protein

NCBI chr 2:173,255,335...173,274,800
Ensembl chr 2:173,255,414...173,274,800

G

integrator complex subunit 14

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of INTS14 protein

NCBI chr 8:65,475,788...65,500,807
Ensembl chr 8:65,475,910...65,500,804

G

integrator complex subunit 6 like

increases expression

fenvalerate results in increased expression of INTS6L mRNA

NCBI chr X:134,258,117...134,325,706
Ensembl chr X:134,258,125...134,309,617

G

integrator complex subunit 7

increases expression

fenvalerate results in increased expression of INTS7 mRNA

NCBI chr13:103,155,123...103,207,953
Ensembl chr13:103,155,090...103,208,592

G

importin 5

increases expression

fenvalerate results in increased expression of IPO5 mRNA

NCBI chr15:97,990,755...98,041,074
Ensembl chr15:98,005,299...98,041,126

G

IQ motif containing with AAA domain 1

increases expression

fenvalerate results in increased expression of IQCA1 mRNA

NCBI chr 9:90,626,735...90,742,563
Ensembl chr 9:90,626,744...90,742,618

G

IQ motif and Sec7 domain ArfGEF 2

increases expression

fenvalerate results in increased expression of IQSEC2 mRNA

NCBI chr X:21,254,799...21,337,179
Ensembl chr X:21,254,914...21,336,584

G

IQ motif and Sec7 domain ArfGEF 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IQSEC3 protein

NCBI chr 4:154,610,933...154,707,310
Ensembl chr 4:154,610,934...154,707,310

G

interferon regulatory factor 5

decreases expression

fenvalerate results in decreased expression of IRF5 mRNA

NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267

G

iroquois homeobox 4

increases expression

fenvalerate results in increased expression of IRX4 mRNA

NCBI chr 1:30,030,561...30,039,549
Ensembl chr 1:30,030,561...30,039,549

G

inositol-3-phosphate synthase 1

decreases expression

fenvalerate results in decreased expression of ISYNA1 protein

NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979

G

integrin subunit alpha 11

increases expression

fenvalerate results in increased expression of ITGA11 mRNA

NCBI chr 8:63,145,998...63,254,714
Ensembl chr 8:63,146,001...63,254,407

G

integrin subunit alpha 9

increases expression

fenvalerate results in increased expression of ITGA9 mRNA

NCBI chr 8:118,307,424...118,615,527
Ensembl chr 8:118,307,381...118,613,754

G

integrin subunit alpha M

increases expression

fenvalerate results in increased expression of ITGAM mRNA

NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503

G

integrin subunit beta 5

decreases expression

fenvalerate results in decreased expression of ITGB5 mRNA

NCBI chr11:66,828,428...66,944,231
Ensembl chr11:66,829,285...66,944,472

G

inositol-trisphosphate 3-kinase C

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ITPKC protein

NCBI chr 1:82,500,957...82,522,533
Ensembl chr 1:82,500,957...82,522,779

G

inositol 1,4,5-trisphosphate receptor, type 1

increases expression

fenvalerate results in increased expression of ITPR1 mRNA

NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491

G

inositol 1,4,5-trisphosphate receptor, type 3

increases expression

fenvalerate results in increased expression of ITPR3 mRNA

PMID:19428952 PMID:30307764

NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337

G

intersectin 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ITSN1 protein

NCBI chr11:30,978,590...31,160,645
Ensembl chr11:30,978,590...31,160,645

G

Jun dimerization protein 2

increases expression

fenvalerate results in increased expression of JDP2 mRNA

NCBI chr 6:105,261,619...105,302,386
Ensembl chr 6:105,261,373...105,301,485

G

JNK1/MAPK8 associated membrane protein like

increases expression

fenvalerate results in increased expression of JKAMPL mRNA

NCBI chr 4:105,520,442...105,521,542
Ensembl chr 4:105,520,442...105,521,542

G

JunD proto-oncogene, AP-1 transcription factor subunit

decreases expression

fenvalerate results in decreased expression of JUND mRNA

NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799

G

KN motif and ankyrin repeat domains 2

increases expression

fenvalerate results in increased expression of KANK2 mRNA

NCBI chr 8:20,311,676...20,341,107
Ensembl chr 8:20,311,676...20,340,900

G

katanin catalytic subunit A1 like 1

increases expression

fenvalerate results in increased expression of KATNAL1 mRNA

NCBI chr12:6,094,663...6,156,114
Ensembl chr12:6,102,836...6,157,553

G

katanin regulatory subunit B1 like 1

increases expression

fenvalerate results in increased expression of KATNBL1 mRNA

NCBI chr 3:99,183,748...99,225,789
Ensembl chr 3:99,183,716...99,225,786

G

kelch repeat and BTB domain containing 6

increases expression

fenvalerate results in increased expression of KBTBD6 mRNA

NCBI chr15:54,848,285...54,850,042
Ensembl chr15:54,848,446...54,850,453

G

kelch repeat and BTB domain containing 8

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KBTBD8 protein

NCBI chr 4:127,675,967...127,688,785
Ensembl chr 4:127,676,141...127,687,697

G

potassium voltage-gated channel subfamily A member 5

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNA5 protein

NCBI chr 4:159,354,689...159,358,173
Ensembl chr 4:159,350,097...159,357,697

G

potassium voltage-gated channel subfamily A member 6

increases expression

fenvalerate results in increased expression of KCNA6 mRNA

NCBI chr 4:159,542,941...159,576,189
Ensembl chr 4:159,542,615...159,576,189

G

potassium voltage-gated channel subfamily A regulatory beta subunit 1

increases expression

fenvalerate results in increased expression of KCNAB1 mRNA

NCBI chr 2:149,137,025...149,603,540
Ensembl chr 2:149,137,041...149,603,534

G

potassium voltage-gated channel subfamily B member 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNB2 protein

NCBI chr 5:3,567,012...4,028,564
Ensembl chr 5:3,569,685...4,028,599

G

potassium voltage-gated channel subfamily C member 2

increases expression

fenvalerate results in increased expression of KCNC2 mRNA

NCBI chr 7:47,700,035...47,883,979
Ensembl chr 7:47,700,288...47,883,968

G

potassium voltage-gated channel subfamily C member 3

increases expression

fenvalerate results in increased expression of KCNC3 mRNA

NCBI chr 1:95,080,960...95,095,165
Ensembl chr 1:95,080,960...95,095,160

G

potassium voltage-gated channel subfamily D member 3

increases expression

fenvalerate results in increased expression of KCND3 mRNA

NCBI chr 2:192,937,950...193,155,345
Ensembl chr 2:192,937,950...193,155,345

G

potassium voltage-gated channel modifier subfamily G member 2

increases expression

fenvalerate results in increased expression of KCNG2 mRNA

NCBI chr18:73,742,224...73,810,420
Ensembl chr18:73,743,074...73,808,723

G

potassium voltage-gated channel modifier subfamily G member 3

increases expression

fenvalerate results in increased expression of KCNG3 mRNA

NCBI chr 6:11,051,311...11,099,264
Ensembl chr 6:11,051,134...11,099,264

G

potassium voltage-gated channel subfamily H member 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNH3 protein

NCBI chr 7:130,365,593...130,383,859
Ensembl chr 7:130,366,011...130,383,855

G

potassium voltage-gated channel subfamily H member 5

increases expression

fenvalerate results in increased expression of KCNH5 mRNA

NCBI chr 6:93,615,174...93,908,107
Ensembl chr 6:93,624,529...93,908,107

G

potassium voltage-gated channel interacting protein 1

increases expression

fenvalerate results in increased expression of KCNIP1 mRNA

NCBI chr10:18,219,519...18,588,833
Ensembl chr10:18,219,519...18,589,045

G

potassium inwardly-rectifying channel, subfamily J, member 11

increases expression

fenvalerate results in increased expression of KCNJ11 mRNA

NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082

G

potassium inwardly-rectifying channel, subfamily J, member 14

increases expression

fenvalerate results in increased expression of KCNJ14 mRNA

NCBI chr 1:96,293,159...96,300,810
Ensembl chr 1:96,293,435...96,495,459

G

potassium inwardly-rectifying channel, subfamily J, member 5

increases expression

fenvalerate results in increased expression of KCNJ5 mRNA

NCBI chr 8:30,724,923...30,753,083
Ensembl chr 8:30,724,925...30,753,518

G

potassium two pore domain channel subfamily K member 10

increases expression

fenvalerate results in increased expression of KCNK10 mRNA

NCBI chr 6:117,690,052...117,826,120
Ensembl chr 6:117,694,222...117,825,695

G

potassium two pore domain channel subfamily K member 4

increases expression

fenvalerate results in increased expression of KCNK4 mRNA

NCBI chr 1:204,117,941...204,129,494
Ensembl chr 1:204,114,572...204,125,925

G

potassium calcium-activated channel subfamily N member 2

increases expression

fenvalerate results in increased expression of KCNN2 mRNA

NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347

G

potassium voltage-gated channel, modifier subfamily S, member 3

increases expression

fenvalerate results in increased expression of KCNS3 mRNA

NCBI chr 6:33,808,314...33,865,018
Ensembl chr 6:33,808,216...33,865,125

G

potassium sodium-activated channel subfamily T member 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNT1 protein

NCBI chr 3:8,682,964...8,736,615
Ensembl chr 3:8,682,113...8,736,667

G

potassium voltage-gated channel modifier subfamily V member 1

increases expression

fenvalerate results in increased expression of KCNV1 mRNA

NCBI chr 7:76,260,695...76,269,170
Ensembl chr 7:76,260,695...76,269,170

G

potassium voltage-gated channel modifier subfamily V member 2

increases expression

fenvalerate results in increased expression of KCNV2 mRNA

NCBI chr 1:224,999,552...225,014,062
Ensembl chr 1:224,999,552...225,014,062

G

potassium channel tetramerization domain containing 1

increases expression

fenvalerate results in increased expression of KCTD1 mRNA

NCBI chr18:6,122,390...6,316,434
Ensembl chr18:6,122,390...6,317,393

G

lysine demethylase 3A

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KDM3A protein

NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073

G

Kiaa0408-like

increases expression

fenvalerate results in increased expression of KIAA0408L mRNA

NCBI chr 1:28,615,600...28,630,309
Ensembl chr 1:28,615,606...28,630,309

G

kinesin family member 13A

increases expression

fenvalerate results in increased expression of KIF13A mRNA

NCBI chr17:17,766,597...17,948,517
Ensembl chr17:17,766,597...17,943,615

G

kinesin family member 15

increases expression

fenvalerate results in increased expression of KIF15 mRNA

NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750

G

kinesin family member 1B

increases expression

fenvalerate results in increased expression of KIF1B mRNA

NCBI chr 5:159,607,697...159,742,778
Ensembl chr 5:159,561,271...159,742,778

G

kinesin family member 2C

increases expression

fenvalerate results in increased expression of KIF2C mRNA

NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637

G

kinesin family member 3a

increases expression

fenvalerate results in increased expression of KIF3A mRNA

NCBI chr10:37,725,930...37,761,183
Ensembl chr10:37,725,970...37,759,191

G

kinesin family member 5A

increases expression

fenvalerate results in increased expression of KIF5A mRNA

NCBI chr 7:63,051,894...63,089,024
Ensembl chr 7:63,049,424...63,092,858

G

kinesin family member 7

increases expression

fenvalerate results in increased expression of KIF7 mRNA

NCBI chr 1:133,639,487...133,658,539
Ensembl chr 1:133,640,065...133,658,576

G

KiSS-1 metastasis-suppressor

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of KISS1 protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of KISS1 protein

PMID:34896426 PMID:36053783

NCBI chr13:44,775,106...44,780,707
Ensembl chr13:44,774,823...44,780,612

G

KIT proto-oncogene receptor tyrosine kinase

increases expression

fenvalerate results in increased expression of KIT mRNA

NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652

G

KIT ligand

increases expression
multiple interactions

fenvalerate results in increased expression of KITLG mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of KITLG mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of KITLG mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of KITLG mRNA

PMID:30307764 PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214

G

kinesin light chain 2

decreases expression

fenvalerate results in decreased expression of KLC2 protein

NCBI chr 1:202,414,555...202,424,787
Ensembl chr 1:202,414,557...202,424,672

G

KLF transcription factor 4

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KLF4 mRNA

NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602

G

kelch-like family member 31

increases expression

fenvalerate results in increased expression of KLHL31 mRNA

NCBI chr 8:78,515,514...78,538,873
Ensembl chr 8:78,515,514...78,538,873

G

kelch-like family member 4

decreases expression

fenvalerate results in decreased expression of KLHL4 mRNA

NCBI chr X:79,429,193...79,719,482
Ensembl chr X:79,622,113...79,719,480

G

kelch-like family member 41

increases expression

fenvalerate results in increased expression of KLHL41 mRNA

NCBI chr 3:54,434,291...54,447,415
Ensembl chr 3:54,434,234...54,449,222

G

kallikrein 1-related peptidase C4

increases expression

fenvalerate results in increased expression of KLK1C4 mRNA

NCBI chr 1:94,434,574...94,438,678
Ensembl chr 1:94,434,534...94,438,709

G

kallikrein 1-related peptidase C9

increases expression

fenvalerate results in increased expression of KLK1C9 mRNA

NCBI chr 1:94,597,359...94,601,245
Ensembl chr 1:94,597,359...94,601,245

G

kallikrein related-peptidase 8

increases expression

fenvalerate results in increased expression of KLK8 mRNA

NCBI chr 1:94,251,803...94,258,646
Ensembl chr 1:94,251,803...94,258,646

G

killer cell lectin like receptor K1

increases expression

fenvalerate results in increased expression of KLRK1 mRNA

NCBI chr 4:163,079,887...163,092,434
Ensembl chr 4:163,081,927...163,092,459

G

kinetochore-localized astrin/SPAG5 binding protein

increases expression

fenvalerate results in increased expression of KNSTRN mRNA

NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715

G

kringle containing transmembrane protein 1

increases expression

fenvalerate results in increased expression of KREMEN1 mRNA

NCBI chr14:80,081,870...80,147,489
Ensembl chr14:80,084,403...80,147,516

G

keratin 15

increases expression

fenvalerate results in increased expression of KRT15 mRNA

NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,066,802...85,171,799

G

keratin 4

decreases expression

fenvalerate results in decreased expression of KRT4 mRNA

NCBI chr 7:133,046,067...133,052,027
Ensembl chr 7:133,046,515...133,052,019

G

keratin 8

increases expression

fenvalerate results in increased expression of KRT8 mRNA

NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728

G

keratin 86

increases expression

fenvalerate results in increased expression of KRT86 mRNA

NCBI chr 7:132,591,489...132,598,142
Ensembl chr 7:132,591,545...132,598,021

G

keratin 90

increases expression

fenvalerate results in increased expression of KRT90 mRNA

NCBI chr 7:132,677,994...132,686,634
Ensembl chr 7:132,677,751...132,686,759

G

keratin associated protein 13-2 like 1

increases expression

fenvalerate results in increased expression of KRTAP13-2L1 mRNA

NCBI chr11:28,121,625...28,122,158

G

keratinocyte associated protein 3

increases expression

fenvalerate results in increased expression of KRTCAP3 mRNA

NCBI chr 6:25,120,938...25,122,522
Ensembl chr 6:25,120,938...25,122,507

G

kynurenine aminotransferase 1

increases activity

fenvalerate results in increased activity of KYAT1 protein

NCBI chr 3:13,459,598...13,493,308
Ensembl chr 3:13,459,591...13,493,355

G

kynureninase

decreases activity

fenvalerate results in decreased activity of KYNU protein

NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488

G

L3MBTL histone methyl-lysine binding protein 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of L3MBTL2 protein

NCBI chr 7:113,186,303...113,209,706
Ensembl chr 7:113,186,370...113,207,489

G

ladinin 1

increases expression

fenvalerate results in increased expression of LAD1 mRNA

NCBI chr13:47,249,605...47,263,967
Ensembl chr13:47,249,605...47,263,967

G

laminin subunit alpha 5

increases expression

fenvalerate results in increased expression of LAMA5 mRNA

NCBI chr 3:167,270,296...167,318,370
Ensembl chr 3:167,270,296...167,318,451

G

laminin subunit gamma 3

increases expression

fenvalerate results in increased expression of LAMC3 mRNA

NCBI chr 3:15,165,220...15,226,697
Ensembl chr 3:15,165,220...15,226,697

G

leucine aminopeptidase 3

decreases expression

fenvalerate results in decreased expression of LAP3 protein

NCBI chr14:65,608,375...65,627,359
Ensembl chr14:65,608,376...65,627,359

G

linker for activation of T cells

decreases expression

fenvalerate results in decreased expression of LAT mRNA

NCBI chr 1:180,936,536...180,941,561
Ensembl chr 1:180,936,534...180,941,578

G

lamin B receptor

increases expression

fenvalerate results in increased expression of LBR mRNA

NCBI chr13:93,539,386...93,564,026
Ensembl chr13:93,538,920...93,564,017

G

lipocalin 1

increases expression

fenvalerate results in increased expression of LCN1 mRNA

NCBI chr 3:9,532,860...9,537,859
Ensembl chr 3:9,532,915...9,536,577

G

lipocalin 2

increases expression

fenvalerate results in increased expression of LCN2 mRNA

NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095

G

lactase

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LCT protein

NCBI chr13:39,781,929...39,824,456
Ensembl chr13:39,781,929...39,824,456

G

lactate dehydrogenase A

decreases expression

fenvalerate results in decreased expression of LDHA protein

NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472

G

lactate dehydrogenase C

increases expression

fenvalerate results in increased expression of LDHC mRNA

NCBI chr 1:97,385,984...97,403,382
Ensembl chr 1:97,382,379...97,403,378

G

lymphoid enhancer binding factor 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LEF1 protein

NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794

G

LEM domain containing 3

increases expression

fenvalerate results in increased expression of LEMD3 mRNA

NCBI chr 7:56,415,053...56,499,047
Ensembl chr 7:56,305,448...56,502,474

G

leukocyte receptor cluster member 1

increases expression

fenvalerate results in increased expression of LENG1 mRNA

NCBI chr 1:65,551,983...65,556,915
Ensembl chr 1:65,551,983...65,556,915

G

leptin

increases expression

fenvalerate results in increased expression of LEP mRNA

NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262

G

leptin receptor

increases expression
multiple interactions

fenvalerate results in increased expression of LEPR mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LEPR protein

PMID:30307764 PMID:34896426

NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908

G

LETM1 domain containing 1

increases expression

fenvalerate results in increased expression of LETMD1 mRNA

NCBI chr 7:131,584,241...131,597,797
Ensembl chr 7:131,584,259...131,597,796

G

luteinizing hormone subunit beta

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LHB protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of LHB protein

PMID:34896426 PMID:36053783

NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972
Ensembl chr 1:95,900,984...95,901,972

G

luteinizing hormone/choriogonadotropin receptor

increases expression
multiple interactions

fenvalerate results in increased expression of LHCGR mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of LHCGR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LHCGR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of LHCGR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of LHR mRNA

PMID:30307764 PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521

G

LIM homeobox 5

increases expression

fenvalerate results in increased expression of LHX5 mRNA

NCBI chr12:36,126,186...36,134,625
Ensembl chr12:36,126,186...36,134,625

G

LIM domain containing 1

increases expression

fenvalerate results in increased expression of LIMD1 mRNA

NCBI chr 8:123,121,363...123,168,476
Ensembl chr 8:123,122,460...123,167,714

G

LIM domain kinase 1

increases expression

fenvalerate results in increased expression of LIMK1 mRNA

NCBI chr12:22,026,697...22,060,605
Ensembl chr12:22,026,672...22,060,606

G

lin-37 DREAM MuvB core complex component

increases expression

fenvalerate results in increased expression of LIN37 mRNA

NCBI chr 1:85,809,065...85,813,235
Ensembl chr 1:85,809,074...85,812,991

G

limb and CNS expressed 1

increases expression

fenvalerate results in increased expression of LIX1 mRNA

NCBI chr 1:58,128,961...58,187,554
Ensembl chr 1:58,128,961...58,185,964

G

leucyl and cystinyl aminopeptidase

increases expression

fenvalerate results in increased expression of LNPEP mRNA

NCBI chr 1:58,258,642...58,355,532
Ensembl chr 1:58,258,642...58,354,544

G

ligand of numb-protein X 1

increases expression

fenvalerate results in increased expression of LNX1 mRNA

NCBI chr14:33,514,429...33,617,086
Ensembl chr14:33,514,436...33,617,086

G

lon peptidase 1, mitochondrial

increases expression

fenvalerate results in increased expression of LONP1 mRNA

NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771

G

lysyl oxidase

increases expression

fenvalerate results in increased expression of LOX mRNA

NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477

G

lysyl oxidase-like 1

increases expression

fenvalerate results in increased expression of LOXL1 mRNA

NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356

G

lysyl oxidase-like 2

increases expression

fenvalerate results in increased expression of LOXL2 mRNA

NCBI chr15:44,683,449...44,773,067
Ensembl chr15:44,683,880...44,773,067

G

lysophosphatidic acid receptor 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LPAR3 protein

NCBI chr 2:235,125,234...235,193,916
Ensembl chr 2:235,149,065...235,193,357

G

lactoperoxidase

decreases expression

fenvalerate results in decreased expression of LPO mRNA

NCBI chr10:72,606,950...72,626,220
Ensembl chr10:72,606,944...72,626,535

G

LIM domain containing preferred translocation partner in lipoma

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LPP protein

NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597

G

leucine rich repeat and fibronectin type III domain containing 1

increases expression

fenvalerate results in increased expression of LRFN1 mRNA

NCBI chr 1:83,742,442...83,761,450
Ensembl chr 1:83,682,964...83,761,449

G

leucine rich repeat and fibronectin type III domain containing 5

increases expression

fenvalerate results in increased expression of LRFN5 mRNA

NCBI chr 6:79,466,403...79,822,821
Ensembl chr 6:79,467,961...79,822,815

G

LDL receptor related protein associated protein 1

increases expression

fenvalerate results in increased expression of LRPAP1 mRNA

NCBI chr14:75,651,371...75,663,380
Ensembl chr14:75,651,376...75,665,414

G

leucine rich repeat containing 1

increases expression

fenvalerate results in increased expression of LRRC1 mRNA

NCBI chr 8:78,239,897...78,407,347
Ensembl chr 8:78,239,900...78,406,490

G

leucine rich repeat containing 20

increases expression

fenvalerate results in increased expression of LRRC20 mRNA

NCBI chr20:29,422,858...29,528,372
Ensembl chr20:29,422,925...29,528,369

G

leucine rich repeat containing 29

decreases expression

fenvalerate results in decreased expression of LRRC29 mRNA

NCBI chr19:33,181,713...33,203,583
Ensembl chr19:33,188,352...33,203,545

G

leucine rich repeat containing 38

increases expression

fenvalerate results in increased expression of LRRC38 mRNA

NCBI chr 5:155,685,495...155,707,578
Ensembl chr 5:155,685,495...155,707,578

G

leucine rich repeat containing 39

increases expression

fenvalerate results in increased expression of LRRC39 mRNA

NCBI chr 2:204,516,122...204,535,463
Ensembl chr 2:204,516,123...204,535,463

G

leucine rich repeat containing 4B

increases expression

fenvalerate results in increased expression of LRRC4B mRNA

NCBI chr 1:94,922,034...94,956,309
Ensembl chr 1:94,935,603...94,956,263

G

leucine rich repeat containing 51

increases expression

fenvalerate results in increased expression of LRRC51 mRNA

NCBI chr 1:156,278,617...156,297,838
Ensembl chr 1:156,278,618...156,297,773

G

leucine rich repeat containing 73

increases expression

fenvalerate results in increased expression of LRRC73 mRNA

NCBI chr 9:14,726,157...14,730,144
Ensembl chr 9:14,726,158...14,729,158

G

leucine rich repeat containing 8 VRAC subunit C

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LRRC8C protein

NCBI chr14:4,223,901...4,315,590
Ensembl chr14:4,227,832...4,315,249

G

limbic system-associated membrane protein

increases expression

fenvalerate results in increased expression of LSAMP mRNA

NCBI chr11:58,547,533...60,717,328
Ensembl chr11:58,554,805...60,717,029

G

large 60S subunit nuclear export GTPase 1

increases expression

fenvalerate results in increased expression of LSG1 mRNA

NCBI chr11:70,132,919...70,168,526
Ensembl chr11:70,143,847...70,168,518

G

lymphocyte-specific protein 1

increases expression

fenvalerate results in increased expression of LSP1 mRNA

NCBI chr 1:197,614,677...197,648,414
Ensembl chr 1:197,614,687...197,648,416

G

latent transforming growth factor beta binding protein 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LTBP2 protein

NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208

G

lysophospholipase 1

increases expression

fenvalerate results in increased expression of LYPLA1 protein

NCBI chr 5:14,679,605...14,708,774
Ensembl chr 5:14,679,606...14,708,746

G

mab-21 like 1

increases expression

fenvalerate results in increased expression of MAB21L1 mRNA

NCBI chr 2:139,943,496...139,945,885
Ensembl chr 2:139,943,496...139,945,885

G

mab-21 like 2

increases expression

fenvalerate results in increased expression of MAB21L2 mRNA

NCBI chr 2:171,946,573...171,949,655
Ensembl chr 2:171,946,573...171,949,655

G

MAF bZIP transcription factor F

increases expression

fenvalerate results in increased expression of MAFF mRNA

NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851

G

myelin-associated glycoprotein

increases expression

fenvalerate results in increased expression of MAG mRNA

NCBI chr 1:86,148,227...86,163,726
Ensembl chr 1:86,148,228...86,163,656

G

MAGE family member B16

increases expression

fenvalerate results in increased expression of MAGEB16 mRNA

NCBI chr X:43,693,205...43,725,664
Ensembl chr X:43,693,211...43,725,657

G

membrane associated guanylate kinase, WW and PDZ domain containing 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAGI2 protein

NCBI chr 4:14,386,389...15,870,036
Ensembl chr 4:14,386,399...15,870,240

G

male germ cell-associated kinase

increases expression

fenvalerate results in increased expression of MAK mRNA

NCBI chr17:23,683,753...23,731,125
Ensembl chr17:23,693,878...23,730,001

G

MAK16 homolog

increases expression

fenvalerate results in increased expression of MAK16 mRNA

NCBI chr16:60,972,699...60,981,250
Ensembl chr16:60,972,697...60,983,243

G

mal, T-cell differentiation protein

increases expression

fenvalerate results in increased expression of MAL mRNA

PMID:30307764 PMID:31524104

NCBI chr 3:114,864,378...114,888,136
Ensembl chr 3:114,864,378...114,888,136

G

MAM domain containing 4

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of MAMDC4 protein

NCBI chr 3:8,382,387...8,391,003
Ensembl chr 3:8,382,387...8,391,003

G

mannosidase, alpha, class 1A, member 2

increases expression

fenvalerate results in increased expression of MAN1A2 mRNA

NCBI chr 2:187,947,484...188,096,332
Ensembl chr 2:187,951,617...188,096,332

G

mannosidase, alpha, class 1B, member 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAN1B1 protein

NCBI chr 3:8,143,877...8,165,007
Ensembl chr 3:8,143,381...8,165,006

G

mannosidase, alpha, class 2C, member 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAN2C1 protein

NCBI chr 8:57,537,879...57,549,691
Ensembl chr 8:57,537,321...57,549,690

G

monoamine oxidase A

decreases activity

fenvalerate results in decreased activity of MAOA protein

NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593

G

mitogen-activated protein kinase kinase kinase 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAP3K1 protein

NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463

G

mitogen-activated protein kinase kinase kinase 19

increases expression

fenvalerate results in increased expression of MAP3K19 mRNA

NCBI chr13:39,300,150...39,343,502
Ensembl chr13:39,300,163...39,343,767

G

mitogen-activated protein kinase kinase kinase 6

increases expression

fenvalerate results in increased expression of MAP3K6 mRNA

NCBI chr 5:145,440,126...145,452,213
Ensembl chr 5:145,440,346...145,452,212

G

mitogen-activated protein kinase kinase kinase 9

increases expression

fenvalerate results in increased expression of MAP3K9 mRNA

NCBI chr 6:101,423,754...101,488,822
Ensembl chr 6:101,430,292...101,488,822

G

mitogen-activated protein kinase kinase kinase kinase 4

increases expression

fenvalerate results in increased expression of MAP4K4 mRNA

NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698

G

microtubule-associated protein 7

increases expression

fenvalerate results in increased expression of MAP7 mRNA

NCBI chr 1:14,910,433...15,037,574
Ensembl chr 1:14,910,551...15,037,574

G

MAP7 domain containing 2

increases expression

fenvalerate results in increased expression of MAP7D2 mRNA

NCBI chr X:35,372,453...35,488,073
Ensembl chr X:35,372,700...35,488,091

G

mitogen activated protein kinase 1

decreases phosphorylation
increases phosphorylation
multiple interactions

fenvalerate results in decreased phosphorylation of MAPK1 protein
fenvalerate results in increased phosphorylation of MAPK1 protein
[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased phosphorylation of MAPK1 protein

PMID:22210404 PMID:28949029 PMID:30307764

NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616

G

mitogen activated protein kinase 3

decreases phosphorylation
multiple interactions
increases phosphorylation

fenvalerate results in decreased phosphorylation of MAPK3 protein
[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased phosphorylation of MAPK3 protein
fenvalerate results in increased phosphorylation of MAPK3 protein

PMID:22210404 PMID:28949029 PMID:30307764

NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863

G

mitogen-activated protein kinase 8

multiple interactions

fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of MAPK8 protein]

NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981

G

membrane associated ring-CH-type finger 10

increases expression

fenvalerate results in increased expression of MARCHF10 mRNA

NCBI chr10:90,332,783...90,423,109
Ensembl chr10:90,332,784...90,421,588

G

microtubule affinity regulating kinase 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MARK1 protein

NCBI chr13:96,450,189...96,555,304
Ensembl chr13:96,451,487...96,555,173

G

MARVEL domain containing 1

increases expression

fenvalerate results in increased expression of MARVELD1 mRNA

NCBI chr 1:240,954,050...240,958,101
Ensembl chr 1:240,954,452...240,958,384

G

microtubule associated serine/threonine kinase 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAST1 protein

NCBI chr19:23,216,418...23,244,224
Ensembl chr19:23,207,991...23,244,235

G

microtubule associated serine/threonine kinase 2

increases expression

fenvalerate results in increased expression of MAST2 mRNA

NCBI chr 5:129,776,293...129,915,502
Ensembl chr 5:129,775,676...129,915,606

G

matrilin 1

increases expression

fenvalerate results in increased expression of MATN1 mRNA

NCBI chr 5:143,117,198...143,127,140
Ensembl chr 5:143,117,504...143,127,059

G

MAU2 sister chromatid cohesion factor

increases expression

fenvalerate results in increased expression of MAU2 mRNA

NCBI chr16:19,383,847...19,414,996
Ensembl chr16:19,383,492...19,408,727

G

methyl-CpG binding domain protein 5

increases expression

fenvalerate results in increased expression of MBD5 mRNA

NCBI chr 3:33,588,854...33,738,730
Ensembl chr 3:33,333,554...33,730,156

G

muscleblind-like splicing regulator 1

increases expression

fenvalerate results in increased expression of MBNL1 mRNA

NCBI chr 2:144,639,819...144,814,395
Ensembl chr 2:144,670,285...144,814,368

G

melanin-concentrating hormone receptor 1

decreases expression

fenvalerate results in decreased expression of MCHR1 mRNA

NCBI chr 7:112,761,554...112,764,746
Ensembl chr 7:112,761,554...112,764,032

G

MCL1 apoptosis regulator, BCL2 family member

multiple interactions

[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of MCL1 protein

NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303

G

minichromosome maintenance 10 replication initiation factor

increases expression

fenvalerate results in increased expression of MCM10 mRNA

NCBI chr17:73,263,788...73,288,346
Ensembl chr17:73,266,095...73,287,364

G

minichromosome maintenance 9 homologous recombination repair factor

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MCM9 protein

NCBI chr20:32,818,219...32,929,577
Ensembl chr20:32,844,951...32,929,600

G

minichromosome maintenance domain containing 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MCMDC2 protein

NCBI chr 5:9,291,967...9,337,526
Ensembl chr 5:9,298,101...9,338,300

G

MCTS family member 2

increases expression

fenvalerate results in increased expression of MCTS2 mRNA

NCBI chr 3:141,163,330...141,164,108

G

MAM domain containing glycosylphosphatidylinositol anchor 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of MDGA2 protein

NCBI chr 6:84,746,422...85,608,640
Ensembl chr 6:84,761,941...85,608,126

G

malic enzyme 2

increases expression
decreases expression

fenvalerate results in increased expression of ME2 mRNA
fenvalerate results in decreased expression of ME2 protein

PMID:30307764 PMID:33656234

NCBI chr18:67,350,833...67,400,987
Ensembl chr18:67,355,795...67,400,987

G

mediator complex subunit 20

increases expression

fenvalerate results in increased expression of MED20 mRNA

NCBI chr 9:13,370,146...13,382,756
Ensembl chr 9:13,370,146...13,382,476

G

mediator complex subunit 23

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MED23 protein

NCBI chr 1:20,490,315...20,558,461
Ensembl chr 1:20,490,315...20,537,463

G

mediator complex subunit 31

increases expression

fenvalerate results in increased expression of MED31 mRNA

NCBI chr10:56,836,944...56,840,326
Ensembl chr10:56,836,944...56,840,326

G

mesenteric estrogen-dependent adipogenesis

increases expression

fenvalerate results in increased expression of MEDAG mRNA

NCBI chr12:5,613,191...5,634,583
Ensembl chr12:5,613,208...5,634,767

G

myocyte enhancer factor 2C

decreases expression

fenvalerate results in decreased expression of MEF2C mRNA

NCBI chr 2:13,973,299...14,136,065
Ensembl chr 2:13,993,438...14,132,880

G

myocyte enhancer factor 2D

increases expression

fenvalerate results in increased expression of MEF2D mRNA

NCBI chr 2:173,606,054...173,635,620
Ensembl chr 2:173,606,490...173,634,457

G

multiple EGF-like domains 10

increases expression

fenvalerate results in increased expression of MEGF10 mRNA

NCBI chr18:50,605,231...50,755,441
Ensembl chr18:50,605,656...50,754,456

G

multiple EGF-like-domains 6

increases expression

fenvalerate results in increased expression of MEGF6 mRNA

NCBI chr 5:164,738,272...164,839,142
Ensembl chr 5:164,738,352...164,839,139

G

multiple EGF-like-domains 8

increases expression

fenvalerate results in increased expression of MEGF8 mRNA

NCBI chr 1:80,902,236...80,951,614
Ensembl chr 1:80,902,574...80,951,613

G

meiosis/spermiogenesis associated 1

increases expression

fenvalerate results in increased expression of MEIG1 mRNA

NCBI chr17:74,810,791...74,828,433
Ensembl chr17:74,814,632...74,828,433

G

methionyl aminopeptidase 1

decreases expression

fenvalerate results in decreased expression of METAP1 mRNA

NCBI chr 2:226,991,305...227,024,360
Ensembl chr 2:226,991,301...227,024,434

G

mex-3 RNA binding family member C

increases expression

fenvalerate results in increased expression of MEX3C mRNA

NCBI chr18:67,167,600...67,188,595
Ensembl chr18:67,166,718...67,188,595

G

microfibril associated protein 3 like

increases expression

fenvalerate results in increased expression of MFAP3L mRNA

NCBI chr16:29,411,643...29,454,665
Ensembl chr16:29,415,849...29,430,863

G

major facilitator superfamily domain containing 11

increases expression

fenvalerate results in increased expression of MFSD11 mRNA

NCBI chr10:102,055,516...102,075,064
Ensembl chr10:102,056,051...102,075,064

G

beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase

increases expression

fenvalerate results in increased expression of MGAT3 mRNA

NCBI chr 7:111,708,353...111,761,825
Ensembl chr 7:111,675,730...111,762,026

G

alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B

increases expression

fenvalerate results in increased expression of MGAT5B mRNA

NCBI chr10:102,120,757...102,190,235
Ensembl chr10:102,120,445...102,190,233

G

monoglyceride lipase

decreases expression

fenvalerate results in decreased expression of MGLL protein

NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179

G

microtubule associated monooxygenase, calponin and LIM domain containing 1

increases expression

fenvalerate results in increased expression of MICAL1 mRNA

NCBI chr20:44,974,137...44,986,089
Ensembl chr20:44,974,138...44,986,089

G

midline 1

increases expression

fenvalerate results in increased expression of MID1 mRNA

NCBI chr X:24,116,674...24,491,205
Ensembl chr X:24,120,293...24,248,353

G

malectin

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MLEC protein

NCBI chr12:41,458,234...41,468,710
Ensembl chr12:41,458,231...41,468,708

G

muscular LMNA-interacting protein

increases expression

fenvalerate results in increased expression of MLIP mRNA

NCBI chr 8:77,935,087...78,204,725
Ensembl chr 8:77,935,079...78,204,254

G

MLLT6, PHD finger containing

increases expression

fenvalerate results in increased expression of MLLT6 mRNA

NCBI chr10:82,657,258...82,678,899
Ensembl chr10:82,656,872...82,676,073

G

membrane metallo-endopeptidase-like 1

increases expression
multiple interactions

fenvalerate results in increased expression of MMEL1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MMEL1 protein

PMID:30307764 PMID:34896426

NCBI chr 5:165,431,278...165,461,716
Ensembl chr 5:165,431,343...165,461,716

G

matrix metallopeptidase 28

increases expression

fenvalerate results in increased expression of MMP28 mRNA

NCBI chr10:68,241,138...68,264,866
Ensembl chr10:68,241,138...68,264,866

G

matrix metallopeptidase 9

increases expression

fenvalerate results in increased expression of MMP9 mRNA

NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120

G

myelin-associated oligodendrocyte basic protein

increases expression

fenvalerate results in increased expression of MOBP mRNA

NCBI chr 8:119,869,504...119,899,605
Ensembl chr 8:119,869,626...119,899,563

G

myelin oligodendrocyte glycoprotein

increases expression

fenvalerate results in increased expression of MOG mRNA

NCBI chr20:1,513,137...1,523,473
Ensembl chr20:1,513,239...1,523,474

G

MORN repeat containing 4

decreases expression

fenvalerate results in decreased expression of MORN4 mRNA

NCBI chr 1:240,888,338...240,898,644
Ensembl chr 1:240,888,344...240,898,716

G

monooxygenase, DBH-like 1

increases expression

fenvalerate results in increased expression of MOXD1 mRNA

NCBI chr 1:21,075,124...21,165,348
Ensembl chr 1:21,075,122...21,161,779

G

MAGUK p55 scaffold protein 2

increases expression

fenvalerate results in increased expression of MPP2 mRNA

NCBI chr10:87,011,434...87,043,883
Ensembl chr10:87,011,434...87,043,896

G

MAGUK p55 scaffold protein 7

increases expression

fenvalerate results in increased expression of MPP7 mRNA

NCBI chr17:55,439,939...55,706,810
Ensembl chr17:55,442,696...55,706,748

G

metallophosphoesterase domain containing 1

increases expression

fenvalerate results in increased expression of MPPED1 mRNA

NCBI chr 7:114,932,221...115,011,797
Ensembl chr 7:114,944,764...115,011,787

G

melanocortin 2 receptor accessory protein 2

increases expression

fenvalerate results in increased expression of MRAP2 mRNA

NCBI chr 8:88,088,293...88,144,636
Ensembl chr 8:88,088,272...88,143,886

G

mannose receptor, C type 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MRC2 protein

NCBI chr10:90,261,986...90,323,187
Ensembl chr10:90,261,394...90,322,856

G

MRE11 homolog, double strand break repair nuclease

increases expression

fenvalerate results in increased expression of MRE11 mRNA

NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279

G

mitochondrial ribosomal protein L17

increases expression

fenvalerate results in increased expression of MRPL17 mRNA

NCBI chr 1:160,162,181...160,163,870
Ensembl chr 1:160,158,807...160,163,815

G

membrane spanning 4-domains A2

increases expression

fenvalerate results in increased expression of MS4A2 mRNA

NCBI chr 1:208,440,179...208,448,716
Ensembl chr 1:208,440,361...208,448,310

G

membrane spanning 4-domains A7

decreases expression

fenvalerate results in decreased expression of MS4A7 mRNA

NCBI chr 1:207,969,117...207,984,743
Ensembl chr 1:207,968,761...207,983,260

G

myostatin

increases expression

fenvalerate results in increased expression of MSTN mRNA

NCBI chr 9:48,452,533...48,458,933
Ensembl chr 9:48,452,533...48,458,933

G

microtubule crosslinking factor 1

increases expression

fenvalerate results in increased expression of MTCL1 mRNA

NCBI chr 9:106,305,282...106,441,782
Ensembl chr 9:106,321,098...106,442,203

G

mitochondrial fission regulator 2

increases expression

fenvalerate results in increased expression of MTFR2 mRNA

NCBI chr 1:15,123,232...15,138,632
Ensembl chr 1:15,070,894...15,148,832

G

methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like

increases expression

fenvalerate results in increased expression of MTHFD2L mRNA

NCBI chr14:17,089,947...17,170,036
Ensembl chr14:17,089,952...17,170,112

G

myotubularin related protein 1

decreases expression

fenvalerate results in decreased expression of MTMR1 mRNA

NCBI chr18:215,031...248,541
Ensembl chr18:215,089...248,541

G

myotubularin related protein 11

increases expression

fenvalerate results in increased expression of MTMR11 mRNA

NCBI chr 2:183,721,983...183,732,148
Ensembl chr 2:183,723,530...183,732,148

G

myotubularin related protein 2

increases expression

fenvalerate results in increased expression of MTMR2 mRNA

NCBI chr 8:10,617,993...10,670,724
Ensembl chr 8:10,617,993...10,668,172

G

mitochondrial tRNA translation optimization 1

increases expression

fenvalerate results in increased expression of MTO1 mRNA

NCBI chr 8:79,309,681...79,335,231
Ensembl chr 8:79,309,982...79,335,231

G

mechanistic target of rapamycin kinase

decreases phosphorylation
multiple interactions
decreases expression

fenvalerate results in decreased phosphorylation of MTOR protein
SB 203580 inhibits the reaction [fenvalerate results in decreased phosphorylation of MTOR protein]
fenvalerate results in decreased expression of MTOR mRNA

PMID:31734597 PMID:34748853

NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311

G

mitochondrial translation release factor 1 like

increases expression

fenvalerate results in increased expression of MTRF1L mRNA

NCBI chr 1:42,208,553...42,221,020
Ensembl chr 1:42,210,583...42,220,836

G

MYB proto-oncogene like 2

increases expression

fenvalerate results in increased expression of MYBL2 mRNA

NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708

G

myosin binding protein C1

increases expression

fenvalerate results in increased expression of MYBPC1 mRNA

NCBI chr 7:22,930,350...23,015,981
Ensembl chr 7:22,930,350...23,015,957

G

MYCN proto-oncogene, bHLH transcription factor

increases expression

fenvalerate results in increased expression of MYCN mRNA

NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590

G

myelin expression factor 2

increases expression

fenvalerate results in increased expression of MYEF2 mRNA

NCBI chr 3:112,338,241...112,374,122
Ensembl chr 3:112,338,241...112,374,181

G

myosin heavy chain 4

increases expression

fenvalerate results in increased expression of MYH4 mRNA

NCBI chr10:51,923,149...51,946,297
Ensembl chr10:51,885,913...51,946,295

G

myosin regulatory light chain interacting protein

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein

NCBI chr17:19,286,649...19,308,295
Ensembl chr17:19,286,650...19,308,295

G

myosin IA

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYO1A protein

NCBI chr 7:63,542,988...63,557,944
Ensembl chr 7:63,542,988...63,557,944

G

myosin 1C

increases expression

fenvalerate results in increased expression of MYO1C mRNA

NCBI chr10:60,498,372...60,520,752
Ensembl chr10:60,498,280...60,520,752

G

myomesin 2

increases expression

fenvalerate results in increased expression of MYOM2 mRNA

NCBI chr16:74,520,148...74,592,658
Ensembl chr16:74,520,157...74,592,772

G

myocardial zonula adherens protein

increases expression

fenvalerate results in increased expression of MYZAP mRNA

NCBI chr 8:72,155,817...72,243,036
Ensembl chr 8:72,131,530...72,243,036

G

N(alpha)-acetyltransferase 25, NatB auxiliary subunit

increases expression

fenvalerate results in increased expression of NAA25 mRNA

NCBI chr12:35,098,256...35,150,498
Ensembl chr12:35,098,075...35,150,467

G

N-acylethanolamine acid amidase

increases expression

fenvalerate results in increased expression of NAAA mRNA

NCBI chr14:15,777,306...15,796,411
Ensembl chr14:15,777,306...15,796,410

G

N-acetylated alpha-linked acidic dipeptidase 2

increases expression

fenvalerate results in increased expression of NAALAD2 protein

NCBI chr 8:15,406,119...15,479,714
Ensembl chr 8:15,407,043...15,479,714

G

nucleosome assembly protein 1-like 2

increases expression

fenvalerate results in increased expression of NAP1L2 mRNA

NCBI chr X:68,174,051...68,176,449
Ensembl chr X:68,173,987...68,176,666

G

NBR1, autophagy cargo receptor

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of NBR1 protein

NCBI chr10:86,477,775...86,506,418
Ensembl chr10:86,478,290...86,506,412

G

nuclear receptor coactivator 7

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of NCOA7 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NCOA7 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of NCOA7 mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 1:26,856,228...27,016,950
Ensembl chr 1:26,856,530...27,015,871

G

NADH:ubiquinone oxidoreductase subunit B10

decreases expression

fenvalerate results in decreased expression of NDUFB10 protein

NCBI chr10:13,749,273...13,751,434
Ensembl chr10:13,749,275...13,751,442

G

NADH:ubiquinone oxidoreductase subunit B9

decreases expression

fenvalerate results in decreased expression of NDUFB9 protein

NCBI chr 7:90,480,948...90,487,367
Ensembl chr 7:90,436,621...90,488,009

G

N-terminal EF-hand calcium binding protein 1

increases expression

fenvalerate results in increased expression of NECAB1 mRNA

NCBI chr 5:28,357,859...28,578,642
Ensembl chr 5:28,357,859...28,578,642
Ensembl chr 5:28,357,859...28,578,642

G

N-terminal EF-hand calcium binding protein 3

increases expression

fenvalerate results in increased expression of NECAB3 mRNA

NCBI chr 3:143,049,477...143,064,372
Ensembl chr 3:143,049,478...143,075,361

G

nectin cell adhesion molecule 2

increases expression

fenvalerate results in increased expression of NECTIN2 mRNA

NCBI chr 1:79,372,123...79,407,379
Ensembl chr 1:79,372,119...79,407,360

G

NEDD4 E3 ubiquitin protein ligase

increases expression

fenvalerate results in increased expression of NEDD4 mRNA

NCBI chr 8:73,384,095...73,468,951
Ensembl chr 8:73,383,695...73,468,951

G

NEDD4 like E3 ubiquitin protein ligase

increases expression

fenvalerate results in increased expression of NEDD4L mRNA

NCBI chr18:58,393,759...58,726,709
Ensembl chr18:58,393,509...58,723,137

G

neurofilament heavy chain

increases expression

fenvalerate results in increased expression of NEFH mRNA

NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351

G

neurofilament light chain

increases expression

fenvalerate results in increased expression of NEFL mRNA

NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793

G

NIMA-related kinase 9

increases expression

fenvalerate results in increased expression of NEK9 mRNA

NCBI chr 6:104,944,056...104,984,538
Ensembl chr 6:104,944,056...104,984,538

G

neogenin 1

increases expression

fenvalerate results in increased expression of NEO1 mRNA

NCBI chr 8:59,273,860...59,426,486
Ensembl chr 8:59,275,569...59,430,348

G

NFE2 like bZIP transcription factor 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NFE2L2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NFE2L2 mRNA

PMID:33396045 PMID:34896426

NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737

G

nuclear factor I X

increases expression

fenvalerate results in increased expression of NFIX mRNA

NCBI chr19:23,355,388...23,450,360
Ensembl chr19:23,355,498...23,448,265

G

neuroglobin

increases expression

fenvalerate results in increased expression of NGB mRNA

NCBI chr 6:106,744,378...106,749,830
Ensembl chr 6:106,744,378...106,749,830

G

nerve growth factor receptor

increases expression
decreases expression

fenvalerate results in increased expression of NGFR mRNA
fenvalerate results in decreased expression of NGFR mRNA

PMID:30307764 PMID:34358930

NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518

G

NHS-like 2

increases expression

fenvalerate results in increased expression of NHSL2 mRNA

NCBI chr X:66,969,953...67,209,464
Ensembl chr X:66,970,151...67,200,911

G

NIM1 serine/threonine protein kinase

increases expression

fenvalerate results in increased expression of NIM1K mRNA

NCBI chr 2:51,670,764...51,714,782
Ensembl chr 2:51,670,772...51,714,762

G

ninjurin 2

increases expression

fenvalerate results in increased expression of NINJ2 mRNA

NCBI chr 4:153,306,439...153,408,618
Ensembl chr 4:153,306,553...153,408,617

G

nitrilase family, member 2

decreases expression

fenvalerate results in decreased expression of NIT2 protein

NCBI chr11:43,363,839...43,378,713
Ensembl chr11:43,363,985...43,375,024

G

NK2 homeobox 1

increases expression

fenvalerate results in increased expression of NKX2-1 mRNA

NCBI chr 6:73,996,601...74,001,483
Ensembl chr 6:73,996,601...73,999,791

G

NK2 homeobox 2

increases expression

fenvalerate results in increased expression of NKX2-2 mRNA

NCBI chr 3:134,619,701...134,630,282
Ensembl chr 3:134,620,039...134,622,411

G

NK2 homeobox 3

increases expression

fenvalerate results in increased expression of NKX2-3 mRNA

NCBI chr 1:242,478,130...242,481,083
Ensembl chr 1:242,478,130...242,481,083

G

nemo like kinase

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NLK protein

NCBI chr10:63,467,388...63,590,960
Ensembl chr10:63,438,222...63,589,730

G

NME/NM23 nucleoside diphosphate kinase 4

increases expression

fenvalerate results in increased expression of NME4 mRNA

NCBI chr10:15,114,624...15,118,479
Ensembl chr10:15,002,926...15,118,479

G

neuromedin U

increases expression

fenvalerate results in increased expression of NMU mRNA

NCBI chr14:31,844,564...31,872,196
Ensembl chr14:31,844,728...31,872,192

G

NOC3-like DNA replication regulator

increases expression

fenvalerate results in increased expression of NOC3L mRNA

NCBI chr 1:236,556,037...236,585,372
Ensembl chr 1:236,556,789...236,585,318

G

nucleolar complex associated 4 homolog

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NOC4L protein

NCBI chr12:46,016,077...46,020,615
Ensembl chr12:46,016,069...46,020,614

G

nucleolar protein 4

increases expression

fenvalerate results in increased expression of NOL4 mRNA

NCBI chr18:13,932,499...14,294,873
Ensembl chr18:13,932,510...14,296,286

G

nucleolar and coiled-body phosphoprotein 1

increases expression

fenvalerate results in increased expression of NOLC1 mRNA

NCBI chr 1:244,921,275...244,932,089
Ensembl chr 1:244,921,377...244,932,088

G

NADPH oxidase organizer 1

increases expression

fenvalerate results in increased expression of NOXO1 mRNA

NCBI chr10:13,723,253...13,726,008
Ensembl chr10:13,721,473...13,726,061

G

neuronal PAS domain protein 2

decreases expression

fenvalerate results in decreased expression of NPAS2 mRNA

NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320

G

NPC intracellular cholesterol transporter 2

decreases expression

fenvalerate results in decreased expression of NPC2 protein

NCBI chr 6:104,397,239...104,418,161
Ensembl chr 6:104,378,644...104,418,155

G

neuropeptide FF receptor 2

increases expression

fenvalerate results in increased expression of NPFFR2 mRNA

NCBI chr14:18,513,120...18,558,074
Ensembl chr14:18,513,277...18,521,919

G

N-acetylneuraminate pyruvate lyase

decreases expression
multiple interactions

fenvalerate results in decreased expression of NPL mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NPL protein

PMID:30307764 PMID:34896426

NCBI chr13:65,655,099...65,697,464
Ensembl chr13:65,655,118...65,697,372

G

natriuretic peptide A

increases expression

fenvalerate results in increased expression of NPPA mRNA

NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351

G

natriuretic peptide receptor 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NPR2 protein

NCBI chr 5:57,883,171...57,901,590
Ensembl chr 5:57,883,171...57,901,580

G

NAD(P)H quinone dehydrogenase 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NQO1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NQO1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of NQO1 mRNA

PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557

G

nuclear receptor subfamily 0, group B, member 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of NR0B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NR0B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of NR0B1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr X:50,756,886...50,761,014
Ensembl chr X:50,756,886...50,761,011

G

nuclear receptor subfamily 0, group B, member 2

decreases expression

fenvalerate results in decreased expression of NR0B2 mRNA

NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609

G

nuclear receptor subfamily 1, group D, member 1

decreases expression

fenvalerate results in decreased expression of NR1D1 mRNA

NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705

G

nuclear receptor subfamily 1, group H, member 4

multiple interactions

fenvalerate inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein]

NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047

G

nuclear receptor subfamily 1, group I, member 2

increases activity
multiple interactions

fenvalerate results in increased activity of NR1I2 protein
fenvalerate binds to and results in increased activity of NR1I2 protein
fenvalerate results in increased activity of NR1I2 protein; fenvalerate results in increased activity of NR1I2 protein polymorphism

PMID:15548381 PMID:16054614 PMID:19249324 PMID:21115097 PMID:22206814 More...

NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658

G

nuclear receptor subfamily 1, group I, member 3

increases expression
multiple interactions

fenvalerate results in increased expression of NR1I3 mRNA
fenvalerate binds to and results in decreased activity of NR1I3 protein; fenvalerate inhibits the reaction [artemisinin binds to and results in increased activity of NR1I3 protein]

PMID:22310298 PMID:31538121

NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906

G

nuclear receptor subfamily 3, group C, member 1

increases expression

fenvalerate results in increased expression of NR3C1 mRNA

NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375

G

nuclear receptor subfamily 3, group C, member 2

affects methylation
multiple interactions

fenvalerate affects the methylation of NR3C2 gene
fenvalerate inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NR3C2 protein

PMID:23548413 PMID:29149346 PMID:34896426

NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885

G

nuclear receptor subfamily 4, group A, member 2

increases expression

fenvalerate results in increased expression of NR4A2 mRNA

NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877

G

nuclear receptor subfamily 5, group A, member 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NR5A1 mRNA

NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328

G

nuclear respiratory factor 1

increases expression

fenvalerate results in increased expression of NRF1 mRNA

NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328

G

neuregulin 1

increases expression

fenvalerate results in increased expression of NRG1 mRNA

NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884

G

neuregulin 2

increases expression

fenvalerate results in increased expression of NRG2 mRNA

NCBI chr18:27,616,542...27,798,505
Ensembl chr18:27,619,661...27,798,505

G

nuclear receptor interacting protein 3

increases expression

fenvalerate results in increased expression of NRIP3 mRNA

NCBI chr 1:163,789,738...163,815,036
Ensembl chr 1:163,789,738...163,815,600

G

neural retina leucine zipper

increases expression

fenvalerate results in increased expression of NRL mRNA

NCBI chr15:29,007,059...29,011,480
Ensembl chr15:29,008,104...29,009,832

G

neurensin 1

increases expression

fenvalerate results in increased expression of NRSN1 mRNA

NCBI chr17:39,806,238...39,824,550
Ensembl chr17:39,806,238...39,823,813

G

neurexin 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NRXN2 protein

NCBI chr 1:203,726,420...203,842,301
Ensembl chr 1:203,735,753...203,842,297

G

netrin 5

increases expression

fenvalerate results in increased expression of NTN5 mRNA

NCBI chr 1:96,156,948...96,165,997
Ensembl chr 1:96,156,985...96,165,630

G

neurotrophic receptor tyrosine kinase 2

increases expression
decreases expression

fenvalerate results in increased expression of NTRK2 mRNA
fenvalerate results in decreased expression of NTRK2 mRNA

PMID:30307764 PMID:34358930

NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136

G

neurotensin receptor 1

increases expression

fenvalerate results in increased expression of NTSR1 mRNA

NCBI chr 3:167,606,215...167,656,371
Ensembl chr 3:167,606,215...167,656,377

G

nuclear distribution C, dynein complex regulator

increases expression

fenvalerate results in increased expression of NUDC protein

NCBI chr 5:145,758,006...145,771,390
Ensembl chr 5:145,758,002...145,771,425

G

nudix hydrolase 13

decreases expression

fenvalerate results in decreased expression of NUDT13 mRNA

NCBI chr15:4,001,787...4,022,404
Ensembl chr15:4,001,794...4,022,293

G

nucleoporin 214

increases expression

fenvalerate results in increased expression of NUP214 mRNA

NCBI chr 3:15,255,111...15,340,568
Ensembl chr 3:15,255,119...15,340,568

G

nucleoporin 58

increases expression

fenvalerate results in increased expression of NUP58 mRNA

NCBI chr15:34,358,170...34,407,160
Ensembl chr15:34,358,277...34,407,060

G

nuclear RNA export factor 2

increases expression

fenvalerate results in increased expression of NXF7 mRNA

NCBI chr X:98,135,953...98,157,117
Ensembl chr X:98,135,950...98,157,089

G

2'-5'-oligoadenylate synthetase 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of OAS3 protein

NCBI chr12:35,779,028...35,802,781
Ensembl chr12:35,779,022...35,802,781

G

ornithine aminotransferase

decreases expression

fenvalerate results in decreased expression of OAT protein

NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682

G

outer dynein arm docking complex subunit 4

increases expression

fenvalerate results in increased expression of ODAD4 mRNA

NCBI chr10:85,480,089...85,508,603
Ensembl chr10:85,480,094...85,508,603

G

outer dense fiber of sperm tails 1

decreases expression

fenvalerate results in decreased expression of ODF1 protein

NCBI chr 7:69,377,427...69,389,662
Ensembl chr 7:69,380,116...69,389,664

G

outer dense fiber of sperm tails 2

decreases expression
multiple interactions

fenvalerate results in decreased expression of ODF2 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ODF2 protein

PMID:33656234 PMID:34896426

NCBI chr 3:13,160,981...13,207,223
Ensembl chr 3:13,161,494...13,206,985

G

odr-4 GPCR localization factor homolog

increases expression

fenvalerate results in increased expression of ODR4 mRNA

NCBI chr13:62,369,109...62,424,287
Ensembl chr13:62,394,608...62,424,209

G

O-linked N-acetylglucosamine (GlcNAc) transferase

increases expression

fenvalerate results in increased expression of OGT mRNA

NCBI chr X:66,771,278...66,816,148
Ensembl chr X:66,771,349...66,816,146

G

olfactomedin-like 2A

increases expression

fenvalerate results in increased expression of OLFML2A mRNA

NCBI chr 3:22,688,590...22,717,917
Ensembl chr 3:22,688,598...22,717,909

G

oligodendrocyte transcription factor 2

decreases expression

fenvalerate results in decreased expression of OLIG2 mRNA

NCBI chr11:30,475,510...30,478,886
Ensembl chr11:30,475,398...30,480,152

G

olfactory receptor gene Olr1493

increases expression

fenvalerate results in increased expression of OLR1493 mRNA

NCBI chr10:58,495,709...58,496,647
Ensembl chr10:58,491,442...58,498,164

G

oligodendrocytic myelin paranodal and inner loop protein

increases expression

fenvalerate results in increased expression of OPALIN mRNA

NCBI chr 1:239,891,137...239,909,388
Ensembl chr 1:239,891,142...239,908,788

G

opioid binding protein/cell adhesion molecule-like

increases expression

fenvalerate results in increased expression of OPCML mRNA

NCBI chr 8:26,788,988...27,304,551
Ensembl chr 8:26,192,841...27,300,620

G

opsin 1, short wave sensitive

increases expression

fenvalerate results in increased expression of OPN1SW mRNA

NCBI chr 4:57,977,317...57,980,457
Ensembl chr 4:57,977,313...57,980,457

G

opioid receptor, kappa 1

increases expression

fenvalerate results in increased expression of OPRK1 mRNA

NCBI chr 5:13,860,016...13,877,823
Ensembl chr 5:13,860,021...13,877,823

G

opioid related nociceptin receptor 1

increases expression

fenvalerate results in increased expression of OPRL1 mRNA

NCBI chr 3:168,831,934...168,839,920
Ensembl chr 3:168,834,003...168,839,920

G

opticin

increases expression

fenvalerate results in increased expression of OPTC mRNA

NCBI chr13:45,353,954...45,368,254
Ensembl chr13:45,355,148...45,365,237

G

olfactory receptor family 1 subfamily N member 1

increases expression

fenvalerate results in increased expression of OR1N1 mRNA

NCBI chr 3:20,413,262...20,414,197
Ensembl chr 3:20,413,262...20,414,203

G

olfactory receptor family 6 subfamily A member 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of OR6A2 protein

NCBI chr 1:160,827,258...160,828,241
Ensembl chr 1:160,793,997...160,831,557

G

origin recognition complex, subunit 4

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ORC4 protein

NCBI chr 3:33,290,844...33,334,022
Ensembl chr 3:33,294,355...33,333,824

G

origin recognition complex, subunit 6

increases expression

fenvalerate results in increased expression of ORC6 mRNA

NCBI chr19:21,757,867...21,765,638
Ensembl chr19:21,757,866...21,765,662

G

oxysterol binding protein

increases expression

fenvalerate results in increased expression of OSBP mRNA

NCBI chr 1:208,888,697...208,918,511
Ensembl chr 1:208,887,895...208,918,506

G

oxysterol binding protein-like 1A

increases expression

fenvalerate results in increased expression of OSBPL1A mRNA

NCBI chr18:3,904,006...4,094,635
Ensembl chr18:3,904,006...4,094,585

G

OTU deubiquitinase with linear linkage specificity like

increases expression

fenvalerate results in increased expression of OTULINL mRNA

NCBI chr 2:78,405,994...78,433,860
Ensembl chr 2:78,408,593...78,433,838

G

ovo like transcriptional repressor 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of OVOL1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of OVOL1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of OVOL1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 1:202,855,261...202,868,858
Ensembl chr 1:202,855,265...202,866,831

G

purinergic receptor P2X 2

increases expression

fenvalerate results in increased expression of P2RX2 mRNA

NCBI chr12:46,338,979...46,342,891
Ensembl chr12:46,339,549...46,342,891

G

purinergic receptor P2X 3

increases expression

fenvalerate results in increased expression of P2RX3 mRNA

NCBI chr 3:70,080,850...70,124,664
Ensembl chr 3:70,080,851...70,125,178

G

purinergic receptor P2X 5

increases expression

fenvalerate results in increased expression of P2RX5 mRNA

NCBI chr10:57,777,737...57,789,426
Ensembl chr10:57,777,819...57,789,423

G

pyrimidinergic receptor P2Y4

increases expression

fenvalerate results in increased expression of P2RY4 mRNA

NCBI chr X:65,681,680...65,717,404
Ensembl chr X:65,683,232...65,721,748

G

phosphofurin acidic cluster sorting protein 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PACS1 protein

NCBI chr 1:202,437,503...202,569,473
Ensembl chr 1:202,437,505...202,569,473

G

peptidyl arginine deiminase 3

increases expression

fenvalerate results in increased expression of PADI3 mRNA

NCBI chr 5:153,089,717...153,117,146
Ensembl chr 5:153,089,717...153,117,146

G

PAF1 homolog, Paf1/RNA polymerase II complex component

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PAF1 protein

NCBI chr 1:83,683,654...83,689,233
Ensembl chr 1:83,668,813...83,689,237

G

paralemmin A kinase anchor protein

increases expression

fenvalerate results in increased expression of PAKAP mRNA

NCBI chr 5:72,536,986...72,648,524
NCBI chr 5:72,313,646...72,450,645
Ensembl chr 5:72,181,718...72,648,524

G

paralemmin

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PALM protein

NCBI chr 7:9,886,634...9,912,389
Ensembl chr 7:9,886,643...9,912,555

G

palmdelphin

increases expression

fenvalerate results in increased expression of PALMD mRNA

NCBI chr 2:204,889,526...204,941,355
Ensembl chr 2:204,889,533...204,941,519

G

poly (ADP-ribose) polymerase 1

increases cleavage
multiple interactions

fenvalerate results in increased cleavage of PARP1 protein
CAT protein inhibits the reaction [fenvalerate results in increased cleavage of PARP1 protein]

NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404

G

PARP1 binding protein

increases expression

fenvalerate results in increased expression of PARPBP mRNA

NCBI chr 7:22,511,427...22,580,834
Ensembl chr 7:22,511,427...22,573,695

G

parvin, beta

increases expression

fenvalerate results in increased expression of PARVB mRNA

NCBI chr 7:115,360,254...115,445,767
Ensembl chr 7:115,360,261...115,445,766

G

PAS domain containing serine/threonine kinase

increases expression

fenvalerate results in increased expression of PASK mRNA

NCBI chr 9:93,844,275...93,886,036
Ensembl chr 9:93,844,278...93,885,111

G

PAT1 homolog 1, processing body mRNA decay factor

increases expression

fenvalerate results in increased expression of PATL1 mRNA

NCBI chr 1:208,831,115...208,862,904
Ensembl chr 1:208,831,115...208,862,857

G

protocadherin 20

increases expression

fenvalerate results in increased expression of PCDH20 mRNA

NCBI chr15:64,425,534...64,431,790
Ensembl chr15:64,425,534...64,431,790

G

protocadherin 9

increases expression

fenvalerate results in increased expression of PCDH9 mRNA

NCBI chr15:69,340,108...70,237,531
Ensembl chr15:69,340,645...70,237,538

G

protocadherin beta 21

increases expression

fenvalerate results in increased expression of PCDHB9 mRNA

NCBI chr18:29,218,209...29,221,142
Ensembl chr18:29,218,225...29,221,142

G

PC-esterase domain containing 1A

decreases expression

fenvalerate results in decreased expression of PCED1A mRNA

NCBI chr 3:117,600,958...117,622,992
Ensembl chr 3:117,616,921...117,622,962

G

proliferating cell nuclear antigen

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of PCNA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PCNA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of PCNA mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of PCNA mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995

G

proprotein convertase subtilisin/kexin type 1 inhibitor

increases expression

fenvalerate results in increased expression of PCSK1N mRNA

NCBI chr X:14,580,036...14,583,478
Ensembl chr X:14,580,038...14,583,566

G

proprotein convertase subtilisin/kexin type 5

increases expression

fenvalerate results in increased expression of PCSK5 mRNA

NCBI chr 1:214,837,847...215,267,626
Ensembl chr 1:214,837,927...215,267,600

G

phosphodiesterase 12

increases expression

fenvalerate results in increased expression of PDE12 mRNA

NCBI chr16:1,920,062...1,925,638
Ensembl chr16:1,915,386...1,925,887

G

phosphodiesterase 4A

increases expression

fenvalerate results in increased expression of PDE4A mRNA

NCBI chr 8:19,690,816...19,753,538
Ensembl chr 8:19,703,290...19,751,961

G

phosphodiesterase 4B

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PDE4B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PDE4B mRNA

PMID:33051911 PMID:33396045

NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696

G

phosphodiesterase 8B

increases expression

fenvalerate results in increased expression of PDE8B mRNA

NCBI chr 2:26,275,117...26,479,725
Ensembl chr 2:26,276,635...26,509,209

G

platelet derived growth factor D

increases expression

fenvalerate results in increased expression of PDGFD mRNA

NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395

G

pyruvate dehydrogenase E1 subunit alpha 2

increases expression
decreases expression

fenvalerate results in increased expression of PDHA2 mRNA
fenvalerate results in decreased expression of PDHA2 protein

PMID:30307764 PMID:33656234

NCBI chr 2:229,872,300...229,873,848

G

PDZ and LIM domain 2

increases expression

fenvalerate results in increased expression of PDLIM2 mRNA

NCBI chr15:45,235,421...45,250,187
Ensembl chr15:45,237,477...45,249,242

G

PDZ and LIM domain 7

decreases expression

fenvalerate results in decreased expression of PDLIM7 mRNA

NCBI chr17:9,124,565...9,139,814
Ensembl chr17:9,124,649...9,139,811

G

PDS5 cohesin associated factor A

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PDS5A protein

NCBI chr14:42,551,653...42,651,074
Ensembl chr14:42,552,647...42,648,669

G

pyridoxal kinase like 1

decreases expression

fenvalerate results in decreased expression of PDXKL1 mRNA

NCBI chr20:10,162,934...10,192,572
Ensembl chr20:10,164,099...10,192,739

G

PDZ domain containing 4

increases expression

fenvalerate results in increased expression of PDZD4 mRNA

NCBI chr X:151,530,390...151,560,779
Ensembl chr X:151,530,390...151,560,826

G

proline, glutamate and leucine rich protein 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PELP1 protein

NCBI chr10:55,094,798...55,111,833
Ensembl chr10:55,094,796...55,111,994

G

peroxisomal biogenesis factor 11 alpha

increases expression

fenvalerate results in increased expression of PEX11A mRNA

NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172

G

peroxisomal biogenesis factor 6

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PEX6 protein

NCBI chr 9:14,258,145...14,270,335
Ensembl chr 9:14,258,145...14,270,303

G

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2

increases expression

fenvalerate results in increased expression of PFKFB2 mRNA

NCBI chr13:42,147,473...42,174,699
Ensembl chr13:42,147,478...42,174,699

G

phosphoglycerate mutase 1

decreases expression

fenvalerate results in decreased expression of PGAM1 protein

NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452

G

phosphoglycerate mutase 2

decreases expression

fenvalerate results in decreased expression of PGAM2 protein

NCBI chr14:80,681,796...80,683,907
Ensembl chr14:80,681,776...80,683,940

G

post-GPI attachment to proteins inositol deacylase 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PGAP1 protein

NCBI chr 9:55,975,574...56,044,325
Ensembl chr 9:55,975,667...56,044,464

G

piggyBac transposable element derived 5

increases expression

fenvalerate results in increased expression of PGBD5 mRNA

NCBI chr19:52,336,751...52,401,906
Ensembl chr19:52,336,751...52,402,397

G

progastricsin

increases expression

fenvalerate results in increased expression of PGC mRNA

NCBI chr 9:13,257,462...13,265,682
Ensembl chr 9:13,257,462...13,265,682

G

phosphoglycerate kinase 2

increases expression

fenvalerate results in increased expression of PGK2 protein

NCBI chr 9:20,480,367...20,481,933
Ensembl chr 9:20,480,203...20,571,481

G

progesterone receptor

multiple interactions

fenvalerate inhibits the reaction [Progesterone results in increased expression of PGR protein]

NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344

G

phosphatase and actin regulator 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PHACTR1 protein

NCBI chr17:21,560,364...22,040,166
Ensembl chr17:21,562,721...22,039,831

G

prohibitin 2

increases expression

fenvalerate results in increased expression of PHB2 mRNA

NCBI chr 4:157,517,662...157,522,268
Ensembl chr 4:157,517,577...157,522,272

G

PH domain containing endocytic trafficking adaptor 2

increases expression

fenvalerate results in increased expression of PHETA2 mRNA

NCBI chr 7:113,855,437...113,861,910
Ensembl chr 7:113,857,249...113,861,871

G

phosphate regulating endopeptidase X-linked

increases expression

fenvalerate results in increased expression of PHEX mRNA

NCBI chr X:37,607,553...37,856,183
Ensembl chr X:37,610,760...37,854,469

G

PHD finger protein 14

increases expression

fenvalerate results in increased expression of PHF14 mRNA

NCBI chr 4:40,009,691...40,195,877
Ensembl chr 4:40,009,264...40,195,885

G

PHD finger protein 21A

increases expression

fenvalerate results in increased expression of PHF21A mRNA

NCBI chr 3:78,158,760...78,331,903
Ensembl chr 3:78,194,549...78,331,865

G

pleckstrin homology-like domain, family A, member 1

increases expression

fenvalerate results in increased expression of PHLDA1 mRNA; fenvalerate results in increased expression of PHLDA1 protein

NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861

G

phosphoethanolamine/phosphocholine phosphatase 1

decreases expression

fenvalerate results in decreased expression of PHOSPHO1 protein

NCBI chr10:80,762,062...80,769,596
Ensembl chr10:80,760,792...80,770,342

G

piercer of microtubule wall 1

increases expression

fenvalerate results in increased expression of PIERCE1 mRNA

NCBI chr 3:11,797,031...11,801,568
Ensembl chr 3:11,797,031...11,801,568

G

phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIK3CA protein

NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032

G

phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIK3CB protein

NCBI chr 8:99,594,600...99,699,772
Ensembl chr 8:99,594,644...99,699,663

G

PTEN induced kinase 1

increases expression

fenvalerate results in increased expression of PINK1 mRNA

NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635

G

phospholipase A2 inhibitor and Ly6/Plaur domain containing

increases expression

fenvalerate results in increased expression of PINLYP mRNA

NCBI chr 1:80,134,642...80,140,488
Ensembl chr 1:80,134,643...80,139,996

G

phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIP5K1A protein

NCBI chr 2:182,628,299...182,671,584
Ensembl chr 2:182,628,300...182,671,598

G

paired-like homeodomain 1

increases expression

fenvalerate results in increased expression of PITX1 mRNA

NCBI chr17:8,794,134...8,800,292
Ensembl chr17:8,794,134...8,800,291

G

PKHD1 like 1

increases expression

fenvalerate results in increased expression of PKHD1L1 mRNA

NCBI chr 7:75,620,384...75,795,335
Ensembl chr 7:75,620,484...75,795,335

G

PBX/knotted 1 homeobox 1

decreases expression

fenvalerate results in decreased expression of PKNOX1 mRNA

NCBI chr20:9,662,866...9,705,030
Ensembl chr20:9,662,899...9,703,727

G

plakophilin 3

decreases expression

fenvalerate results in decreased expression of PKP3 mRNA

NCBI chr 1:196,187,914...196,198,843
Ensembl chr 1:196,187,835...196,198,844

G

phospholipase A2 group IIA

decreases expression

fenvalerate results in decreased expression of PLA2G2A mRNA

NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014

G

phospholipase A2, group IID

increases expression

fenvalerate results in increased expression of PLA2G2D mRNA

NCBI chr 5:151,016,010...151,022,531
Ensembl chr 5:151,018,870...151,022,525

G

phospholipase A2 group VI

decreases expression

fenvalerate results in decreased expression of PLA2G6 mRNA

NCBI chr 7:110,851,378...110,891,557
Ensembl chr 7:110,851,378...110,891,114

G

phospholipase A and acyltransferase 5

increases expression

fenvalerate results in increased expression of PLAAT5 mRNA

NCBI chr 1:204,847,600...204,878,456
Ensembl chr 1:204,847,600...204,878,184

G

plasminogen activator, urokinase receptor

decreases expression

fenvalerate results in decreased expression of PLAUR mRNA

NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595

G

phospholipase C, beta 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLCB2 protein

NCBI chr 3:105,683,676...105,704,384
Ensembl chr 3:105,684,815...105,704,302

G

phospholipase C, delta 4

increases expression

fenvalerate results in increased expression of PLCD4 mRNA

NCBI chr 9:76,115,523...76,158,602
Ensembl chr 9:76,117,168...76,142,453

G

phosphatidylinositol-specific phospholipase C, X domain containing 3

increases expression

fenvalerate results in increased expression of PLCXD3 mRNA

NCBI chr 2:53,567,022...53,746,384
Ensembl chr 2:53,567,022...53,746,384

G

phospholipase D1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLD1 protein

NCBI chr 2:110,849,205...111,047,304
Ensembl chr 2:110,893,608...111,047,692

G

pleckstrin homology and coiled-coil domain containing D1

increases expression

fenvalerate results in increased expression of PLEKHD1 mRNA

NCBI chr 6:100,340,655...100,371,942
Ensembl chr 6:100,340,655...100,371,941

G

pleckstrin homology, MyTH4 and FERM domain containing H2

increases expression

fenvalerate results in increased expression of PLEKHH2 mRNA

NCBI chr 6:10,032,837...10,132,081
Ensembl chr 6:10,032,660...10,140,794

G

pleckstrin homology domain containing M3

increases expression

fenvalerate results in increased expression of PLEKHM3 mRNA

NCBI chr 9:66,166,233...66,325,332
Ensembl chr 9:66,166,321...66,325,294

G

polo-like kinase 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLK3 protein

NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317

G

plasmolipin

increases expression

fenvalerate results in increased expression of PLLP mRNA

NCBI chr19:10,315,104...10,335,892
Ensembl chr19:10,315,104...10,335,892

G

procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLOD3 protein

NCBI chr12:19,676,384...19,686,945
Ensembl chr12:19,676,386...19,686,960

G

proteolipid protein 1

increases expression

fenvalerate results in increased expression of PLP1 mRNA

NCBI chr X:100,184,039...100,201,035
Ensembl chr X:100,185,767...100,201,032

G

phospholipid phosphatase related 5

increases expression

fenvalerate results in increased expression of PLPPR5 mRNA

NCBI chr 2:205,525,466...205,737,892
Ensembl chr 2:205,458,176...205,717,599

G

phorbol-12-myristate-13-acetate-induced protein 1

multiple interactions

fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PMAIP1 protein]

NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429

G

pro-melanin-concentrating hormone

increases expression

fenvalerate results in increased expression of PMCH mRNA

NCBI chr 7:22,511,934...22,513,250
Ensembl chr 7:22,511,934...22,513,250

G

PML nuclear body scaffold

affects methylation

fenvalerate affects the methylation of PML gene

NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971

G

phosphomannomutase 2

increases expression

fenvalerate results in increased expression of PMM2 mRNA

NCBI chr10:6,961,521...6,982,913
Ensembl chr10:6,961,709...6,983,098

G

peripheral myelin protein 22

increases expression

fenvalerate results in increased expression of PMP22 mRNA

NCBI chr10:47,795,709...47,825,715
Ensembl chr10:47,795,709...47,825,714

G

pancreatic lipase

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PNLIP protein

NCBI chr 1:257,774,012...257,811,656
Ensembl chr 1:257,798,581...257,811,654

G

pinin, desmosome associated protein

increases expression

fenvalerate results in increased expression of PNN mRNA

NCBI chr 6:76,758,138...76,766,451
Ensembl chr 6:76,758,117...76,766,889

G

patatin-like phospholipase domain containing 8

increases expression

fenvalerate results in increased expression of PNPLA8 mRNA

NCBI chr 6:61,329,810...61,391,736
Ensembl chr 6:61,329,810...61,391,734

G

POC1 centriolar protein A

increases expression

fenvalerate results in increased expression of POC1A mRNA

NCBI chr 8:106,922,058...106,991,678
Ensembl chr 8:106,922,978...106,991,089

G

protein O-fucosyltransferase 2

increases expression

fenvalerate results in increased expression of POFUT2 mRNA

NCBI chr20:11,367,073...11,377,788
Ensembl chr20:11,367,096...11,377,743

G

DNA polymerase nu

increases expression

fenvalerate results in increased expression of POLN mRNA

NCBI chr14:76,579,983...76,752,460
Ensembl chr14:76,580,546...76,752,463

G

porcupine O-acyltransferase

increases expression

fenvalerate results in increased expression of PORCN mRNA

NCBI chr X:14,285,864...14,298,481
Ensembl chr X:14,285,871...14,298,481

G

periostin

increases expression

fenvalerate results in increased expression of POSTN mRNA

NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099

G

POU class 1 homeobox 1

increases expression

fenvalerate results in increased expression of POU1F1 mRNA

NCBI chr11:3,316,818...3,334,804
Ensembl chr11:3,317,058...3,334,801

G

POU class 2 homeobox associating factor 3

increases expression

fenvalerate results in increased expression of POU2AF3 mRNA

NCBI chr 8:51,588,237...51,597,114
Ensembl chr 8:51,588,237...51,603,855

G

pro-platelet basic protein

increases expression

fenvalerate results in increased expression of PPBP mRNA

NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130

G

PTPRF interacting protein alpha 2

increases expression

fenvalerate results in increased expression of PPFIA2 mRNA

NCBI chr 7:41,765,716...42,240,104
Ensembl chr 7:41,765,575...42,239,599

G

PTPRF interacting protein alpha 4

increases expression
multiple interactions

fenvalerate results in increased expression of PPFIA4 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PPFIA4 protein

PMID:30307764 PMID:34896426

NCBI chr13:45,753,827...45,802,305
Ensembl chr13:45,753,827...45,802,261

G

peptidylprolyl isomerase A

decreases expression

fenvalerate results in decreased expression of PPIA protein

NCBI chr14:81,279,292...81,282,960
Ensembl chr14:81,275,091...81,299,601

G

peptidylprolyl isomerase G

increases expression
multiple interactions

fenvalerate results in increased expression of PPIG mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PPIG protein

PMID:30307764 PMID:34896426

NCBI chr 3:54,484,023...54,512,929
Ensembl chr 3:54,484,023...54,512,926

G

protein phosphatase 1 catalytic subunit gamma

increases expression

fenvalerate results in increased expression of PPP1CC protein

NCBI chr12:34,383,072...34,400,553
Ensembl chr12:34,383,072...34,400,553

G

protein phosphatase 1, regulatory (inhibitor) subunit 1C

increases expression

fenvalerate results in increased expression of PPP1R1C mRNA

NCBI chr 3:64,616,700...64,719,696
Ensembl chr 3:64,616,700...64,724,104

G

protein phosphatase 1, regulatory subunit 36

increases expression

fenvalerate results in increased expression of PPP1R36 mRNA

NCBI chr 6:95,138,526...95,159,102
Ensembl chr 6:95,139,007...95,159,102

G

protein phosphatase 1, regulatory subunit 3B

increases expression

fenvalerate results in increased expression of PPP1R3B mRNA

NCBI chr16:56,830,011...56,842,395
Ensembl chr16:56,829,660...56,842,406

G

protein phosphatase 3 catalytic subunit gamma

increases expression

fenvalerate results in increased expression of PPP3CC mRNA

NCBI chr15:45,289,917...45,362,012
Ensembl chr15:45,290,373...45,361,832

G

protein phosphatase 3, regulatory subunit B, alpha

increases expression

fenvalerate results in increased expression of PPP3R1 mRNA

NCBI chr14:91,556,743...91,606,391
Ensembl chr14:91,604,121...91,606,907

G

proline-rich protein BstNI subfamily 3

increases expression

fenvalerate results in increased expression of PRB3 mRNA

NCBI chr 4:165,564,424...165,569,229
Ensembl chr 4:165,564,424...165,569,227

G

PR/SET domain 2

increases expression

fenvalerate results in increased expression of PRDM2 mRNA

NCBI chr 5:155,421,066...155,531,884
Ensembl chr 5:155,422,134...155,531,825

G

phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2

increases expression

fenvalerate results in increased expression of PREX2 mRNA

NCBI chr 5:7,937,692...8,253,112
Ensembl chr 5:7,942,573...8,253,068

G

protein kinase cAMP-dependent type I regulatory subunit beta

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRKAR1B protein

NCBI chr12:15,492,233...15,624,942
Ensembl chr12:15,511,801...15,624,942

G

protein kinase C, beta

increases expression

fenvalerate results in increased expression of PRKCB mRNA

NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536

G

protein kinase C, iota

increases expression

fenvalerate results in increased expression of PRKCI mRNA

NCBI chr 2:112,321,919...112,382,305
Ensembl chr 2:112,321,929...112,382,352

G

protein kinase D1

increases expression

fenvalerate results in increased expression of PRKD1 mRNA

NCBI chr 6:67,725,193...68,039,002
Ensembl chr 6:67,725,905...68,039,042

G

protein kinase cGMP-dependent 2

increases expression

fenvalerate results in increased expression of PRKG2 mRNA

NCBI chr14:10,559,882...10,668,479
Ensembl chr14:10,559,882...10,666,888

G

protein kinase cAMP-dependent X-linked catalytic subunit

increases expression

fenvalerate results in increased expression of PRKX mRNA

NCBI chr X:41,823,349...41,866,844
Ensembl chr X:41,823,355...41,866,669

G

prolactin

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRL protein

NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062

G

prolactin family 8, subfamily A, member 3

increases expression

fenvalerate results in increased expression of PRL8A3 mRNA

NCBI chr17:37,508,328...37,514,832
Ensembl chr17:37,508,328...37,514,825

G

protamine 1

increases expression
multiple interactions

fenvalerate results in increased expression of PRM1 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PRM1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRM1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PRM1 mRNA

PMID:30307764 PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr10:4,871,817...4,872,312

G

protamine 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRM2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PRM2 mRNA

PMID:33396045 PMID:34896426

NCBI chr10:4,876,285...4,877,026
Ensembl chr10:4,873,372...4,877,026

G

protamine 3

increases expression

fenvalerate results in increased expression of PRM3 mRNA

NCBI chr10:4,877,471...4,877,985
Ensembl chr10:4,877,471...4,877,985

G

proline rich protein 2-like 1

increases expression

fenvalerate results in increased expression of PRP2L1 mRNA

NCBI chr10:88,462,262...88,540,642
Ensembl chr10:88,462,289...88,523,061

G

pre-mRNA processing factor 38B

increases expression

fenvalerate results in increased expression of PRPF38B mRNA

NCBI chr 2:196,553,224...196,562,271
Ensembl chr 2:196,553,225...196,562,250

G

phosphoribosyl pyrophosphate synthetase 2

increases expression

fenvalerate results in increased expression of PRPS2 mRNA

NCBI chr X:26,975,915...27,013,184
Ensembl chr X:26,976,061...27,013,181

G

proline rich 27

increases expression

fenvalerate results in increased expression of PRR27 mRNA

NCBI chr14:20,232,757...20,248,617
Ensembl chr14:20,232,758...20,248,595

G

proline rich 36

increases expression

fenvalerate results in increased expression of PRR36 mRNA

NCBI chr12:2,560,533...2,567,766
Ensembl chr12:2,560,536...2,567,742

G

proline-rich coiled-coil 2B

increases expression

fenvalerate results in increased expression of PRRC2B mRNA

NCBI chr 3:15,433,357...15,519,105
Ensembl chr 3:15,465,294...15,519,104

G

proline-rich transmembrane protein 1

increases expression

fenvalerate results in increased expression of PRRT1 mRNA

NCBI chr20:4,117,957...4,121,643
Ensembl chr20:4,117,957...4,121,600

G

proline-rich transmembrane protein 3

increases expression

fenvalerate results in increased expression of PRRT3 mRNA

NCBI chr 4:146,641,173...146,650,487
Ensembl chr 4:146,641,173...146,650,317

G

serine protease 21

increases expression

fenvalerate results in increased expression of PRSS21 mRNA

NCBI chr10:12,899,820...12,905,612
Ensembl chr10:12,900,535...12,905,618

G

serine protease 22

increases expression

fenvalerate results in increased expression of PRSS22 mRNA

NCBI chr10:13,029,153...13,033,863
Ensembl chr10:13,029,153...13,033,863

G

serine protease 36

increases expression

fenvalerate results in increased expression of PRSS36 mRNA

NCBI chr 1:182,543,085...182,561,141
Ensembl chr 1:182,543,085...182,559,280

G

serine protease 37

decreases expression

fenvalerate results in decreased expression of PRSS37 mRNA

NCBI chr 4:69,322,977...69,334,555
Ensembl chr 4:69,322,977...69,334,555

G

pregnancy-specific beta 1-glycoprotein

increases expression

fenvalerate results in increased expression of PSGB1 mRNA

NCBI chr 1:77,923,170...77,932,605
Ensembl chr 1:77,923,170...77,932,053

G

PC4 and SRSF1 interacting protein 1

increases expression

fenvalerate results in increased expression of PSIP1 mRNA

NCBI chr 5:97,847,010...97,879,280
Ensembl chr 5:97,847,015...97,879,257

G

proteasome 20S subunit alpha 2

decreases expression

fenvalerate results in decreased expression of PSMA2 protein

NCBI chr17:50,554,536...50,564,923
Ensembl chr17:50,551,924...50,564,938

G

proteasome 20S subunit beta 1

decreases expression

fenvalerate results in decreased expression of PSMB1 protein

NCBI chr 1:56,442,432...56,463,544
Ensembl chr 1:56,420,618...56,463,560

G

proteasome 20S subunit beta 5

decreases expression

fenvalerate results in decreased expression of PSMB5 protein

NCBI chr15:28,072,772...28,077,367
Ensembl chr15:28,072,781...28,077,440

G

proteasome 26S subunit, ATPase 4

increases expression

fenvalerate results in increased expression of PSMC4 protein

NCBI chr 1:83,349,127...83,357,497
Ensembl chr 1:83,348,592...83,357,494

G

proteasome 26S subunit ubiquitin receptor, non-ATPase 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PSMD2 protein

NCBI chr11:80,248,364...80,258,991
Ensembl chr11:80,248,364...80,259,043

G

platelet-activating factor receptor

increases expression

fenvalerate results in increased expression of PTAFR mRNA

NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251

G

phosphatidylserine synthase 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PTDSS2 protein

NCBI chr 1:196,241,439...196,267,632
Ensembl chr 1:196,241,494...196,267,685

G

prostaglandin F2 receptor inhibitor

affects methylation

fenvalerate affects the methylation of PTGFRN gene

NCBI chr 2:188,469,521...188,544,795
Ensembl chr 2:188,469,521...188,544,795

G

prostaglandin-endoperoxide synthase 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of PTGS1 protein

NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586

G

parathyroid hormone 1 receptor

increases expression

fenvalerate results in increased expression of PTH1R mRNA

NCBI chr 8:110,693,910...110,725,458
Ensembl chr 8:110,697,485...110,719,729

G

protein tyrosine kinase 2 beta

increases expression

fenvalerate results in increased expression of PTK2B mRNA

NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282

G

protein tyrosine kinase 7

increases expression

fenvalerate results in increased expression of PTK7 mRNA

NCBI chr 9:14,352,155...14,418,473
Ensembl chr 9:14,351,202...14,418,494

G

protein tyrosine phosphatase 4A3

increases expression

fenvalerate results in increased expression of PTP4A3 mRNA

NCBI chr 7:105,650,640...105,660,921
Ensembl chr 7:105,628,029...105,660,919

G

protein tyrosine phosphatase, non-receptor type 5

increases expression

fenvalerate results in increased expression of PTPN5 mRNA

NCBI chr 1:97,620,638...97,681,186
Ensembl chr 1:97,620,642...97,679,882

G

protein tyrosine phosphatase, receptor type, K

increases expression

fenvalerate results in increased expression of PTPRK mRNA

NCBI chr 1:16,738,896...17,236,687
Ensembl chr 1:16,850,576...17,103,605

G

protein tyrosine phosphatase, receptor type, S

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PTPRS protein

NCBI chr 9:1,245,408...1,307,015
Ensembl chr 9:1,245,410...1,306,947

G

protein tyrosine phosphatase, receptor type Z1

increases expression

fenvalerate results in increased expression of PTPRZ1 mRNA

NCBI chr 4:51,397,316...51,595,220
Ensembl chr 4:51,397,601...51,595,218

G

purine-rich element binding protein G

increases expression

fenvalerate results in increased expression of PURG mRNA

NCBI chr16:58,732,327...58,763,356
Ensembl chr16:58,720,335...58,763,359

G

pseudouridine synthase 10

increases expression

fenvalerate results in increased expression of PUS10 mRNA

NCBI chr14:97,621,228...97,684,059
Ensembl chr14:97,621,391...97,684,046

G

pseudouridine synthase 3

increases expression

fenvalerate results in increased expression of PUS3 mRNA

NCBI chr 8:33,910,461...33,918,716
Ensembl chr 8:33,911,357...33,918,714

G

glycogen phosphorylase, muscle associated

increases expression

fenvalerate results in increased expression of PYGM mRNA

NCBI chr 1:203,690,550...203,705,369
Ensembl chr 1:203,690,533...203,705,368

G

pygopus family PHD finger 2

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PYGO2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PYGO2 mRNA

PMID:33051911 PMID:33396045

NCBI chr 2:174,849,670...174,854,758
Ensembl chr 2:174,849,936...174,854,758

G

glutamine rich 2

increases expression

fenvalerate results in increased expression of QRICH2 mRNA

NCBI chr10:101,669,240...101,697,643
Ensembl chr10:101,669,224...101,697,656

G

quiescin sulfhydryl oxidase 1

increases expression

fenvalerate results in increased expression of QSOX1 mRNA

NCBI chr13:67,949,780...67,987,434
Ensembl chr13:67,949,780...67,987,459

G

RAB14, member RAS oncogene family

increases expression

fenvalerate results in increased expression of RAB14 mRNA

NCBI chr 3:18,501,953...18,523,253
Ensembl chr 3:18,501,963...18,523,172

G

RAB6B, member RAS oncogene family

increases expression

fenvalerate results in increased expression of RAB6B mRNA

NCBI chr 8:103,695,328...103,764,023
Ensembl chr 8:103,695,631...103,805,732

G

Rab7b, member RAS oncogene family

increases expression

fenvalerate results in increased expression of RAB7B mRNA

NCBI chr13:43,121,168...43,147,581
Ensembl chr13:43,121,226...43,147,581

G

rabaptin, RAB GTPase binding effector protein 2

decreases expression

fenvalerate results in decreased expression of RABEP2 mRNA

NCBI chr 1:181,010,305...181,026,651
Ensembl chr 1:181,010,305...181,026,648

G

RAB GTPase activating protein 1

increases expression

fenvalerate results in increased expression of RABGAP1 mRNA

NCBI chr 3:21,208,012...21,326,013
Ensembl chr 3:21,208,055...21,326,013

G

RAB, member RAS oncogene family-like 6

increases expression

fenvalerate results in increased expression of RABL6 mRNA

NCBI chr 3:8,402,666...8,428,588
Ensembl chr 3:8,402,672...8,428,611

G

RAD50 double strand break repair protein

increases expression

fenvalerate results in increased expression of RAD50 mRNA

NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396

G

ribonucleic acid export 1

increases expression

fenvalerate results in increased expression of RAE1 mRNA

NCBI chr 3:161,779,096...161,794,048
Ensembl chr 3:161,779,088...161,794,038

G

Ral GTPase activating protein catalytic subunit alpha 1

increases expression

fenvalerate results in increased expression of RALGAPA1 mRNA

NCBI chr 6:72,977,432...73,252,378
Ensembl chr 6:72,977,432...73,252,378

G

RAP1 GTPase activating protein 2

increases expression

fenvalerate results in increased expression of RAP1GAP2 mRNA

NCBI chr10:59,255,400...59,472,536
Ensembl chr10:59,255,278...59,472,170

G

Rap1 GTPase-GDP dissociation stimulator 1

increases expression

fenvalerate results in increased expression of RAP1GDS1 mRNA

NCBI chr 2:227,500,366...227,645,213
Ensembl chr 2:227,500,367...227,645,169

G

Rap guanine nucleotide exchange factor 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RAPGEF2 protein

NCBI chr 2:164,207,513...164,322,157
Ensembl chr 2:164,207,513...164,244,247

G

Ras association (RalGDS/AF-6) and pleckstrin homology domains 1

increases expression

fenvalerate results in increased expression of RAPH1 mRNA

NCBI chr 9:61,907,476...61,990,170
Ensembl chr 9:61,907,758...61,961,209

G

receptor-associated protein of the synapse

increases expression

fenvalerate results in increased expression of RAPSN mRNA

NCBI chr 3:77,015,073...77,024,378
Ensembl chr 3:76,983,471...77,024,373

G

RAS p21 protein activator 2

increases expression

fenvalerate results in increased expression of RASA2 mRNA

NCBI chr 8:97,119,983...97,236,687
Ensembl chr 8:97,118,802...97,236,671

G

RAS protein-specific guanine nucleotide-releasing factor 1

increases expression

fenvalerate results in increased expression of RASGRF1 mRNA

NCBI chr 8:90,445,154...90,574,274
Ensembl chr 8:90,445,154...90,574,269

G

RAS-like family 11 member B

decreases expression

fenvalerate results in decreased expression of RASL11B mRNA

NCBI chr14:34,014,924...34,019,146
Ensembl chr14:34,014,509...34,019,152

G

defensin RatNP-3 precursor

increases expression

fenvalerate results in increased expression of RATNP-3B mRNA

NCBI chr16:70,544,364...70,546,533
Ensembl chr16:70,513,888...70,546,522

G

retina and anterior neural fold homeobox

increases expression

fenvalerate results in increased expression of RAX mRNA

NCBI chr18:59,463,347...59,467,469
Ensembl chr18:59,463,737...59,467,431

G

RB binding protein 9, serine hydrolase

increases expression

fenvalerate results in increased expression of RBBP9 mRNA

NCBI chr 3:131,925,095...131,939,042
Ensembl chr 3:131,925,341...131,932,156

G

RANBP2-type and C3HC4-type zinc finger containing 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of RBCK1 protein

NCBI chr 3:140,789,079...140,806,017
Ensembl chr 3:140,789,080...140,806,005

G

RNA binding fox-1 homolog 3

increases expression

fenvalerate results in increased expression of RBFOX3 mRNA

NCBI chr10:103,720,355...104,157,277
Ensembl chr10:103,720,636...104,156,935

G

RNA binding motif protein 17

increases expression

fenvalerate results in increased expression of RBM17 mRNA

NCBI chr17:66,937,140...66,954,034
Ensembl chr17:66,937,140...66,954,014

G

RNA binding motif protein 18

increases expression

fenvalerate results in increased expression of RBM18 mRNA

NCBI chr 3:19,467,333...19,487,171
Ensembl chr 3:19,467,335...19,487,178

G

RNA binding motif protein 19

decreases expression

fenvalerate results in decreased expression of RBM19 mRNA

NCBI chr12:36,365,775...36,451,033
Ensembl chr12:36,365,772...36,450,993

G

RNA binding motif protein 20

increases expression

fenvalerate results in increased expression of RBM20 mRNA

NCBI chr 1:252,683,760...252,907,465
Ensembl chr 1:252,683,771...252,886,060

G

RNA binding motif protein 7

increases expression

fenvalerate results in increased expression of RBM7 mRNA

NCBI chr 8:48,831,894...48,838,399
Ensembl chr 8:48,831,894...48,838,411

G

retinol binding protein 2

increases expression

fenvalerate results in increased expression of RBP2 mRNA

NCBI chr 8:99,079,293...99,104,489
Ensembl chr 8:99,079,104...99,104,473

G

recombination signal binding protein for immunoglobulin kappa J region

increases expression

fenvalerate results in increased expression of RBPJ mRNA

NCBI chr14:57,338,493...57,523,330
Ensembl chr14:57,338,507...57,523,353

G

RCC1 and BTB domain containing protein 2

increases expression

fenvalerate results in increased expression of RCBTB2 mRNA

NCBI chr15:48,319,809...48,364,441
Ensembl chr15:48,323,866...48,383,750

G

RD3 like

increases expression

fenvalerate results in increased expression of RD3L mRNA

NCBI chr 6:131,042,274...131,044,178
Ensembl chr 6:131,042,185...131,044,163

G

retinol dehydrogenase 14

decreases expression

fenvalerate results in decreased expression of RDH14 protein

NCBI chr 6:33,156,569...33,161,712
Ensembl chr 6:33,156,569...33,161,712

G

reversion-inducing-cysteine-rich protein with kazal motifs

decreases expression

fenvalerate results in decreased expression of RECK mRNA

NCBI chr 5:58,102,961...58,169,516
Ensembl chr 5:58,102,981...58,169,502

G

RecQ like helicase

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RECQL protein

NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945

G

receptor accessory protein 1

increases expression

fenvalerate results in increased expression of REEP1 mRNA

NCBI chr 4:103,746,004...103,862,347
Ensembl chr 4:103,745,633...103,862,338

G

receptor accessory protein 2

increases expression

fenvalerate results in increased expression of REEP2 mRNA

NCBI chr18:26,438,130...26,447,165
Ensembl chr18:26,438,346...26,447,161

G

RRAD and GEM like GTPase 1

increases expression

fenvalerate results in increased expression of REM1 mRNA

NCBI chr 3:141,103,722...141,112,206
Ensembl chr 3:141,103,766...141,112,203

G

replication initiator 1

increases expression

fenvalerate results in increased expression of REPIN1 mRNA

NCBI chr 4:77,548,724...77,554,242
Ensembl chr 4:77,548,849...77,554,257

G

reticulophagy regulator family member 3

increases expression

fenvalerate results in increased expression of RETREG3 mRNA

NCBI chr10:86,028,767...86,052,575
Ensembl chr10:86,028,774...86,052,692

G

RNA exonuclease 1 homolog

increases expression

fenvalerate results in increased expression of REXO1 mRNA

NCBI chr 7:9,154,050...9,174,035
Ensembl chr 7:9,154,061...9,173,454

G

RNA exonuclease 5

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of REXO5 protein

NCBI chr 1:174,168,633...174,264,526
Ensembl chr 1:174,168,694...174,241,486

G

replication factor C subunit 1

decreases expression

fenvalerate results in decreased expression of RFC1 mRNA

NCBI chr14:42,966,279...43,041,372
Ensembl chr14:42,966,324...43,041,370

G

regulatory factor X3

increases expression

fenvalerate results in increased expression of RFX3 mRNA

NCBI chr 1:225,449,872...225,709,622
Ensembl chr 1:225,456,187...225,709,402

G

regulatory factor X, 7

increases expression

fenvalerate results in increased expression of RFX7 mRNA

NCBI chr 8:73,254,051...73,339,209
Ensembl chr 8:73,254,051...73,339,209

G

RGD1565959

increases expression

fenvalerate results in increased expression of RGD1565959 mRNA

NCBI chr 9:12,873,697...12,886,364
Ensembl chr 9:12,873,697...12,886,364

G

regulator of G-protein signaling 22

increases expression

fenvalerate results in increased expression of RGS22 mRNA

NCBI chr 7:67,188,531...67,308,805
Ensembl chr 7:67,188,519...67,308,875

G

regulator of G-protein signaling 8

increases expression

fenvalerate results in increased expression of RGS8 mRNA

NCBI chr13:65,804,703...65,848,955
Ensembl chr13:65,804,797...65,846,807

G

Rh-associated glycoprotein

increases expression

fenvalerate results in increased expression of RHAG mRNA

NCBI chr 9:20,069,800...20,097,836
Ensembl chr 9:20,069,807...20,097,836

G

rhomboid 5 homolog 1

decreases expression

fenvalerate results in decreased expression of RHBDF1 mRNA

NCBI chr10:15,406,832...15,419,765
Ensembl chr10:15,406,859...15,419,763

G

regulatory subunit of type II PKA R-subunit domain containing 1

increases expression

fenvalerate results in increased expression of RIIAD1 mRNA

NCBI chr 2:182,099,924...182,110,544
Ensembl chr 2:182,101,795...182,110,319

G

RIMS binding protein 2

increases expression
multiple interactions

fenvalerate results in increased expression of RIMBP2 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RIMBP2 protein

PMID:30307764 PMID:34896426

NCBI chr12:27,747,615...27,946,256
Ensembl chr12:27,747,980...27,956,763

G

regulating synaptic membrane exocytosis 2

increases expression

fenvalerate results in increased expression of RIMS2 mRNA

NCBI chr 7:70,248,104...70,759,134
Ensembl chr 7:70,243,872...70,757,491

G

ring finger protein 1

decreases expression

fenvalerate results in decreased expression of RING1 mRNA

NCBI chr20:4,830,120...4,833,623
Ensembl chr20:4,830,053...4,833,620

G

RHO family interacting cell polarization regulator 2

increases expression
multiple interactions

fenvalerate results in increased expression of RIPOR2 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RIPOR2 protein

PMID:30307764 PMID:34896426

NCBI chr17:40,323,748...40,547,482
Ensembl chr17:40,323,867...40,548,092

G

ripply transcriptional repressor 3

increases expression

fenvalerate results in increased expression of RIPPLY3 mRNA

NCBI chr11:33,648,471...33,656,587
Ensembl chr11:33,648,486...33,656,584

G

RNA 5'-phosphate and 3'-OH ligase 1

increases expression

fenvalerate results in increased expression of RLIG1 mRNA

NCBI chr 7:35,396,876...35,408,633
Ensembl chr 7:35,397,995...35,409,600

G

relaxin 1

increases expression

fenvalerate results in increased expression of RLN1 mRNA

NCBI chr 1:227,079,960...227,082,960
Ensembl chr 1:227,079,966...227,082,882

G

relaxin 3

increases expression

fenvalerate results in increased expression of RLN3 mRNA

NCBI chr19:24,107,401...24,109,432
Ensembl chr19:24,107,401...24,109,886

G

ribonuclease, RNase A family, 1-like 2

increases expression

fenvalerate results in increased expression of RNASE1L2 mRNA

NCBI chr15:24,421,825...24,423,513
Ensembl chr15:24,421,859...24,423,611

G

ribonuclease A family member 2

increases expression

fenvalerate results in increased expression of RNASE2 mRNA

NCBI chr15:24,449,618...24,450,427
Ensembl chr15:24,449,611...24,450,479

G

Rho family GTPase 1

increases expression

fenvalerate results in increased expression of RND1 mRNA

NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399

G

ring finger protein 157

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF157 protein

NCBI chr10:101,571,972...101,639,874
Ensembl chr10:101,566,295...101,639,942

G

ring finger protein 182

increases expression

fenvalerate results in increased expression of RNF182 mRNA

NCBI chr17:21,026,110...21,081,760
Ensembl chr17:21,030,214...21,094,911

G

ring finger protein 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF2 protein

NCBI chr13:63,553,964...63,584,047
Ensembl chr13:63,554,862...63,583,099

G

ring finger protein 20

increases expression

fenvalerate results in increased expression of RNF20 mRNA

NCBI chr 5:63,976,063...64,001,754
Ensembl chr 5:63,976,045...64,001,754

G

ring finger protein 207

increases expression

fenvalerate results in increased expression of RNF207 mRNA

NCBI chr 5:162,815,351...162,828,325
Ensembl chr 5:162,815,357...162,828,375

G

ring finger protein 213

increases expression

fenvalerate results in increased expression of RNF213 mRNA

NCBI chr10:104,656,329...104,755,669
Ensembl chr10:104,656,883...104,757,918

G

ring finger protein 227

increases expression

fenvalerate results in increased expression of RNF227 mRNA

NCBI chr10:54,061,054...54,063,015
Ensembl chr10:54,059,947...54,063,010

G

ring finger protein 31

increases expression

fenvalerate results in increased expression of RNF31 mRNA

NCBI chr15:29,083,047...29,095,328
Ensembl chr15:29,083,631...29,101,915

G

ring finger protein 8

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF8 protein

NCBI chr20:7,682,258...7,710,448
Ensembl chr20:7,682,322...7,708,491

G

RNA-binding region (RNP1, RRM) containing 3

increases expression

fenvalerate results in increased expression of RNPC3 mRNA

NCBI chr 2:201,432,769...201,457,015
Ensembl chr 2:201,432,684...201,456,747

G

rhophilin associated tail protein 1

decreases expression

fenvalerate results in decreased expression of ROPN1 protein

NCBI chr11:66,097,854...66,127,148
Ensembl chr11:66,097,856...66,127,148

G

rhophilin associated tail protein 1-like

increases expression

fenvalerate results in increased expression of ROPN1L mRNA

NCBI chr 2:82,442,645...82,453,332
Ensembl chr 2:82,441,891...82,453,485

G

ribose 5-phosphate isomerase A

increases expression

fenvalerate results in increased expression of RPIA mRNA

NCBI chr 4:102,723,712...102,749,374
Ensembl chr 4:102,723,712...102,749,355

G

ribosomal protein L39

increases expression

fenvalerate results in increased expression of RPL39 mRNA

NCBI chr X:116,327,216...116,330,211
Ensembl chr18:6,326,330...6,326,692
Ensembl chr X:6,326,330...6,326,692

G

ribosomal protein S4, X-linked, pseudogene 1

increases expression

fenvalerate results in increased expression of RPS4X-PS1 mRNA

NCBI chr 1:231,210,277...231,211,564

G

ribosomal protein S6 kinase A5

decreases expression

fenvalerate results in decreased expression of RPS6KA5 mRNA

NCBI chr 6:119,828,823...120,006,190
Ensembl chr 6:119,828,846...120,006,224

G

RNA pseudouridine synthase domain containing 1

increases expression

fenvalerate results in increased expression of RPUSD1 mRNA

NCBI chr10:14,751,310...14,755,213
Ensembl chr10:14,751,384...14,755,207

G

RRAD, Ras related glycolysis inhibitor and calcium channel regulator

increases expression

fenvalerate results in increased expression of RRAD mRNA

NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417

G

Ras-related GTP binding D

increases expression

fenvalerate results in increased expression of RRAGD mRNA

NCBI chr 5:47,373,902...47,409,369
Ensembl chr 5:47,373,463...47,409,356

G

ribonucleotide reductase catalytic subunit M1

decreases expression

fenvalerate results in decreased expression of RRM1 mRNA

NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261

G

RT1 class Ib, locus N3

increases expression

fenvalerate results in increased expression of RT1-N3 mRNA

NCBI chr20:2,659,132...2,665,536
Ensembl chr20:2,661,584...2,665,530

G

regulator of telomere elongation helicase 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RTEL1 protein

NCBI chr 3:168,427,247...168,465,349
Ensembl chr 3:168,419,579...168,465,348

G

RUNX1 partner transcriptional co-repressor 1

increases expression

fenvalerate results in increased expression of RUNX1T1 mRNA

NCBI chr 5:27,187,674...27,338,070
Ensembl chr 5:27,187,551...27,335,592

G

retinoid X receptor alpha

increases activity

fenvalerate results in increased activity of RXRA protein

NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712

G

retinoid X receptor gamma

affects binding

fenvalerate binds to RXRG protein

NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167

G

ryanodine receptor 1

decreases expression

fenvalerate results in decreased expression of RYR1 mRNA

NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812

G

ryanodine receptor 2

increases expression

fenvalerate results in increased expression of RYR2 mRNA

NCBI chr17:58,389,925...58,975,641
Ensembl chr17:58,389,925...58,975,142

G

S100 calcium binding protein A3

increases expression

fenvalerate results in increased expression of S100A3 mRNA

NCBI chr 2:176,034,283...176,089,702
Ensembl chr 2:176,049,520...176,089,702

G

S100 calcium-binding protein, ventral prostate

increases expression

fenvalerate results in increased expression of S100VP mRNA

NCBI chr 2:176,748,273...176,751,624
Ensembl chr 2:176,748,273...176,751,624

G

sphingosine-1-phosphate receptor 5

increases expression

fenvalerate results in increased expression of S1PR5 mRNA

NCBI chr 8:19,786,676...19,791,862
Ensembl chr 8:19,786,663...19,791,795

G

sterile alpha motif domain containing 9

increases expression

fenvalerate results in increased expression of SAMD9 mRNA

NCBI chr 4:31,164,639...31,184,278
Ensembl chr 4:31,164,510...31,184,322

G

seryl-tRNA synthetase 2, mitochondrial

decreases expression

fenvalerate results in decreased expression of SARS2 mRNA

NCBI chr 1:84,028,972...84,040,725
Ensembl chr 1:84,028,986...84,040,725

G

spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SART1 protein

NCBI chr 1:202,690,472...202,699,136
Ensembl chr 1:202,690,459...202,699,136

G

SAM and SH3 domain containing 3

increases expression

fenvalerate results in increased expression of SASH3 mRNA

NCBI chr X:127,326,815...127,341,521
Ensembl chr X:127,326,859...127,341,519

G

SR-related CTD-associated factor 1

decreases expression

fenvalerate results in decreased expression of SCAF1 mRNA

NCBI chr 1:95,485,448...95,499,389
Ensembl chr 1:95,485,448...95,496,029

G

secretory carrier membrane protein 5

decreases expression

fenvalerate results in decreased expression of SCAMP5 mRNA

NCBI chr 8:57,845,831...57,884,516
Ensembl chr 8:57,846,659...57,872,027

G

SREBF chaperone

increases expression

fenvalerate results in increased expression of SCAP mRNA

NCBI chr 8:110,306,026...110,360,677
Ensembl chr 8:110,306,031...110,360,666

G

scavenger receptor class B, member 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of SCARB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SCARB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of SCARB1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of SCARB1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647

G

stearoyl-Coenzyme A desaturase 2

increases expression

fenvalerate results in increased expression of SCD2 mRNA

NCBI chr 1:243,169,171...243,182,231
Ensembl chr 1:243,169,236...243,182,232

G

sciellin

increases expression

fenvalerate results in increased expression of SCEL mRNA

NCBI chr15:80,339,661...80,456,546
Ensembl chr15:80,339,951...80,456,372

G

secretogranin II

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SCG2 protein

NCBI chr 9:80,803,074...80,808,646
Ensembl chr 9:80,803,075...80,821,097

G

secretogranin V

increases expression

fenvalerate results in increased expression of SCG5 mRNA

NCBI chr 3:100,544,101...100,588,558
Ensembl chr 3:100,544,099...100,588,463

G

secretoglobin family 1A member 1

increases expression

fenvalerate results in increased expression of SCGB1A1 mRNA

NCBI chr 1:205,977,060...205,980,610
Ensembl chr 1:205,977,060...205,980,610

G

secretoglobin, family 1D, member 2

increases expression

fenvalerate results in increased expression of SCGB1D2 mRNA

NCBI chr 1:206,228,546...206,233,587
Ensembl chr 1:206,228,778...206,231,785

G

sodium voltage-gated channel alpha subunit 10

multiple interactions

fenvalerate affects the reaction [SCN10A protein results in increased transport of Sodium]

NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614

G

sodium voltage-gated channel alpha subunit 11

increases expression

fenvalerate results in increased expression of SCN11A mRNA

NCBI chr 8:119,495,550...119,567,044
Ensembl chr 8:119,496,769...119,567,044

G

sodium voltage-gated channel beta subunit 1

multiple interactions

fenvalerate affects the reaction [[SCN2A protein binds to SCN1B protein] which results in increased transport of Sodium]

NCBI chr 1:86,353,917...86,363,820
Ensembl chr 1:86,353,917...86,363,739

G

sodium voltage-gated channel alpha subunit 2

multiple interactions

fenvalerate affects the reaction [[SCN2A protein binds to SCN1B protein] which results in increased transport of Sodium]

NCBI chr 3:50,302,781...50,437,504
Ensembl chr 3:50,302,877...50,437,214

G

sodium voltage-gated channel beta subunit 2

increases expression

fenvalerate results in increased expression of SCN2B mRNA

NCBI chr 8:45,425,629...45,437,765
Ensembl chr 8:45,425,629...45,437,765

G

sodium voltage-gated channel alpha subunit 3

multiple interactions

fenvalerate affects the reaction [[SCN3A protein binds to SCN3B protein] which results in increased transport of Sodium]

NCBI chr 3:50,146,411...50,258,119
Ensembl chr 3:50,148,139...50,258,119

G

sodium voltage-gated channel beta subunit 3

multiple interactions

fenvalerate affects the reaction [[SCN3A protein binds to SCN3B protein] which results in increased transport of Sodium]

NCBI chr 8:40,630,372...40,652,869
Ensembl chr 8:40,630,455...40,652,868

G

sodium voltage-gated channel beta subunit 4

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SCN4B protein

NCBI chr 8:45,446,580...45,462,294
Ensembl chr 8:45,446,215...45,462,292

G

sodium channel epithelial 1 subunit alpha

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SCNN1A protein

NCBI chr 4:158,122,962...158,146,184
Ensembl chr 4:158,122,962...158,146,181

G

scleraxis bHLH transcription factor

decreases expression

fenvalerate results in decreased expression of SCX mRNA

NCBI chr 7:108,176,608...108,178,626
Ensembl chr 7:108,176,608...108,178,626

G

SHH signaling and ciliogenesis regulator SDCCAG8

increases expression

fenvalerate results in increased expression of SDCCAG8 mRNA

NCBI chr13:88,754,521...88,979,363
Ensembl chr13:88,754,626...89,097,111

G

short chain dehydrogenase/reductase family 39U, member 1

increases expression

fenvalerate results in increased expression of SDR39U1 mRNA

NCBI chr15:29,378,156...29,380,989
Ensembl chr15:29,378,026...29,381,560

G

SEC16 homolog B, endoplasmic reticulum export factor

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SEC16B protein

NCBI chr13:69,665,757...69,727,199
Ensembl chr13:69,684,291...69,727,196

G

SEL1L family member 3

increases expression

fenvalerate results in increased expression of SEL1L3 mRNA

NCBI chr14:57,775,515...57,882,076
Ensembl chr14:57,775,501...57,882,644

G

selectin P

increases expression

fenvalerate results in increased expression of SELP mRNA

NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845

G

semaphorin 3G

increases expression

fenvalerate results in increased expression of SEMA3G mRNA

NCBI chr16:6,413,589...6,425,221
Ensembl chr16:6,413,589...6,425,221

G

semaphorin 5A

increases expression

fenvalerate results in increased expression of SEMA5A mRNA

NCBI chr 2:83,309,843...83,741,084
Ensembl chr 2:83,309,843...83,741,084

G

semaphorin 6C

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SEMA6C protein

NCBI chr 2:182,733,635...182,750,066
Ensembl chr 2:182,737,474...182,746,856

G

septin 5

increases expression

fenvalerate results in increased expression of SEPTIN5 mRNA

NCBI chr11:82,373,601...82,379,393
Ensembl chr11:82,369,754...82,379,393

G

septin 6

increases expression

fenvalerate results in increased expression of SEPTIN6 mRNA

NCBI chr X:116,153,255...116,230,334
Ensembl chr X:116,153,255...116,230,115

G

serpin family A member 5

increases expression

fenvalerate results in increased expression of SERPINA5 mRNA

NCBI chr 6:123,009,224...123,028,412
Ensembl chr 6:123,023,306...123,028,407

G

serpin family B member 11

increases expression

fenvalerate results in increased expression of SERPINB11 mRNA

NCBI chr13:23,304,775...23,344,604
Ensembl chr13:23,304,456...23,344,604

G

serpin family B member 3

increases expression

fenvalerate results in increased expression of SERPINB3 mRNA

NCBI chr13:23,274,120...23,280,660
Ensembl chr13:23,274,484...23,313,682

G

serine-rich and transmembrane domain containing 1

increases expression

fenvalerate results in increased expression of SERTM1 mRNA

NCBI chr 2:139,086,905...139,106,528
Ensembl chr 2:139,086,908...139,106,459

G

SET domain containing 1A, histone lysine methyltransferase

increases expression

fenvalerate results in increased expression of SETD1A mRNA

NCBI chr 1:182,386,197...182,411,695
Ensembl chr 1:182,388,060...182,411,090

G

seizure related 6 homolog like

increases expression

fenvalerate results in increased expression of SEZ6L mRNA

NCBI chr12:44,064,901...44,221,814
Ensembl chr12:44,064,935...44,219,663

G

secreted frizzled-related protein 2

increases expression

fenvalerate results in increased expression of SFRP2 mRNA

NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063

G

surfactant protein B

increases expression

fenvalerate results in increased expression of SFTPB mRNA

NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436

G

small G protein signaling modulator 1

increases expression

fenvalerate results in increased expression of SGSM1 mRNA

NCBI chr12:43,320,500...43,386,469
Ensembl chr12:43,321,256...43,386,457

G

SH3 domain containing 21

increases expression

fenvalerate results in increased expression of SH3D21 mRNA

NCBI chr 5:138,429,180...138,444,540
Ensembl chr 5:138,429,180...138,444,407

G

SH3 and multiple ankyrin repeat domains 1

increases expression

fenvalerate results in increased expression of SHANK1 mRNA

NCBI chr 1:94,807,879...94,857,356
Ensembl chr 1:94,808,276...94,855,824

G

SH3 and multiple ankyrin repeat domains 2

decreases expression

fenvalerate results in decreased expression of SHANK2 mRNA

NCBI chr 1:199,146,210...199,590,962
Ensembl chr 1:199,169,429...199,589,394

G

sex hormone binding globulin

affects binding

fenvalerate binds to SHBG protein

NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057

G

shisa family member 7

increases expression

fenvalerate results in increased expression of SHISA7 mRNA

NCBI chr 1:68,993,900...69,012,943
Ensembl chr 1:68,994,025...69,012,943

G

shisa family member 8

increases expression

fenvalerate results in increased expression of SHISA8 mRNA

NCBI chr 7:113,722,408...113,727,858
Ensembl chr 7:113,722,408...113,727,858

G

shisa like 2B

increases expression

fenvalerate results in increased expression of SHISAL2B mRNA

NCBI chr 2:36,002,622...36,019,529
Ensembl chr 2:36,002,651...36,019,123

G

SNF2 histone linker PHD RING helicase

increases expression

fenvalerate results in increased expression of SHPRH mRNA

NCBI chr 1:5,528,827...5,602,537
Ensembl chr 1:5,528,888...5,602,527

G

shroom family member 3

increases expression

fenvalerate results in increased expression of SHROOM3 mRNA

NCBI chr14:15,099,415...15,396,832
Ensembl chr14:15,099,423...15,396,915

G

SID1 transmembrane family, member 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SIDT2 protein

NCBI chr 8:46,232,379...46,248,913
Ensembl chr 8:46,232,383...46,248,700

G

signal-induced proliferation-associated 1 like 2

increases expression

fenvalerate results in increased expression of SIPA1L2 mRNA

NCBI chr19:53,389,792...53,540,466
Ensembl chr19:53,389,805...53,540,428

G

signal-induced proliferation-associated 1 like 3

increases expression

fenvalerate results in increased expression of SIPA1L3 mRNA

NCBI chr 1:84,618,714...84,825,956
Ensembl chr 1:84,618,719...84,703,802

G

sirtuin 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of SIRT1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SIRT1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of SIRT1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of SIRT1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260

G

sirtuin 4

increases expression

fenvalerate results in increased expression of SIRT4 mRNA

NCBI chr12:41,125,533...41,139,440
Ensembl chr12:41,131,262...41,139,439

G

SIX homeobox 3

increases expression

fenvalerate results in increased expression of SIX3 mRNA

NCBI chr 6:9,039,017...9,043,336
Ensembl chr 6:9,036,434...9,053,301

G

SIX homeobox 4

increases expression

fenvalerate results in increased expression of SIX4 mRNA

NCBI chr 6:91,802,328...91,816,002
Ensembl chr 6:91,802,329...91,815,992

G

SIX homeobox 6

increases expression

fenvalerate results in increased expression of SIX6 mRNA

NCBI chr 6:91,634,568...91,639,548
Ensembl chr 6:91,634,568...91,639,548

G

SLAIN motif family, member 1

increases expression

fenvalerate results in increased expression of SLAIN1 mRNA

NCBI chr15:80,482,818...80,542,461
Ensembl chr15:80,482,367...80,542,350

G

solute carrier family 12 member 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SLC12A1 protein

NCBI chr 3:112,406,140...112,482,913
Ensembl chr 3:112,406,140...112,482,899

G

solute carrier family 12, member 6

increases expression

fenvalerate results in increased expression of SLC12A6 mRNA

NCBI chr 3:99,071,577...99,170,266
Ensembl chr 3:99,071,391...99,170,258

G

solute carrier family 12, member 8

increases expression

fenvalerate results in increased expression of SLC12A8 mRNA

NCBI chr11:67,116,876...67,266,548
Ensembl chr11:67,116,877...67,266,834

G

solute carrier family 14 member 2

increases expression

fenvalerate results in increased expression of SLC14A2 mRNA

NCBI chr18:71,612,460...72,039,462
Ensembl chr18:71,612,460...71,792,968

G

solute carrier family 16 member 1

increases expression

fenvalerate results in increased expression of SLC16A1 mRNA

NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611

G

solute carrier family 16, member 13

increases expression

fenvalerate results in increased expression of SLC16A13 mRNA

NCBI chr10:54,925,973...54,937,860
Ensembl chr10:54,926,760...54,937,788

G

solute carrier family 16 member 8

increases expression

fenvalerate results in increased expression of SLC16A8 mRNA

NCBI chr 7:110,818,274...110,822,069
Ensembl chr 7:110,818,274...110,822,069

G

solute carrier family 17 member 7

increases expression

fenvalerate results in increased expression of SLC17A7 mRNA

NCBI chr 1:95,649,709...95,661,591
Ensembl chr 1:95,649,745...95,661,588

G

solute carrier family 1 member 6

increases expression

fenvalerate results in increased expression of SLC1A6 mRNA

NCBI chr 7:10,841,836...10,870,424
Ensembl chr 7:10,841,837...10,870,449

G

solute carrier family 22, member 23

increases expression

fenvalerate results in increased expression of SLC22A23 mRNA

NCBI chr17:30,544,106...30,709,790
Ensembl chr17:30,544,106...30,709,790

G

solute carrier family 24 member 3

increases expression

fenvalerate results in increased expression of SLC24A3 mRNA

NCBI chr 3:132,552,119...133,051,192
Ensembl chr 3:132,551,595...133,051,192

G

solute carrier family 24 member 4

increases expression

fenvalerate results in increased expression of SLC24A4 mRNA

NCBI chr 6:121,279,590...121,419,811
Ensembl chr 6:121,280,031...121,414,949

G

solute carrier family 25 member 21

decreases expression

fenvalerate results in decreased expression of SLC25A21 mRNA

NCBI chr 6:74,203,439...74,702,902
Ensembl chr 6:74,203,440...74,702,680

G

solute carrier family 26 member 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC26A3 protein

NCBI chr 6:48,023,892...48,064,829
Ensembl chr 6:48,023,892...48,064,772

G

solute carrier family 30 member 9

increases expression

fenvalerate results in increased expression of SLC30A9 mRNA

NCBI chr14:40,816,284...40,870,992
Ensembl chr14:40,816,290...40,870,929

G

solute carrier family 32 member 1

increases expression

fenvalerate results in increased expression of SLC32A1 mRNA

NCBI chr 3:147,267,373...147,271,842
Ensembl chr 3:147,267,373...147,271,844

G

solute carrier family 35 member C2

increases expression

fenvalerate results in increased expression of SLC35C2 mRNA

NCBI chr 3:154,012,262...154,023,549
Ensembl chr 3:154,012,416...154,023,488

G

solute carrier family 36, member 3

increases expression

fenvalerate results in increased expression of SLC36A3 mRNA

NCBI chr10:39,243,531...39,273,433
Ensembl chr10:39,243,595...39,270,567

G

solute carrier family 38, member 1

decreases expression
increases expression

fenvalerate results in decreased expression of SLC38A1 mRNA
fenvalerate results in increased expression of SLC38A1 mRNA

PMID:28369636 PMID:30307764

NCBI chr 7:127,733,230...127,802,541
Ensembl chr 7:127,738,226...127,802,218

G

solute carrier family 38, member 2

decreases expression

fenvalerate results in decreased expression of SLC38A2 mRNA

NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436

G

solute carrier family 38, member 5

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC38A5 protein

NCBI chr X:14,213,727...14,222,498
Ensembl chr X:14,213,729...14,222,498

G

solute carrier family 39 member 5

increases expression

fenvalerate results in increased expression of SLC39A5 mRNA

NCBI chr 7:822,873...830,865
Ensembl chr 7:824,818...830,242

G

solute carrier family 44 member 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC44A2 protein

NCBI chr 8:19,870,867...19,905,345
Ensembl chr 8:19,870,888...19,905,342

G

solute carrier family 45, member 1

increases expression

fenvalerate results in increased expression of SLC45A1 mRNA

NCBI chr 5:161,105,137...161,129,375
Ensembl chr 5:161,105,235...161,129,303

G

solute carrier family 45, member 3

increases expression

fenvalerate results in increased expression of SLC45A3 mRNA

NCBI chr13:43,407,293...43,427,588
Ensembl chr13:43,407,293...43,427,588

G

solute carrier family 4 member 4

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC4A4 protein

NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883

G

solute carrier family 51 member A

increases expression

fenvalerate results in increased expression of SLC51A mRNA

NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485

G

solute carrier family 52 member 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC52A2 protein

NCBI chr 7:108,246,003...108,267,642
Ensembl chr 7:108,262,612...108,268,034

G

solute carrier family 52 member 3

increases expression

fenvalerate results in increased expression of SLC52A3 mRNA

NCBI chr 3:140,498,924...140,515,845
Ensembl chr 3:140,509,473...140,514,096

G

solute carrier family 5 member 1

increases expression

fenvalerate results in increased expression of SLC5A1 mRNA

NCBI chr14:77,553,990...77,618,589
Ensembl chr14:77,553,843...77,618,547

G

solute carrier family 66 member 3

decreases expression

fenvalerate results in decreased expression of SLC66A3 mRNA

NCBI chr 6:39,774,801...39,786,554
Ensembl chr 6:39,774,808...39,786,303

G

solute carrier family 7 member 1

increases expression

fenvalerate results in increased expression of SLC7A1 mRNA

NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849

G

solute carrier family 9 member A4

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC9A4 protein

NCBI chr 9:42,825,334...42,879,729
Ensembl chr 9:42,825,064...42,879,422

G

solute carrier family 9 member A6

increases expression

fenvalerate results in increased expression of SLC9A6 mRNA

NCBI chr X:134,430,677...134,486,747
Ensembl chr X:134,420,756...134,485,375

G

solute carrier organic anion transporter family, member 3a1

increases expression

fenvalerate results in increased expression of SLCO3A1 mRNA

NCBI chr 1:128,106,232...128,388,043
Ensembl chr 1:128,106,228...128,387,925

G

schlafen family member 4

increases expression

fenvalerate results in increased expression of SLFN4 mRNA

NCBI chr10:67,994,601...68,018,141
Ensembl chr10:68,000,028...68,018,138
Ensembl chr10:68,000,028...68,018,138

G

schlafen family member 9

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLFN13 protein

NCBI chr10:67,909,105...67,955,912
Ensembl chr10:67,909,106...67,925,383

G

SRA stem-loop interacting RNA binding protein

increases expression

fenvalerate results in increased expression of SLIRP mRNA

NCBI chr 6:107,088,760...107,097,791
Ensembl chr 6:107,088,403...107,097,791

G

slit guidance ligand 1

increases expression

fenvalerate results in increased expression of SLIT1 mRNA

NCBI chr 1:240,409,559...240,558,127
Ensembl chr 1:240,409,561...240,558,127

G

slit guidance ligand 2

increases expression

fenvalerate results in increased expression of SLIT2 mRNA

NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948

G

SLIT and NTRK-like family, member 3

increases expression

fenvalerate results in increased expression of SLITRK3 mRNA

NCBI chr 2:157,680,067...157,697,404
Ensembl chr 2:157,687,535...157,696,709

G

sarcolipin

increases expression

fenvalerate results in increased expression of SLN mRNA

NCBI chr 8:54,221,389...54,248,110
Ensembl chr 8:54,243,542...54,247,791

G

secreted Ly6/Plaur domain containing 2

increases expression

fenvalerate results in increased expression of SLURP2 mRNA

NCBI chr 7:106,627,775...106,631,655
Ensembl chr 7:106,627,775...106,631,655

G

SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4

increases expression

fenvalerate results in increased expression of SMARCA4 mRNA

NCBI chr 8:20,167,717...20,258,975
Ensembl chr 8:20,167,717...20,258,975

G

SNF2 related chromatin remodeling ATPase with DExD box 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SMARCAD1 protein

NCBI chr 4:94,311,441...94,379,184
Ensembl chr 4:94,311,489...94,372,563

G

SWI/SNF related BAF chromatin remodeling complex subunit C2

increases expression

fenvalerate results in increased expression of SMARCC2 mRNA

NCBI chr 7:881,844...910,090
Ensembl chr 7:881,421...909,978

G

structural maintenance of chromosomes 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SMC3 protein

NCBI chr 1:252,601,422...252,644,522
Ensembl chr 1:252,601,753...252,644,522

G

small integral membrane protein 29

increases expression

fenvalerate results in increased expression of SMIM29 mRNA

NCBI chr20:5,618,845...5,620,856
Ensembl chr20:5,618,845...5,620,813

G

small muscle protein, X-linked

increases expression

fenvalerate results in increased expression of SMPX mRNA

NCBI chr X:37,233,209...37,292,266
Ensembl chr X:37,234,294...37,276,708

G

submaxillary gland androgen regulated protein 3B

increases expression

fenvalerate results in increased expression of SMR3B mRNA

NCBI chr14:19,783,815...19,788,557
Ensembl chr14:19,783,816...19,788,492

G

synaptosome associated protein 29

increases expression

fenvalerate results in increased expression of SNAP29 mRNA

NCBI chr11:83,578,479...83,608,953
Ensembl chr11:83,578,489...83,608,958

G

synaptosome associated protein 91

increases expression

fenvalerate results in increased expression of SNAP91 mRNA

NCBI chr 8:87,738,056...87,852,690
Ensembl chr 8:87,738,824...87,852,367

G

synuclein, alpha interacting protein

increases expression

fenvalerate results in increased expression of SNCAIP mRNA

NCBI chr18:46,205,846...46,343,932
Ensembl chr18:46,207,152...46,343,929

G

synuclein, gamma

increases expression

fenvalerate results in increased expression of SNCG mRNA

NCBI chr16:9,700,513...9,705,751
Ensembl chr16:9,700,514...9,705,368

G

sushi, nidogen and EGF-like domains 1

increases expression
multiple interactions

fenvalerate results in increased expression of SNED1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SNED1 protein

PMID:30307764 PMID:34896426

NCBI chr 9:93,774,087...93,834,003
Ensembl chr 9:93,774,119...93,830,694

G

small nucleolar RNA host gene 11

increases expression

fenvalerate results in increased expression of SNHG11 mRNA

NCBI chr 3:147,031,367...147,037,043

G

small nuclear ribonucleoprotein U11/U12 subunit 48

increases expression

fenvalerate results in increased expression of SNRNP48 mRNA

NCBI chr17:26,596,266...26,616,058
Ensembl chr17:26,596,275...26,616,040

G

syntrophin, gamma 2

increases expression

fenvalerate results in increased expression of SNTG2 mRNA

NCBI chr 6:46,801,893...47,003,390
Ensembl chr 6:46,801,377...47,003,372

G

sorting nexin 18

increases expression

fenvalerate results in increased expression of SNX18 mRNA

NCBI chr 2:45,232,325...45,258,345
Ensembl chr 2:45,232,325...45,258,345

G

sorting nexin 5

increases expression

fenvalerate results in increased expression of SNX5 mRNA

NCBI chr 3:131,621,875...131,641,127
Ensembl chr 3:131,621,880...131,641,192

G

sine oculis binding protein homolog

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SOBP protein

NCBI chr20:46,482,265...46,661,452
Ensembl chr20:46,482,765...46,663,541

G

suppressor of cytokine signaling 1

increases expression

fenvalerate results in increased expression of SOCS1 mRNA

NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383

G

superoxide dismutase 1

multiple interactions
decreases activity
increases activity

[cypermethrin co-treated with fenvalerate] results in increased activity of SOD1 protein
fenvalerate metabolite results in decreased activity of SOD1 protein; fenvalerate results in decreased activity of SOD1 protein
fenvalerate results in increased activity of SOD1 protein

PMID:10355540 PMID:15892188

NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249

G

sorbin and SH3 domain containing 3

increases expression

fenvalerate results in increased expression of SORBS3 mRNA

NCBI chr15:45,252,921...45,284,758
Ensembl chr15:45,253,379...45,284,758

G

sortilin-related VPS10 domain containing receptor 2

increases expression

fenvalerate results in increased expression of SORCS2 mRNA

NCBI chr14:74,371,089...74,735,943
Ensembl chr14:74,371,415...74,735,943

G

sortilin-related VPS10 domain containing receptor 3

increases expression

fenvalerate results in increased expression of SORCS3 mRNA

NCBI chr 1:247,099,178...247,734,027
Ensembl chr 1:247,099,408...247,734,027

G

sortilin related receptor 1

increases expression

fenvalerate results in increased expression of SORL1 mRNA

NCBI chr 8:42,341,704...42,504,435
Ensembl chr 8:42,341,704...42,504,513

G

sclerostin

increases expression

fenvalerate results in increased expression of SOST mRNA

NCBI chr10:86,912,517...86,915,561
Ensembl chr10:86,911,517...86,915,561

G

sosondowah ankyrin repeat domain family member A

increases expression

fenvalerate results in increased expression of SOWAHA mRNA

NCBI chr10:37,641,823...37,645,390
Ensembl chr10:37,643,444...37,645,102

G

SRY-box transcription factor 17

increases expression

fenvalerate results in increased expression of SOX17 mRNA

NCBI chr 5:15,016,660...15,022,228
Ensembl chr 5:15,016,731...15,022,228

G

SRY-box transcription factor 4

increases expression

fenvalerate results in increased expression of SOX4 mRNA

NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665

G

SRY-box transcription factor 9

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of SOX9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SOX9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SOX9 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of SOX9 mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994

G

Sp3 transcription factor

increases expression

fenvalerate results in increased expression of SP3 mRNA

NCBI chr 3:57,811,855...57,857,150
Ensembl chr 3:57,812,075...57,860,342

G

sperm acrosome associated 6

increases expression

fenvalerate results in increased expression of SPACA6 mRNA

NCBI chr 1:58,672,128...58,689,309
Ensembl chr 1:58,677,797...58,688,562

G

sperm associated antigen 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SPAG1 protein

NCBI chr 7:67,361,474...67,421,369
Ensembl chr 7:67,361,477...67,421,368

G

sperm adhesion molecule 1

increases expression

fenvalerate results in increased expression of SPAM1 mRNA

NCBI chr 4:53,302,745...53,312,913
Ensembl chr 4:53,302,745...53,312,908

G

spermatogenesis associated 13

increases expression

fenvalerate results in increased expression of SPATA13 mRNA

NCBI chr15:34,778,479...34,907,645
Ensembl chr15:34,778,473...34,905,114

G

spermatogenesis associated 24

decreases expression

fenvalerate results in decreased expression of SPATA24 mRNA

NCBI chr18:27,249,047...27,257,129
Ensembl chr18:27,248,609...27,257,124

G

spermatogenesis associated 2-like

increases expression

fenvalerate results in increased expression of SPATA2L mRNA

NCBI chr19:51,269,078...51,273,605
Ensembl chr19:51,269,078...51,273,510

G

spermatogenesis associated 6

increases expression

fenvalerate results in increased expression of SPATA6 mRNA

NCBI chr 5:126,593,122...126,676,557
Ensembl chr 5:126,593,122...126,676,557

G

speedy/RINGO cell cycle regulator family member A

increases expression

fenvalerate results in increased expression of SPDYA mRNA

NCBI chr 6:23,905,574...23,954,926
Ensembl chr 6:23,910,223...23,954,850

G

SPHK1 interactor, AKAP domain containing

increases expression

fenvalerate results in increased expression of SPHKAP mRNA

NCBI chr 9:84,509,383...84,657,582
Ensembl chr 9:84,510,964...84,657,559

G

serine peptidase inhibitor, Kazal type 8

increases expression

fenvalerate results in increased expression of SPINK8 mRNA

NCBI chr 8:109,814,062...109,828,994
Ensembl chr 8:109,817,365...109,828,994

G

sprouty RTK signaling antagonist 3

increases expression

fenvalerate results in increased expression of SPRY3 mRNA

NCBI chr12:16,663,188...16,673,124
Ensembl chr12:16,663,389...16,672,531

G

SPRY domain containing 4

decreases expression

fenvalerate results in decreased expression of SPRYD4 protein

NCBI chr 7:633,400...637,564
Ensembl chr 7:633,394...637,557

G

spectrin, beta, non-erythrocytic 1

increases expression

fenvalerate results in increased expression of SPTBN1 mRNA

NCBI chr14:103,841,713...104,016,900
Ensembl chr14:103,842,684...104,008,507

G

sequestosome 1

multiple interactions
decreases expression

3-methyladenine inhibits the reaction [fenvalerate results in decreased expression of SQSTM1 protein]; SB 203580 inhibits the reaction [fenvalerate results in decreased expression of SQSTM1 protein]

NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673

G

sterol regulatory element binding transcription factor 2

increases expression
multiple interactions

fenvalerate results in increased expression of SREBF2 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SREBF2 protein

PMID:30307764 PMID:34896426

NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848

G

sushi-repeat-containing protein, X-linked

increases expression

fenvalerate results in increased expression of SRPX mRNA

NCBI chr X:12,676,984...12,751,296
Ensembl chr X:12,566,645...12,747,882

G

serine and arginine rich splicing factor 10

increases expression

fenvalerate results in increased expression of SRSF10 mRNA

NCBI chr 5:148,088,759...148,102,964
Ensembl chr 5:148,088,823...148,101,768

G

serine and arginine rich splicing factor 11

decreases expression

fenvalerate results in decreased expression of SRSF11 mRNA

NCBI chr 2:247,074,623...247,101,460
Ensembl chr 2:247,074,631...247,101,425

G

sulfiredoxin 1

increases expression

fenvalerate results in increased expression of SRXN1 mRNA

NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448

G

scavenger receptor cysteine rich family member with 4 domains

increases expression

fenvalerate results in increased expression of SSC4D mRNA

NCBI chr12:20,702,931...20,723,732
Ensembl chr12:20,702,950...20,718,706

G

structure specific recognition protein 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SSRP1 protein

NCBI chr 3:70,124,371...70,134,481
Ensembl chr 3:70,118,655...70,134,482

G

somatostatin

increases expression

fenvalerate results in increased expression of SST mRNA

NCBI chr11:76,956,896...76,958,173
Ensembl chr11:76,956,896...76,958,173

G

ST6 beta-galactoside alpha-2,6-sialyltransferase 1

increases expression

fenvalerate results in increased expression of ST6GAL1 mRNA

NCBI chr11:77,526,837...77,653,474
Ensembl chr11:77,526,837...77,653,310

G

ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6

increases expression

fenvalerate results in increased expression of ST6GALNAC6 mRNA

NCBI chr 3:15,894,275...15,907,502
Ensembl chr 3:15,885,968...15,907,496

G

stabilin 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of STAB2 protein

NCBI chr 7:21,249,426...21,433,051
Ensembl chr 7:21,249,391...21,434,042

G

signal transducing adaptor family member 1

increases expression

fenvalerate results in increased expression of STAP1 mRNA

NCBI chr14:21,950,466...21,981,395
Ensembl chr14:21,952,496...21,981,245

G

steroidogenic acute regulatory protein

decreases expression
increases expression
multiple interactions

fenvalerate results in decreased expression of STAR mRNA; fenvalerate results in decreased expression of STAR protein
fenvalerate results in increased expression of STAR mRNA; fenvalerate results in increased expression of STAR protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of STAR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of STAR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of STAR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of STAR mRNA

PMID:15907653 PMID:18053657 PMID:19892000 PMID:33051911 PMID:33396045 More...

NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672

G

StAR-related lipid transfer domain containing 9

increases expression

fenvalerate results in increased expression of STARD9 mRNA

NCBI chr 3:107,581,097...107,672,746
Ensembl chr 3:107,581,164...107,673,898

G

serine/threonine kinase 32C

increases expression

fenvalerate results in increased expression of STK32C mRNA

NCBI chr 1:193,900,718...193,981,723
Ensembl chr 1:193,900,718...193,981,723

G

serine/threonine kinase 36

increases expression

fenvalerate results in increased expression of STK36 mRNA

NCBI chr 9:76,176,922...76,204,423
Ensembl chr 9:76,176,920...76,204,422

G

stathmin 3

increases expression

fenvalerate results in increased expression of STMN3 mRNA

NCBI chr 3:168,416,810...168,424,946
Ensembl chr 3:168,416,810...168,425,056

G

STN1 subunit of CST complex

increases expression

fenvalerate results in increased expression of STN1 mRNA

NCBI chr 1:246,391,311...246,429,844
Ensembl chr 1:246,395,613...246,429,531

G

storkhead box 2

increases expression

fenvalerate results in increased expression of STOX2 mRNA

NCBI chr16:44,848,179...45,087,238
Ensembl chr16:44,848,078...45,085,105

G

STE20 related adaptor alpha

decreases expression

fenvalerate results in decreased expression of STRADA mRNA

NCBI chr10:91,094,849...91,123,890
Ensembl chr10:91,094,687...91,123,830

G

striatin 4

increases expression

fenvalerate results in increased expression of STRN4 mRNA

NCBI chr 1:77,482,267...77,511,862
Ensembl chr 1:77,482,094...77,511,858

G

syntaxin 11

increases expression

fenvalerate results in increased expression of STX11 mRNA

NCBI chr 1:7,293,427...7,320,060
Ensembl chr 1:7,289,976...7,320,164

G

syntaxin 12

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of STX12 protein

NCBI chr 5:145,062,978...145,092,423
Ensembl chr 5:145,063,587...145,092,377

G

syntaxin 1A

increases expression

fenvalerate results in increased expression of STX1A mRNA

NCBI chr12:21,641,971...21,670,022
Ensembl chr12:21,641,969...21,669,930

G

syntaxin binding protein 2

increases expression

fenvalerate results in increased expression of STXBP2 mRNA

NCBI chr12:1,689,364...1,701,145
Ensembl chr12:1,689,410...1,700,458

G

syntaxin binding protein 5

increases expression

fenvalerate results in increased expression of STXBP5 mRNA

NCBI chr 1:4,182,489...4,335,290
Ensembl chr 1:4,185,529...4,335,101

G

succinate-CoA ligase ADP-forming subunit beta

increases expression

fenvalerate results in increased expression of SUCLA2 mRNA

NCBI chr15:48,752,356...48,805,495
Ensembl chr15:48,752,312...48,805,138

G

sulfatase 1

increases expression

fenvalerate results in increased expression of SULF1 mRNA

NCBI chr 5:6,362,894...6,526,174
Ensembl chr 5:6,362,911...6,525,584

G

sulfatase 2

increases expression

fenvalerate results in increased expression of SULF2 mRNA

NCBI chr 3:154,822,079...154,904,566
Ensembl chr 3:154,822,085...154,904,415

G

synaptic vesicle glycoprotein 2b

increases expression

fenvalerate results in increased expression of SV2B mRNA

NCBI chr 1:128,978,471...129,152,479
Ensembl chr 1:128,978,473...129,152,479

G

sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1

increases expression

fenvalerate results in increased expression of SVEP1 mRNA

NCBI chr 5:72,811,200...72,988,185
Ensembl chr 5:72,811,410...72,988,525

G

supervillin

increases expression

fenvalerate results in increased expression of SVIL mRNA

NCBI chr17:52,648,502...52,844,114
Ensembl chr17:52,648,502...52,793,404

G

synaptonemal complex central element protein 3

decreases expression

fenvalerate results in decreased expression of SYCE3 mRNA

NCBI chr 7:120,456,800...120,482,882
Ensembl chr 7:120,456,800...120,482,973

G

SYF2 pre-mRNA-splicing factor

increases expression

fenvalerate results in increased expression of SYF2 mRNA

NCBI chr 5:147,156,492...147,164,416
Ensembl chr 5:147,156,480...147,164,414

G

synapsin II

increases expression

fenvalerate results in increased expression of SYN2 mRNA

NCBI chr 4:148,178,846...148,347,010
Ensembl chr 4:148,186,270...148,344,192

G

synaptojanin 2 binding protein

increases expression

fenvalerate results in increased expression of SYNJ2BP mRNA

NCBI chr 6:101,189,714...101,227,400
Ensembl chr 6:101,189,714...101,227,406

G

synergin, gamma

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SYNRG protein

NCBI chr10:68,848,828...68,931,252
Ensembl chr10:68,849,642...68,931,250

G

synaptophysin-like 2

increases expression

fenvalerate results in increased expression of SYPL2 mRNA

NCBI chr 2:195,849,062...195,863,794
Ensembl chr 2:195,849,062...195,863,794

G

synaptotagmin 13

increases expression

fenvalerate results in increased expression of SYT13 mRNA

NCBI chr 3:78,877,114...78,917,527
Ensembl chr 3:78,877,114...78,917,392

G

synaptotagmin 17

increases expression

fenvalerate results in increased expression of SYT17 mRNA

NCBI chr 1:172,695,275...172,761,906
Ensembl chr 1:172,696,120...172,761,960

G

synaptotagmin 2

increases expression

fenvalerate results in increased expression of SYT2 mRNA

NCBI chr13:46,088,046...46,197,976
Ensembl chr13:46,185,282...46,193,859

G

synaptotagmin 5

increases expression

fenvalerate results in increased expression of SYT5 mRNA

NCBI chr 1:69,277,351...69,285,071
Ensembl chr 1:69,277,351...69,285,067

G

synaptotagmin 7

increases expression

fenvalerate results in increased expression of SYT7 mRNA

NCBI chr 1:207,031,359...207,093,787
Ensembl chr 1:207,031,592...207,089,026

G

synaptotagmin 9

increases expression

fenvalerate results in increased expression of SYT9 mRNA

NCBI chr 1:161,275,882...161,456,384
Ensembl chr 1:161,275,734...161,455,007

G

trace-amine-associated receptor 1

increases expression

fenvalerate results in increased expression of TAAR1 mRNA

NCBI chr 1:21,517,742...21,518,740
Ensembl chr 1:21,517,258...21,532,084

G

TGF-beta activated kinase 1/MAP3K7 binding protein 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TAB2 protein

NCBI chr 1:2,375,026...2,425,115
Ensembl chr 1:2,375,490...2,424,756

G

tachykinin receptor 1

increases expression

fenvalerate results in increased expression of TACR1 mRNA

NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733

G

tachykinin receptor 2

increases expression

fenvalerate results in increased expression of TACR2 mRNA

NCBI chr20:30,208,907...30,223,446
Ensembl chr20:30,208,907...30,223,446

G

transgelin

decreases expression

fenvalerate results in decreased expression of TAGLN mRNA

NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668

G

transgelin 3

increases expression

fenvalerate results in increased expression of TAGLN3 mRNA

NCBI chr11:55,099,887...55,113,457
Ensembl chr11:55,099,743...55,113,485

G

trafficking regulator and scaffold protein tamalin

increases expression

fenvalerate results in increased expression of TAMALIN mRNA

NCBI chr 7:132,338,900...132,359,519
Ensembl chr 7:132,338,900...132,346,666

G

TAR DNA binding protein

increases expression

fenvalerate results in increased expression of TARDBP mRNA

NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055

G

taste receptor, type 2, member 118

increases expression

fenvalerate results in increased expression of TAS2R118 mRNA

NCBI chr 4:52,449,208...52,450,107
Ensembl chr 4:52,449,208...52,450,107

G

taste receptor, type 2, member 126

increases expression

fenvalerate results in increased expression of TAS2R126 mRNA

NCBI chr 4:71,333,821...71,334,747
Ensembl chr 4:71,333,821...71,334,747

G

Tax1 binding protein 3

increases expression

fenvalerate results in increased expression of TAX1BP3 mRNA

NCBI chr10:57,795,845...57,800,363
Ensembl chr10:57,795,382...57,800,363

G

TBC1 domain family, member 17

decreases expression

fenvalerate results in decreased expression of TBC1D17 mRNA

NCBI chr 1:95,324,770...95,333,156
Ensembl chr 1:95,322,737...95,333,005

G

TBC1 domain family, member 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBC1D2 protein

NCBI chr 5:60,884,114...60,931,717
Ensembl chr 5:60,884,124...60,931,352

G

TBC1 domain family, member 22B

decreases expression

fenvalerate results in decreased expression of TBC1D22B mRNA

NCBI chr20:7,619,096...7,675,232
Ensembl chr20:7,619,240...7,675,231

G

TBC1 domain family, member 30

increases expression

fenvalerate results in increased expression of TBC1D30 mRNA

NCBI chr 7:56,779,570...56,869,092
Ensembl chr 7:56,782,165...56,870,515

G

TBC1 domain family, member 4

increases expression

fenvalerate results in increased expression of TBC1D4 mRNA

NCBI chr15:78,256,030...78,434,168
Ensembl chr15:78,257,121...78,434,265

G

T-box transcription factor 15

increases expression

fenvalerate results in increased expression of TBX15 mRNA

NCBI chr 2:186,576,650...186,687,748
Ensembl chr 2:186,576,676...186,687,663

G

T-box transcription factor 3

increases expression

fenvalerate results in increased expression of TBX3 mRNA

NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708

G

T-box transcription factor 5

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBX5 protein

NCBI chr12:36,686,344...36,739,253
Ensembl chr12:36,688,014...36,734,885

G

T cell activation inhibitor, mitochondrial

increases expression

fenvalerate results in increased expression of TCAIM mRNA

NCBI chr 8:122,414,827...122,446,105
Ensembl chr 8:122,414,818...122,446,092

G

transcription factor 3

increases expression

fenvalerate results in increased expression of TCF3 mRNA

NCBI chr 7:9,280,571...9,302,315
Ensembl chr 7:9,280,571...9,302,314

G

t-complex 11 like 1

increases expression

fenvalerate results in increased expression of TCP11L1 mRNA

NCBI chr 3:91,047,006...91,092,687
Ensembl chr 3:90,998,270...91,092,006

G

tectonic family member 1

increases expression

fenvalerate results in increased expression of TCTN1 mRNA

NCBI chr12:34,309,795...34,347,190
Ensembl chr12:34,309,897...34,342,267

G

L-threonine dehydrogenase

increases expression

fenvalerate results in increased expression of TDH mRNA

NCBI chr15:37,739,823...37,753,365
Ensembl chr15:37,739,823...37,753,365

G

tubulin epsilon and delta complex 1

increases expression

fenvalerate results in increased expression of TEDC1 mRNA

NCBI chr 6:132,234,764...132,245,164
Ensembl chr 6:132,236,925...132,244,928

G

transmembrane epididymal protein 1B

increases expression

fenvalerate results in increased expression of TEDDM1 mRNA

NCBI chr13:66,000,188...66,002,536
Ensembl chr13:66,000,281...66,001,189

G

transmembrane epididymal family member 3

increases expression

fenvalerate results in increased expression of TEDDM3 mRNA

NCBI chr11:79,988,984...79,990,143
Ensembl chr11:79,989,077...79,989,961

G

tektin 3

increases expression

fenvalerate results in increased expression of TEKT3 mRNA

NCBI chr10:47,729,635...47,763,589
Ensembl chr10:47,729,635...47,763,588

G

teneurin transmembrane protein 2

increases expression

fenvalerate results in increased expression of TENM2 mRNA

NCBI chr10:20,480,662...21,706,415
Ensembl chr10:20,481,854...21,705,597

G

teneurin transmembrane protein 3

increases expression

fenvalerate results in increased expression of TENM3 mRNA

NCBI chr16:41,251,909...43,978,594
Ensembl chr16:41,252,182...43,978,594

G

tet methylcytosine dioxygenase 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TET1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TET1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TET1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr20:25,761,042...25,840,926
Ensembl chr20:25,768,120...25,833,052

G

testis expressed 14, intercellular bridge forming factor

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TEX14 protein

NCBI chr10:72,231,766...72,356,938
Ensembl chr10:72,231,801...72,355,805

G

testis expressed 46

increases expression

fenvalerate results in increased expression of TEX46 mRNA

NCBI chr 5:148,849,307...148,853,742
Ensembl chr 5:148,849,307...148,853,742

G

transcription factor CP2

increases expression

fenvalerate results in increased expression of TFCP2 mRNA

NCBI chr 7:131,616,777...131,658,995
Ensembl chr 7:131,616,785...131,658,939

G

transcription factor binding to IGHM enhancer 3

increases expression

fenvalerate results in increased expression of TFE3 mRNA

NCBI chr X:14,729,547...14,742,830
Ensembl chr X:14,729,550...14,742,571

G

trefoil factor 1

increases expression

fenvalerate results in increased expression of TFF1 mRNA

PMID:10064545 PMID:12396874

NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597

G

transforming growth factor, beta 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TGFB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TGFB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TGFB1 protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TGFB1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847

G

transforming growth factor, beta 2

multiple interactions

[fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of TGFB2 mRNA

NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405

G

transglutaminase 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TGM1 protein

NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523

G

trans-golgi network protein 2

increases expression
multiple interactions

fenvalerate results in increased expression of TGOLN2 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TGOLN2 protein

PMID:30307764 PMID:34896426

NCBI chr 4:104,663,356...104,671,208
Ensembl chr 4:104,663,353...104,671,164

G

tyrosine hydroxylase

multiple interactions
decreases expression

3-methyladenine inhibits the reaction [fenvalerate results in decreased expression of TH protein]; SB 203580 inhibits the reaction [fenvalerate results in decreased expression of TH protein]

NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767

G

THAP domain containing 3

increases expression

fenvalerate results in increased expression of THAP3 mRNA

NCBI chr 5:162,488,480...162,494,149
Ensembl chr 5:162,488,480...162,494,149

G

thrombomodulin

increases expression

fenvalerate results in increased expression of THBD mRNA

NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193

G

thrombospondin 3

increases expression

fenvalerate results in increased expression of THBS3 mRNA

NCBI chr 2:174,621,788...174,633,594
Ensembl chr 2:174,621,812...174,633,594

G

THO complex subunit 2

increases expression

fenvalerate results in increased expression of THOC2 mRNA

NCBI chr X:120,634,966...120,749,569
Ensembl chr X:120,634,968...120,749,513

G

thimet oligopeptidase 1

decreases expression

fenvalerate results in decreased expression of THOP1 protein

NCBI chr 7:8,632,911...8,645,339
Ensembl chr 7:8,632,916...8,645,275

G

thyroid hormone receptor alpha

decreases expression

fenvalerate results in decreased expression of THRA mRNA
fenvalerate results in decreased expression of THRA protein

PMID:28369636 PMID:32693020 PMID:34358930

NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936

G

thyroid hormone receptor beta

decreases expression
decreases localization

fenvalerate results in decreased expression of THRB mRNA
fenvalerate results in decreased localization of THRB protein
fenvalerate results in decreased expression of THRB protein

PMID:28369636 PMID:32693020

NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916

G

Thy-1 cell surface antigen

decreases expression
multiple interactions

fenvalerate results in decreased expression of THY1 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of THY1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of THY1 mRNA

PMID:30307764 PMID:33051911 PMID:33396045

NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659

G

TIA1 cytotoxic granule-associated RNA binding protein

increases expression

fenvalerate results in increased expression of TIA1 mRNA

NCBI chr 4:118,852,765...118,883,252
Ensembl chr 4:118,852,837...118,880,586

G

tigger transposable element derived 5

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TIGD5 protein

NCBI chr 7:107,596,724...107,599,243
Ensembl chr 7:107,596,724...107,599,243

G

TIMP metallopeptidase inhibitor 2

increases expression

fenvalerate results in increased expression of TIMP2 mRNA

NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611

G

thymidine kinase 1

increases expression

fenvalerate results in increased expression of TK1 mRNA

NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920

G

TLC domain containing 3B

increases expression

fenvalerate results in increased expression of TLCD3B mRNA

NCBI chr 1:181,421,104...181,439,744
Ensembl chr 1:181,422,830...181,439,743

G

tousled-like kinase 2

increases expression

fenvalerate results in increased expression of TLK2 mRNA

NCBI chr10:90,154,449...90,248,562
Ensembl chr10:90,156,813...90,248,561

G

transmembrane channel-like 8

increases expression

fenvalerate results in increased expression of TMC8 mRNA

NCBI chr10:103,000,038...103,010,601
Ensembl chr10:102,998,402...103,010,590

G

transmembrane and coiled-coil domain family 1

increases expression

fenvalerate results in increased expression of TMCC1 mRNA

NCBI chr 4:149,069,252...149,239,585
Ensembl chr 4:149,069,260...149,239,620

G

transmembrane and coiled-coil domain family 3

increases expression

fenvalerate results in increased expression of TMCC3 mRNA

NCBI chr 7:28,893,972...29,171,935
Ensembl chr 7:28,893,967...29,171,926

G

transmembrane and coiled-coil domains 5A

increases expression

fenvalerate results in increased expression of TMCO5A mRNA

NCBI chr 3:103,732,936...103,746,242
Ensembl chr 3:103,732,945...103,746,249

G

transmembrane p24 trafficking protein 1

decreases expression

fenvalerate results in decreased expression of TMED1 mRNA

NCBI chr 8:20,059,937...20,063,567
Ensembl chr 8:20,059,892...20,063,677

G

transmembrane protein 116

increases expression

fenvalerate results in increased expression of TMEM116 mRNA

NCBI chr12:35,021,912...35,089,409
Ensembl chr12:35,041,572...35,089,430

G

transmembrane protein 117

decreases expression

fenvalerate results in decreased expression of TMEM117 mRNA

NCBI chr 7:125,757,591...126,219,692
Ensembl chr 7:125,757,591...126,219,690

G

transmembrane protein 120B

increases expression

fenvalerate results in increased expression of TMEM120B mRNA

NCBI chr12:33,447,441...33,487,257
Ensembl chr12:33,446,660...33,487,200

G

transmembrane protein 132E

increases expression

fenvalerate results in increased expression of TMEM132E mRNA

NCBI chr10:67,330,863...67,386,790
Ensembl chr10:67,330,751...67,386,789

G

transmembrane protein 178B

increases expression

fenvalerate results in increased expression of TMEM178B mRNA

NCBI chr 4:68,659,425...69,035,690
Ensembl chr 4:68,657,343...69,035,690

G

transmembrane protein 200C

increases expression

fenvalerate results in increased expression of TMEM200C mRNA

NCBI chr 9:108,806,063...108,811,901
Ensembl chr 9:108,805,787...108,812,226

G

transmembrane protein 237

increases expression

fenvalerate results in increased expression of TMEM237 mRNA

NCBI chr 9:60,533,348...60,569,253
Ensembl chr 9:60,535,233...60,572,567

G

transmembrane protein 52

increases expression

fenvalerate results in increased expression of TMEM52 mRNA

NCBI chr 5:166,048,669...166,050,423
Ensembl chr 5:166,046,565...166,050,433

G

transmembrane protein 59-like

increases expression

fenvalerate results in increased expression of TMEM59L mRNA

NCBI chr16:18,941,370...18,945,381
Ensembl chr16:18,941,567...18,945,381

G

transmembrane protein 63c

increases expression

fenvalerate results in increased expression of TMEM63C mRNA

NCBI chr 6:106,667,389...106,738,778
Ensembl chr 6:106,672,934...106,736,990

G

transmembrane protein 89

increases expression

fenvalerate results in increased expression of TMEM89 mRNA

NCBI chr 8:109,571,377...109,572,271
Ensembl chr 8:109,571,377...109,572,271

G

transmembrane inner ear

increases expression

fenvalerate results in increased expression of TMIE mRNA

NCBI chr 8:110,849,713...110,864,803
Ensembl chr 8:110,850,034...110,864,803

G

tropomodulin 4

increases expression

fenvalerate results in increased expression of TMOD4 mRNA

NCBI chr 2:182,695,709...182,700,540
Ensembl chr 2:182,695,709...182,700,540

G

tenascin C

increases expression

fenvalerate results in increased expression of TNC mRNA

NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624

G

tumor necrosis factor

increases expression

fenvalerate results in increased expression of TNF mRNA

NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629

G

TNF receptor superfamily member 11B

increases expression

fenvalerate results in increased expression of TNFRSF11B mRNA

NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538

G

TNF receptor superfamily member 21

increases expression

fenvalerate results in increased expression of TNFRSF21 mRNA

NCBI chr 9:17,879,156...17,954,085
Ensembl chr 9:17,879,156...17,954,085

G

tankyrase 1 binding protein 1

decreases expression

fenvalerate results in decreased expression of TNKS1BP1 mRNA

NCBI chr 3:70,135,335...70,160,071
Ensembl chr 3:70,137,837...70,160,038

G

troponin C1, slow skeletal and cardiac type

increases expression

fenvalerate results in increased expression of TNNC1 mRNA

NCBI chr16:6,400,801...6,405,634
Ensembl chr16:6,402,171...6,405,634

G

troponin T2, cardiac type

increases expression

fenvalerate results in increased expression of TNNT2 mRNA

NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388

G

transition protein 1

increases expression
multiple interactions

fenvalerate results in increased expression of TNP1 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TNP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TNP1 mRNA

PMID:30307764 PMID:33051911 PMID:33396045

NCBI chr 9:74,594,463...74,595,072
Ensembl chr 9:74,594,466...74,595,274

G

transition protein 2

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of TNP2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TNP2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TNP2 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr10:4,879,812...4,880,540
Ensembl chr10:4,879,812...4,880,538

G

trinucleotide repeat containing adaptor 6A

increases expression

fenvalerate results in increased expression of TNRC6A mRNA

NCBI chr 1:177,561,898...177,715,669
Ensembl chr 1:177,646,030...177,715,660

G

TOX high mobility group box family member 3

increases expression

fenvalerate results in increased expression of TOX3 mRNA

NCBI chr19:16,648,338...16,757,151
Ensembl chr19:16,648,342...16,757,148

G

tumor protein p53

increases expression

fenvalerate results in increased expression of TP53 mRNA; fenvalerate results in increased expression of TP53 protein

NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524

G

Tp53 tumor protein p53 regulating kinase A

increases expression

fenvalerate results in increased expression of TP53RK mRNA

NCBI chr 3:154,219,672...154,224,841
Ensembl chr 3:154,220,851...154,224,328

G

tubulin polyglutamylase complex subunit 1

increases expression

fenvalerate results in increased expression of TPGS1 mRNA

NCBI chr 7:10,029,842...10,035,764
Ensembl chr 7:10,029,854...10,035,764

G

tubulin polymerization-promoting protein family member 2

decreases expression

fenvalerate results in decreased expression of TPPP2 protein

NCBI chr15:24,614,284...24,627,123
Ensembl chr15:24,614,006...24,618,967

G

tyrosylprotein sulfotransferase 1

increases expression

fenvalerate results in increased expression of TPST1 mRNA

NCBI chr12:26,544,536...26,605,706
Ensembl chr12:26,544,536...26,605,704

G

transformer 2 alpha

increases expression

fenvalerate results in increased expression of TRA2A mRNA

NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:78,220,883...78,239,712

G

TraB domain containing 2B

increases expression

fenvalerate results in increased expression of TRABD2B mRNA

NCBI chr 5:127,941,198...128,158,946
Ensembl chr 5:127,941,114...128,143,747

G

TNF receptor-associated protein 1

decreases expression

fenvalerate results in decreased expression of TRAP1 protein

NCBI chr10:11,464,882...11,498,931
Ensembl chr10:11,464,821...11,498,981

G

T cell receptor associated transmembrane adaptor 1

increases expression

fenvalerate results in increased expression of TRAT1 mRNA

NCBI chr11:52,035,750...52,077,805
Ensembl chr11:52,035,750...52,077,805

G

tRNA aspartic acid methyltransferase 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of DNMT2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TRDMT1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRDMT1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of DNMT2 mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr17:76,601,966...76,646,104
Ensembl chr17:76,610,543...76,645,439

G

triadin

increases expression

fenvalerate results in increased expression of TRDN mRNA

NCBI chr 1:23,955,651...24,410,494
Ensembl chr 1:23,955,651...24,410,595

G

trehalase

increases expression

fenvalerate results in increased expression of TREH mRNA

NCBI chr 8:44,990,182...45,003,881
Ensembl chr 8:44,990,182...45,003,540

G

thyrotropin releasing hormone

increases expression

fenvalerate results in increased expression of TRH mRNA

NCBI chr 4:124,742,111...124,777,094
Ensembl chr 4:124,742,111...124,744,637

G

thyrotropin releasing hormone receptor

increases expression

fenvalerate results in increased expression of TRHR mRNA

NCBI chr 7:75,348,672...75,393,310
Ensembl chr 7:75,348,672...75,393,309

G

tripartite motif-containing 16

increases expression

fenvalerate results in increased expression of TRIM16 mRNA

NCBI chr10:47,485,982...47,509,010
Ensembl chr10:47,486,297...47,551,907

G

tripartite motif-containing 35

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRIM35 protein

NCBI chr15:40,493,697...40,510,246
Ensembl chr15:40,493,755...40,510,240

G

tripartite motif-containing 47

decreases expression

fenvalerate results in decreased expression of TRIM47 mRNA

NCBI chr10:101,337,573...101,342,044
Ensembl chr10:101,337,573...101,342,044

G

tripartite motif-containing 9

increases expression

fenvalerate results in increased expression of TRIM9 mRNA

NCBI chr 6:88,756,824...88,856,588
Ensembl chr 6:88,757,303...88,856,542

G

tRNA methyltransferase 10A

increases expression

fenvalerate results in increased expression of TRMT10A mRNA

NCBI chr 2:226,669,445...226,684,166
Ensembl chr 2:226,669,832...226,684,151

G

tRNA methyltransferase 9B (putative)

increases expression

fenvalerate results in increased expression of TRMT9B mRNA

NCBI chr16:55,740,551...55,792,198
Ensembl chr16:55,743,018...55,792,144

G

transient receptor potential cation channel, subfamily A, member 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPA1 protein

NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570

G

transient receptor potential cation channel, subfamily C, member 1

increases expression
multiple interactions

fenvalerate results in increased expression of TRPC1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPC1 protein

PMID:30307764 PMID:34896426

NCBI chr 8:96,263,322...96,314,220
Ensembl chr 8:96,263,329...96,314,276

G

transient receptor potential cation channel, subfamily C, member 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPC3 protein

NCBI chr 2:119,481,313...119,619,333
Ensembl chr 2:119,481,400...119,558,855

G

transient receptor potential cation channel, subfamily C, member 4

increases expression
multiple interactions

fenvalerate results in increased expression of TRPC4 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPC4 protein

PMID:30307764 PMID:34896426

NCBI chr 2:138,307,676...138,476,856
Ensembl chr 2:138,308,084...138,476,768

G

transient receptor potential cation channel, subfamily M, member 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TRPM2 mRNA

PMID:33396045 PMID:34896426

NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181

G

transient receptor potential cation channel, subfamily M, member 8

increases expression

fenvalerate results in increased expression of TRPM8 mRNA

NCBI chr 9:88,897,039...88,990,167
Ensembl chr 9:88,903,880...88,988,552

G

transcriptional repressor GATA binding 1

increases expression

fenvalerate results in increased expression of TRPS1 mRNA

NCBI chr 7:81,916,668...82,142,733
Ensembl chr 7:81,921,601...82,141,905

G

transient receptor potential cation channel, subfamily V, member 1

increases expression

fenvalerate results in increased expression of TRPV1 mRNA

NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513

G

thyroid stimulating hormone subunit beta

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TSHB protein

NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559

G

translocator protein

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of TSPO mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TSPO mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TSPO mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of TSPO mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450

G

testis specific protein, Y-linked 1

increases expression

fenvalerate results in increased expression of TSPY1 mRNA

G

TSPY-like 4

increases expression

fenvalerate results in increased expression of TSPYL4 mRNA

NCBI chr20:38,098,756...38,100,752
Ensembl chr20:38,098,677...38,103,053

G

tetratricopeptide repeat domain 39B

increases expression

fenvalerate results in increased expression of TTC39B mRNA

NCBI chr 5:97,603,329...97,708,103
Ensembl chr 5:97,609,392...97,736,270

G

tetratricopeptide repeat domain 7B

increases expression

fenvalerate results in increased expression of TTC7B mRNA

NCBI chr 6:119,587,389...119,799,167
Ensembl chr 6:119,587,390...119,799,330

G

tetratricopeptide repeat domain 9

increases expression

fenvalerate results in increased expression of TTC9 mRNA

NCBI chr 6:101,333,274...101,368,110
Ensembl chr 6:101,333,141...101,368,110

G

TELO2 interacting protein 2

increases expression

fenvalerate results in increased expression of TTI2 mRNA

NCBI chr16:60,980,665...60,988,587
Ensembl chr16:60,979,039...60,988,569

G

tweety family member 1

increases expression

fenvalerate results in increased expression of TTYH1 mRNA

NCBI chr 1:70,053,312...70,071,872
Ensembl chr 1:70,053,324...70,071,845

G

tubulin, alpha 1C

increases expression

fenvalerate results in increased expression of TUBA1C protein

NCBI chr 7:130,192,050...130,199,655
Ensembl chr 7:130,192,016...130,199,647
Ensembl chr X:130,192,016...130,199,647

G

tubulin, beta 4B class IVb

decreases expression

fenvalerate results in decreased expression of TUBB4B protein

NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296

G

tubulin, epsilon 1

increases expression

fenvalerate results in increased expression of TUBE1 mRNA

NCBI chr20:42,552,390...42,570,324
Ensembl chr20:42,552,437...42,570,314

G

Tu translation elongation factor, mitochondrial

increases expression

fenvalerate results in increased expression of TUFM mRNA

NCBI chr 1:181,073,788...181,077,395
Ensembl chr 1:181,073,788...181,077,395

G

TUB like protein 1

increases expression

fenvalerate results in increased expression of TULP1 mRNA

NCBI chr20:6,412,170...6,424,103
Ensembl chr20:6,412,171...6,424,073

G

TYRO3 protein tyrosine kinase

decreases expression

fenvalerate results in decreased expression of TYRO3 mRNA

NCBI chr 3:106,777,686...106,797,154
Ensembl chr 3:106,777,635...106,797,142

G

ubiquitin-like modifier activating enzyme 7

increases expression

fenvalerate results in increased expression of UBA7 mRNA

NCBI chr 8:108,665,289...108,674,097
Ensembl chr 8:108,665,292...108,674,099

G

ubiquitin associated protein 1-like

increases expression

fenvalerate results in increased expression of UBAP1L mRNA

NCBI chr 8:65,877,488...65,897,593
Ensembl chr 8:65,884,729...65,897,593

G

ubiquitin-conjugating enzyme E2B

increases expression

fenvalerate results in increased expression of UBE2B mRNA

NCBI chr10:36,248,434...36,263,379
Ensembl chr10:36,248,438...36,264,665

G

ubiquitin-conjugating enzyme E2N

increases expression

fenvalerate results in increased expression of UBE2N protein

NCBI chr 7:30,154,330...30,184,373
Ensembl chr 7:30,154,616...30,184,355

G

ubiquitin conjugating enzyme E2 QL1

increases expression

fenvalerate results in increased expression of UBE2QL1 mRNA

NCBI chr 1:33,548,814...33,589,174
Ensembl chr 1:33,548,814...33,589,174

G

ubiquitin conjugating enzyme E2 U

increases expression

fenvalerate results in increased expression of UBE2U mRNA

NCBI chr 5:115,118,234...115,187,296
Ensembl chr 5:115,118,495...115,186,874

G

ubiquitin protein ligase E3D

decreases expression

fenvalerate results in decreased expression of UBE3D mRNA

NCBI chr 8:87,245,503...87,413,104
Ensembl chr 8:87,245,589...87,413,057

G

ubiquitination factor E4A

increases expression

fenvalerate results in increased expression of UBE4A mRNA

NCBI chr 8:45,236,022...45,278,129
Ensembl chr 8:45,236,026...45,278,038

G

ubiquilin 3

increases expression

fenvalerate results in increased expression of UBQLN3 mRNA

NCBI chr 1:158,604,629...158,607,318
Ensembl chr 1:158,604,355...158,607,389

G

ubiquitin protein ligase E3 component n-recognin 4

increases expression

fenvalerate results in increased expression of UBR4 mRNA

NCBI chr 5:151,635,825...151,743,931
Ensembl chr 5:151,635,868...151,743,784

G

UBX domain protein 11

increases expression

fenvalerate results in increased expression of UBXN11 mRNA

NCBI chr 5:146,329,666...146,353,529
Ensembl chr 5:146,329,842...146,353,526

G

ubiquitin C-terminal hydrolase L1

increases expression

fenvalerate results in increased expression of UCHL1 mRNA

NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590

G

upper zone of growth plate and cartilage matrix associated

increases expression

fenvalerate results in increased expression of UCMA mRNA

NCBI chr17:73,293,977...73,303,709
Ensembl chr17:73,293,978...73,303,611

G

UDP-glucose glycoprotein glucosyltransferase 2

increases expression

fenvalerate results in increased expression of UGGT2 mRNA

NCBI chr15:96,074,557...96,239,365
Ensembl chr15:96,074,564...96,237,806

G

UDP glycosyltransferase 8

increases expression

fenvalerate results in increased expression of UGT8 mRNA

NCBI chr 2:214,264,483...214,332,769
Ensembl chr 2:214,264,483...214,332,660

G

unc-13 homolog B

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of UNC13B protein

NCBI chr 5:57,288,999...57,504,110
Ensembl chr 5:57,289,227...57,502,926

G

unc-13 homolog C

increases expression

fenvalerate results in increased expression of UNC13C mRNA

NCBI chr 8:74,247,026...74,697,629
Ensembl chr 8:74,247,899...74,673,223

G

unc-5 netrin receptor B

increases expression

fenvalerate results in increased expression of UNC5B mRNA

NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537

G

unc-5 netrin receptor D

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of UNC5D protein

NCBI chr16:62,860,119...63,406,932
Ensembl chr16:62,860,174...63,401,143

G

unc-79 homolog, NALCN channel complex subunit

increases expression

fenvalerate results in increased expression of UNC79 mRNA

NCBI chr 6:122,082,369...122,327,641
Ensembl chr 6:122,080,308...122,327,591

G

uroplakin 2

increases expression

fenvalerate results in increased expression of UPK2 mRNA

NCBI chr 8:44,779,198...44,781,190
Ensembl chr 8:44,779,198...44,781,190

G

ubiquinol cytochrome c reductase core protein 2

increases expression

fenvalerate results in increased expression of UQCRC2 mRNA

NCBI chr 1:175,167,933...175,198,499
Ensembl chr 1:175,167,894...175,199,453

G

ubiquitin specific peptidase 11

increases expression

fenvalerate results in increased expression of USP11 mRNA

NCBI chr X:1,473,349...1,489,520
Ensembl chr X:1,473,350...1,489,520

G

ubiquitin specific peptidase 25

increases expression

fenvalerate results in increased expression of USP25 mRNA

NCBI chr11:15,603,654...15,711,356
Ensembl chr11:15,603,881...15,711,348

G

ubiquitin specific peptidase 31

increases expression

fenvalerate results in increased expression of USP31 mRNA

NCBI chr 1:176,211,334...176,278,183
Ensembl chr 1:176,215,889...176,278,355

G

ubiquitin specific peptidase 4

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of USP4 protein

NCBI chr 8:109,035,402...109,079,382
Ensembl chr 8:109,036,099...109,080,427

G

ubiquitin specific peptidase 49

increases expression

fenvalerate results in increased expression of USP49 mRNA

NCBI chr 9:13,305,640...13,366,132
Ensembl chr 9:13,308,178...13,366,132

G

USP6 N-terminal like

increases expression

fenvalerate results in increased expression of USP6NL mRNA

NCBI chr17:71,828,433...71,956,878
Ensembl chr17:71,830,469...71,956,027

G

utrophin

increases expression

fenvalerate results in increased expression of UTRN mRNA

NCBI chr 1:6,720,854...7,224,313
Ensembl chr 1:6,722,594...7,224,313

G

vesicle-associated membrane protein 1

increases expression

fenvalerate results in increased expression of VAMP1 mRNA

NCBI chr 4:158,012,634...158,019,350
Ensembl chr 4:158,012,663...158,019,349

G

vav guanine nucleotide exchange factor 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of VAV1 protein

NCBI chr 9:2,161,985...2,209,951
Ensembl chr 9:2,157,900...2,208,937

G

ventral anterior homeobox 2

increases expression

fenvalerate results in increased expression of VAX2 mRNA

NCBI chr 4:116,195,528...116,219,597
Ensembl chr 4:116,195,528...116,219,594

G

versican

increases expression

fenvalerate results in increased expression of VCAN mRNA

NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637

G

valosin-containing protein

decreases expression

fenvalerate results in decreased expression of VCP protein

NCBI chr 5:57,210,167...57,229,571
Ensembl chr 5:57,210,168...57,229,571

G

voltage-dependent anion channel 2

decreases expression

fenvalerate results in decreased expression of VDAC2 protein

NCBI chr15:2,462,877...2,476,802
Ensembl chr15:2,463,056...2,476,553

G

vitamin D receptor

increases expression

fenvalerate results in increased expression of VDR mRNA

NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677

G

vascular endothelial growth factor A

decreases expression

fenvalerate results in decreased expression of VEGFA mRNA

NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641

G

ventricular zone expressed PH domain-containing 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of VEPH1 protein

NCBI chr 2:150,291,379...150,537,491
Ensembl chr 2:150,296,573...150,537,266

G

vimentin

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of VIM mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of VIM mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of VIM mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187

G

very low density lipoprotein receptor

increases expression

fenvalerate results in increased expression of VLDLR mRNA

NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920

G

ischemia related factor vof-16

increases expression

fenvalerate results in increased expression of VOF16 mRNA

NCBI chr 8:41,953,062...41,955,169

G

vomeronasal 1 receptor 100

increases expression

fenvalerate results in increased expression of VOM1R100 mRNA

NCBI chr 4:122,468,150...122,471,495
Ensembl chr 4:122,462,283...122,473,701

G

vomeronasal 1 receptor 101

increases expression

fenvalerate results in increased expression of VOM1R101 mRNA

NCBI chr 4:122,499,102...122,500,235

G

vomeronasal 1 receptor 90

increases expression

fenvalerate results in increased expression of VOM1R90 mRNA

NCBI chr 4:122,139,053...122,148,056
Ensembl chr 4:122,137,880...122,148,193

G

vomeronasal 2 receptor, 27

increases expression

fenvalerate results in increased expression of VOM2R27 mRNA

NCBI chr 1:66,102,631...66,137,116
Ensembl chr 1:66,102,632...66,137,281

G

vomeronasal 2 receptor, 31

increases expression

fenvalerate results in increased expression of VOM2R31 mRNA

NCBI chr 1:71,183,055...71,211,273
Ensembl chr 1:71,185,371...71,211,267
Ensembl chr 1:71,185,371...71,211,267

G

vomeronasal 2 receptor, 40

increases expression

fenvalerate results in increased expression of VOM2R40 mRNA

NCBI chr 1:139,409,429...139,457,552
Ensembl chr 1:139,409,430...139,457,552

G

vacuolar protein sorting 25 homolog

increases expression

fenvalerate results in increased expression of VPS25 mRNA

NCBI chr10:86,196,062...86,201,606
Ensembl chr10:86,188,812...86,231,829

G

V-set and immunoglobulin domain containing 8

increases expression

fenvalerate results in increased expression of VSIG8 mRNA

NCBI chr13:85,023,177...85,031,364
Ensembl chr13:85,023,177...85,031,364

G

visinin-like 1

increases expression

fenvalerate results in increased expression of VSNL1 mRNA

NCBI chr 6:34,038,641...34,159,479
Ensembl chr 6:34,038,642...34,159,479

G

von Willebrand factor C domain containing 2

increases expression

fenvalerate results in increased expression of VWC2 mRNA

NCBI chr14:85,683,670...85,825,068
Ensembl chr14:85,684,414...85,818,524

G

von Willebrand factor

decreases expression

fenvalerate results in decreased expression of VWF mRNA

NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539

G

WASH complex subunit 2C

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WASHC2 protein

NCBI chr 4:149,267,851...149,325,850
Ensembl chr 4:149,267,924...149,325,851

G

WD repeat domain 12

decreases expression

fenvalerate results in decreased expression of WDR12 mRNA

NCBI chr 9:61,475,498...61,502,762
Ensembl chr 9:61,475,517...61,502,469

G

WD repeat domain 26

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WDR26 protein

NCBI chr13:92,930,282...92,972,061
Ensembl chr13:92,930,285...92,977,295

G

WD repeat domain 35

increases expression

fenvalerate results in increased expression of WDR35 mRNA

NCBI chr 6:31,771,315...31,831,450
Ensembl chr 6:31,771,360...31,831,029

G

WD repeat domain 44

increases expression

fenvalerate results in increased expression of WDR44 mRNA

NCBI chr X:114,481,890...114,587,307
Ensembl chr X:114,482,006...114,587,224

G

WD repeat domain 81

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WDR81 protein

NCBI chr10:60,281,969...60,295,374
Ensembl chr10:60,281,972...60,295,296

G

WD repeat domain 89

increases expression

fenvalerate results in increased expression of WDR89 mRNA

NCBI chr 6:94,350,468...94,382,085
Ensembl chr 6:94,350,303...94,382,026

G

WAP four-disulfide core domain 18

increases expression

fenvalerate results in increased expression of WFDC18 mRNA

NCBI chr10:68,588,818...68,590,972
Ensembl chr10:68,588,818...68,589,671

G

WAP four-disulfide core domain 5

increases expression

fenvalerate results in increased expression of WFDC5 mRNA

NCBI chr 3:152,849,025...152,854,868
Ensembl chr 3:152,849,025...152,854,904

G

Wnt family member 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WNT1 mRNA

NCBI chr 7:129,938,604...129,942,651
Ensembl chr 7:129,938,604...129,942,651

G

Wnt family member 10B

increases expression

fenvalerate results in increased expression of WNT10B mRNA

NCBI chr 7:129,922,088...129,927,892
Ensembl chr 7:129,922,088...129,927,892

G

Wnt family member 4

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of WNT4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of WNT4 mRNA

PMID:33051911 PMID:33396045

NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859

G

Wnt family member 6

increases expression

fenvalerate results in increased expression of WNT6 mRNA

NCBI chr 9:76,329,882...76,343,523
Ensembl chr 9:76,329,882...76,343,523

G

Wnt family member 7A

increases expression

fenvalerate results in increased expression of WNT7A mRNA

NCBI chr 4:123,863,108...123,908,981
Ensembl chr 4:123,863,108...123,908,981

G

WT1 transcription factor

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WT1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of WT1 mRNA

PMID:34896426 PMID:36053783

NCBI chr 3:91,566,540...91,613,653
Ensembl chr 3:91,567,001...91,613,643

G

WT1 interacting protein

increases expression

fenvalerate results in increased expression of WTIP mRNA

NCBI chr 1:86,731,214...86,764,939
Ensembl chr 1:86,731,265...86,765,014

G

WW and C2 domain containing 2

increases expression

fenvalerate results in increased expression of WWC2 mRNA

NCBI chr16:44,258,372...44,421,815
Ensembl chr16:44,258,372...44,421,812

G

WW domain containing E3 ubiquitin protein ligase 1

increases expression

fenvalerate results in increased expression of WWP1 mRNA

NCBI chr 5:33,092,379...33,185,887
Ensembl chr 5:33,098,494...33,186,046

G

X-linked inhibitor of apoptosis

multiple interactions
increases expression

[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of XIAP protein
fenvalerate results in increased expression of XIAP mRNA

PMID:28949029 PMID:30307764

NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700

G

Y box binding protein 2

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of YBX2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of YBX2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of YBX2 mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr10:54,659,719...54,665,371
Ensembl chr10:54,659,719...54,665,371

G

YdjC chitooligosaccharide deacetylase homolog

increases expression

fenvalerate results in increased expression of YDJC mRNA

NCBI chr11:83,832,177...83,844,691
Ensembl chr11:83,841,306...83,846,336

G

Yip1 domain family, member 3

decreases expression

fenvalerate results in decreased expression of YIPF3 mRNA

NCBI chr 9:14,730,289...14,735,644
Ensembl chr 9:14,730,284...14,735,641

G

yippee-like 1

increases expression

fenvalerate results in increased expression of YPEL1 mRNA

NCBI chr11:83,921,799...83,936,409

G

zinc finger and BTB domain containing 10

increases expression

fenvalerate results in increased expression of ZBTB10 mRNA

NCBI chr 2:92,475,254...92,509,892
Ensembl chr 2:92,479,014...92,512,515

G

zinc finger and BTB domain containing 16

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of ZBTB16 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ZBTB16 mRNA

PMID:33051911 PMID:33396045

NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011

G

zinc finger and BTB domain containing 20

increases expression

fenvalerate results in increased expression of ZBTB20 mRNA

NCBI chr11:57,052,129...57,791,214
Ensembl chr11:57,072,880...57,510,210

G

ZC3HAV1 like

increases expression

fenvalerate results in increased expression of ZC3HAV1L mRNA

NCBI chr 4:66,994,192...67,003,207
Ensembl chr 4:66,994,199...67,001,620

G

zinc finger CCHC-type containing 12

increases expression

fenvalerate results in increased expression of ZCCHC12 mRNA

NCBI chr X:115,433,444...115,436,691
Ensembl chr X:115,433,259...115,436,692

G

zinc finger homeobox 2

increases expression

fenvalerate results in increased expression of ZFHX2 mRNA

NCBI chr15:28,533,155...28,565,667
Ensembl chr15:28,533,156...28,565,128

G

zinc finger protein 148

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ZNF148 protein

NCBI chr11:67,276,455...67,385,803
Ensembl chr11:67,281,707...67,385,772

G

zinc finger protein 292

increases expression

fenvalerate results in increased expression of ZFP292 mRNA

NCBI chr 5:49,384,177...49,468,177
Ensembl chr 5:49,387,893...49,468,265

G

zinc finger protein 316

increases expression

fenvalerate results in increased expression of ZFP316 mRNA

NCBI chr12:11,294,445...11,313,841
Ensembl chr12:11,293,980...11,312,177

G

zinc finger protein 322a

decreases expression

fenvalerate results in decreased expression of ZFP322A mRNA

NCBI chr17:41,773,789...41,789,654
Ensembl chr17:41,773,782...41,790,078

G

zinc finger protein 335

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ZNF335 protein

NCBI chr 3:153,618,587...153,648,213
Ensembl chr 3:153,627,467...153,647,054

G

zinc finger protein 41

increases expression

fenvalerate results in increased expression of ZFP41 mRNA

NCBI chr 7:107,307,303...107,320,164
Ensembl chr 7:107,306,867...107,320,270

G

zinc finger protein 474

increases expression

fenvalerate results in increased expression of ZFP474 mRNA

NCBI chr18:46,041,224...46,071,502
Ensembl chr18:46,041,218...46,100,751

G

zinc finger protein 488

increases expression

fenvalerate results in increased expression of ZFP488 mRNA

NCBI chr16:9,283,039...9,293,681
Ensembl chr16:9,283,043...9,293,671

G

zinc finger protein 536

increases expression

fenvalerate results in increased expression of ZFP536 mRNA

NCBI chr 1:90,000,359...90,463,423
Ensembl chr 1:90,002,858...90,462,990

G

zinc finger protein 592

increases expression

fenvalerate results in increased expression of ZFP592 mRNA

NCBI chr 1:134,951,286...135,002,443
Ensembl chr 1:134,967,783...135,002,443

G

zinc finger protein 668

increases expression

fenvalerate results in increased expression of ZFP668 mRNA

NCBI chr 1:182,474,633...182,484,957
Ensembl chr 1:182,474,633...182,492,878

G

zinc finger protein 771

increases expression

fenvalerate results in increased expression of ZFP771 mRNA

NCBI chr 1:181,864,035...181,875,136
Ensembl chr 1:181,864,219...181,875,141

G

zinc finger protein 846

increases expression

fenvalerate results in increased expression of ZFP846 mRNA

NCBI chr 8:19,119,788...19,137,120
Ensembl chr 8:19,119,945...19,137,281

G

zinc finger protein, multitype 1

increases expression

fenvalerate results in increased expression of ZFPM1 mRNA

NCBI chr19:50,334,352...50,391,029
Ensembl chr19:50,334,682...50,390,591

G

zinc finger protein, multitype 2

increases expression

fenvalerate results in increased expression of ZFPM2 mRNA

NCBI chr 7:71,678,658...72,116,209
Ensembl chr 7:71,678,880...72,116,205

G

zinc finger FYVE-type containing 28

increases expression

fenvalerate results in increased expression of ZFYVE28 mRNA

NCBI chr14:76,468,424...76,554,039
Ensembl chr14:76,468,424...76,554,039

G

Zic family member 1

increases expression

fenvalerate results in increased expression of ZIC1 mRNA

NCBI chr 8:91,908,548...91,918,020
Ensembl chr 8:91,908,576...91,912,731

G

Zic family member 2

decreases expression

fenvalerate results in decreased expression of ZIC2 mRNA

NCBI chr15:99,576,697...99,581,522
Ensembl chr15:99,576,697...99,581,522

G

zinc finger MYM-type containing 3

increases expression

fenvalerate results in increased expression of ZMYM3 mRNA

NCBI chr X:66,528,585...66,544,234
Ensembl chr X:66,528,585...66,544,782

G

ZPR1 zinc finger

increases expression

fenvalerate results in increased expression of ZPR1 mRNA

NCBI chr 8:46,564,898...46,574,719
Ensembl chr 8:46,565,146...46,574,719

G

zinc finger ZZ-type and EF-hand domain containing 1

increases expression

fenvalerate results in increased expression of ZZEF1 mRNA

NCBI chr10:57,413,265...57,550,888
Ensembl chr10:57,411,149...57,549,568

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	19890
role	19839
biological role	19858
biochemical role	19566
metabolite	19533
eukaryotic metabolite	19358
plant metabolite	17979
isovaleric acid	1716
2-(4-chlorophenyl)-3-methylbutyric acid	1710
fenvalerate +	1714
Path 2
Term	Annotations
CHEBI ontology	19890
subatomic particle	19867
composite particle	19888
hadron	19888
baryon	19888
nucleon	19867
atomic nucleus	19888
atom	19888
main group element atom	19806
p-block element atom	19806
carbon group element atom	19746
carbon atom	19743
organic molecular entity	19743
heteroorganic entity	19502
organochalcogen compound	19264
organooxygen compound	19180
carbon oxoacid	18666
carboxylic acid	18663
monocarboxylic acid	18013
fatty acid	16829
short-chain fatty acid	15922
fatty acid 4:0	8226
butyric acid	6737
methylbutyric acid	2487
isovaleric acid	1716
2-(4-chlorophenyl)-3-methylbutyric acid	1710
fenvalerate +	1714

paths to the root